<!DOCTYPE html>
<!-- saved from url=(0061)https://jamanetwork.com/journals/jama/article-abstract/188381 -->
<html id="doc" lang="en" class="page-article js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths gr__jamanetwork_com" style=""><head id="Head1"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script async="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/analytics.js.download"></script><script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/sdk.js.download" async="" crossorigin="anonymous"></script><script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/gpt.js.download"></script><script type="text/javascript" async="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/ec.js.download"></script><script type="text/javascript" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/1.txt"></script><script type="text/javascript" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/1(1).txt"></script><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="format-detection" content="telephone=no">


    
    
    <link rel="shortcut icon" href="https://cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon.ico">
    <link rel="icon" type="image/png" href="https://cdn.jamanetwork.com/UI/app/img/favicons/jama/favicon-192x192.png" sizes="192x192">
    <link rel="apple-touch-icon" sizes="180x180" href="https://cdn.jamanetwork.com/UI/app/img/favicons/jama/apple-touch-icon-180x180.png">

    
    <meta http-equiv="X-UA-Compatible" content="IE=Edge">


    
    <link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/app.min.css">

    
    
    
    
    <link href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/chartist.min.css" type="text/css" rel="stylesheet">
    
    

    <meta property="og:title" content="Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat">
    <meta property="og:type" content="Article">
    <meta property="og:url" content="https://jamanetwork.com/journals/jama/fullarticle/188381">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f1.gif?Expires=2147483647&amp;Signature=T0KfzbG19l-~zD9B9XANH9XoLkAXZqYFzIOzHQNepqqfS1SW0G5aGuUsyiy5YJhGSe2hed54slu4nO5t9olnMZ~JFkGShmBHX6PFhF3cSWzGnFWdz3FqV~wIuKSd47~f6LlOkC1WPmubVhMKnfT4PelpXXHM5X2kNCw4k4jkyfbr5RoqNVCRpgFRcEa5iSbG8Elh4mKcSK9y3wS4rVPSlHRYPpbnIhPt00Ja5XuIEeN-tR0Wh1IMWKqF4Xxtd4JWn9gIJ4-3wK-GDn517C-SyXa8-WbTzRBB-ZcE~zXHh1o0VFJSc~b3kPI8nJbsBMLR-wBnaH7vaPU9XpQPJxNxZQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t1.png?Expires=2147483647&amp;Signature=ZjkRR1bCEyN0xKTzYQp91HmgwK~IL2Wn~HvV1nbN9na2n-SMAx7oDt8eD9qz-dj3-2wIdJ8lXwBtG4QI5J0vL9JlDSICoy3aNBsdNNJucSBTuI7L46OdzpAyJaXBG54-Xo3oO0XEh~UuksqK81X1JDxUJ~higzi6xEhsmTRrrYWmCtdDiOA2OGyaDfWfXYXkkSN5hP3KAlPS4QroWcb7djyxt2lxOvf81Nuiuktl7XgSmr1pulIbIFuBCwqbG9Xn79JHU~LWtqqg3ZNNbzHBLLDAInmANUkm~WcHpCodEU2cp75n9AnxNce2oE5c~FNdEIy0tzTVLHMnwaLrobA6gg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t2.png?Expires=2147483647&amp;Signature=ciSEzICv3U1y7XL6BzZkrbo~ZqqxIZIpNb2d5Yt8sUohRLx3yr6SXbyBl4QBK1~1sdlVC~MJpsXCe2Zy2ZnpkWvG2Y3g9dqXSvm56JR8PI6n9tgGPeyIs5jmepvLuJVUSZV67PYuff~j5tSKR-x0YQmPBP8DHoVuxIbdq887mZnOz76h46s43ugHpEoAhsifhX7pSkW0sxCPX4su1tCLBFFClI0J8F1pj-MENLUJzXd1niN834GU48BYw4EeuJZMjSifgX4tNRFkLuhWVvTRfRqntew6CZCtry-zllCFDadRbFTekdBOPGnHNcZhWeCOWk1KOalomfw1uZFPNEhyaA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f2.gif?Expires=2147483647&amp;Signature=tRZ5tIxBT7F2~GJC7Eiqqw-xlef8b2qQ7IRX1IVXuWAOpzEbmaFFvstCdPwIdcTfmzzAuFQ5lpBC0~bne0qg6SPv-vUDrFRQh~P8w61DICrpLr7oEyb~0RvlXMJYxObQx-42VPFyIGxnfnuN84HgIuSW76sdnY4XL-w8Hw9a3Gsk8ibMsCcuPPkmeHPoJLA0emU1-houEmSj~8qMy7HsjZCRrjHWIENEokTxpSlZ4nP7ZGn6rtoBcM4KdOcUX2pMulTdCndtewWqYgHuZ7zE-YgIvKCeConVcdGWr46CSJYusBRykzu615w2SJF6fzVGwEBO2SmZ-HGaeuTnyxXceg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t3.png?Expires=2147483647&amp;Signature=wESrFzDSOmQ5HKPu-pBqNgmL0cpUM1uFBdanq3v4g1SzHZFsIR-m1SRh~bxInFhxMEe99wozrqCVa5Rhc4Fegp1Uv2GjMctZfF~hVhoCTllU9whXhcbz0n50f7Tii-MWkH6Y79eJwvS-vcsXU-JQ1HS-bvyMgwbLAfkxoSCbgbISvEWRe23X6I-PRUG0ckvniihK~TklkLZIOPSjeHEh4~wHGqytHa4a1PDRmTS201ozHa-WgpTvpIWh-WkoGyYwhkMFIeGR2DRoiils1SM3lhVq7ySPd4gf8iWHWWPp-rMM4zK9XpopuPe8Y0ss272AwD4dIy9EIIHt6e6RUwxMUA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f3.gif?Expires=2147483647&amp;Signature=DI45E0nzmdj8cAWB7D4g2Hlg9jmkbYW5vPM8eOPbC3Qez2GseMjrNVOf-0XV16Y8I14xJcRBnu4XFwsoBdXEmFsqh818qZynZHtHrVHvsOntFZuuAeXzTIdzMkP~ELtREYU9zD~PQI5BlTwYUwei1PSkRlhkRPwa-PZGHbaW588uXEcLpaTxaUiBYkFRnhMK7IUvG0mChHLH9~GxPgS-S4oV1Sab5Z5lXB4xBneKK~BqOr0V~zsZigPqwY-ZwNX2RsJ4dmn9iU1gBQ5K8RfIC~NG6N8rpLyqude8PVGPg2QwZzrBUd2psc54nEZszmdFfVDH8OSxQvYr3nupGuNlxQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:image" content="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t4.png?Expires=2147483647&amp;Signature=iDC5gNvDA8BlGN85HQ--alMzzDFjyJLRp6~woHDCtBByrrDrtLVpNe~N0ABZ0Q21BZ-fR2OuIY~oaw~SxxzbGbX~l3JxQLXS7cBfTroHZ5DNpVGksUG8Fk1P3bVO4iO9Lbi6ZajP~YHjkv59wuWwBF9KzDi2wpA5EeXrw4aneX7w3E~~Nd5Mqm-JeyYnXH3OSPgyRocc1vN7UBmIMKr2BntPwQy84kN0rkyf56wzVvIp45EDJJXEEyyX-oiE45ituYAdyDoSALzdxWpmPfrzLYz7ecpc310z0kyVvRzfKzqon-XU3ywJs4y7NlS5RzWbLA1a~xNja~2Idvda556Cpg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA">
    <meta property="og:description" content="Context Orlistat, a gastrointestinal lipase
inhibitor that reduces dietary fat absorption by approximately 30%,
may promote weight loss and reduce cardiovascular risk factors.Objective To test the hypothesis that orlistat combined with
dietary intervention is more effective than placebo plus diet...">
        <meta property="fb:pages" content="87087958340">
        <meta property="fb:pages" content="117506346528">
        <meta property="fb:pages" content="97538728726">
        <meta property="fb:pages" content="120829458202">
        <meta property="fb:pages" content="114116793520">
        <meta property="fb:pages" content="100679858757">
        <meta property="fb:pages" content="100265333750">
        <meta property="fb:pages" content="234770525256">
        <meta property="fb:pages" content="98784919862">
        <meta property="fb:pages" content="124842870398">
        <meta property="fb:pages" content="759822190741773">
        <meta property="fb:pages" content="1648414928738217">
        <meta property="fb:pages" content="122228711814384">

    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:site" content="@JAMA_current">





<meta name="citation_author" content="Michael H. Davidson"><meta name="citation_author" content="Jonathan Hauptman"><meta name="citation_author" content="Mario DiGirolamo"><meta name="citation_author" content="John P. Foreyt"><meta name="citation_author" content="Charles H. Halsted"><meta name="citation_author" content="David Heber"><meta name="citation_author" content="Douglas C. Heimburger"><meta name="citation_author" content="Charles P. Lucas"><meta name="citation_author" content="David C. Robbins"><meta name="citation_author" content="Jain Chung"><meta name="citation_author" content="Steven B. Heymsfield"><meta name="citation_title" content="Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial"><meta name="citation_firstpage" content="235"><meta name="citation_lastpage" content="242"><meta name="citation_doi" content="10.1001/jama.281.3.235"><meta name="citation_keyword" content="obesity"><meta name="citation_keyword" content="orlistat"><meta name="citation_keyword" content="weight reduction"><meta name="citation_keyword" content="weight maintenance regimens"><meta name="citation_keyword" content="diet"><meta name="citation_abstract" content="ContextOrlistat, a gastrointestinal lipase
inhibitor that reduces dietary fat absorption by approximately 30%,
may promote weight loss and reduce cardiovascular risk factors.ObjectiveTo test the hypothesis that orlistat combined with
dietary intervention is more effective than placebo plus diet for
weight loss and maintenance over 2 years.DesignRandomized, double-blind, placebo-controlled study
conducted from October 1992 to October 1995.Setting and ParticipantsObese adults (body mass index
[weight in kilograms divided by the square of height in meters],
30-43 kg/m2) evaluated at 18 US research centers.InterventionSubjects received placebo plus a controlled-energy
diet during a 4-week lead-in. On study day 1, the diet was continued
and subjects were randomized to receive placebo 3 times a day or
orlistat, 120 mg 3 times a day, for 52 weeks. After 52 weeks, subjects
began a weight-maintenance diet, and the placebo group
(n=133) continued to receive placebo and
orlistat-treated subjects were rerandomized to receive placebo 3 times
a day (n=138), orlistat, 60 mg (n=152)
or 120 mg (n=153) 3 times a day, for an additional 52
weeks.Main Outcome MeasuresBody weight change and changes in blood
pressure and serum lipid, glucose, and insulin levels.ResultsA total of 1187 subjects entered the protocol, and 892
were randomly assigned on day 1 to double-blind treatment. For
intent-to-treat analysis, 223 placebo-treated subjects and 657
orlistat-treated subjects were evaluated. During the first year
orlistat-treated subjects lost more weight (mean±SEM,
8.76±0.37 kg) than placebo-treated subjects
(5.81±0.67 kg) (P&amp;lt;.001). Subjects treated
with orlistat, 120 mg 3 times a day, during year 1 and year 2 regained
less weight during year 2 (3.2±0.45 kg; 35.2% regain)
than those who received orlistat, 60 mg (4.26±0.57 kg;
51.3% regain), or placebo (5.63±0.42 kg; 63.4%
regain) in year 2 (P&amp;lt;.001). Treatment with orlistat, 120 mg
3 times a day, was associated with improvements in fasting low-density
lipoprotein cholesterol and insulin levels.ConclusionsTwo-year treatment with orlistat plus diet
significantly promotes weight loss, lessens weight regain, and improves
some obesity-related disease risk factors."><meta name="citation_journal_title" content="JAMA"><meta name="citation_journal_abbrev" content="JAMA"><meta name="citation_volume" content="281"><meta name="citation_issue" content="3"><meta name="citation_publication_date" content="1999/01/20"><meta name="citation_issn" content="0098-7484"><meta name="citation_publisher" content="American Medical Association"><meta name="citation_reference" content="citation_title=Overweight and obesity in the United States.;  citation_authors=Flegal  K; Carroll  M; Kuczmarski  R; Johnson  C;  citation_journal_title=Int J Obes Relat Metab Disord.;  citation_year=1998;  citation_volume=22;  citation_pages=38-47.; "><meta name="citation_reference" content="citation_title=Weighing the Options Criteria for Evaluating Weight-management Programs.;  citation_author=Thomas  PR;  citation_text=Washington, DC: National Academy Press; 1995.; "><meta name="citation_reference" content="citation_org=National Task Force on the Prevention and Treatment of Obesity; citation_title=Long-term pharmacotherapy in the management of obesity.;  citation_journal_title=JAMA.;  citation_year=1996;  citation_volume=276;  citation_pages=1907-1915.; "><meta name="citation_reference" content="citation_title=Obesity and heart disease.;  citation_author=Eckel  RH;  citation_journal_title=Circulation.;  citation_year=1997;  citation_volume=96;  citation_pages=3248-3250.; "><meta name="citation_reference" content="citation_title=Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance.;  citation_authors=Meigs  J; Nathan  D; Wilson  P; Cupples  L; Singer  D;  citation_journal_title=Ann Intern Med.;  citation_year=1998;  citation_volume=128;  citation_pages=524-533.; "><meta name="citation_reference" content="citation_title=Medical hazards of obesity.;  citation_author=Pi-Sunyer  FX;  citation_journal_title=Ann Intern Med.;  citation_year=1993;  citation_volume=19;  citation_pages=655-660.; "><meta name="citation_reference" content="citation_title=Health hazards of obesity.;  citation_author=Bray  GA;  citation_journal_title=Endocrinol Metab Clin North Am.;  citation_year=1996;  citation_volume=25;  citation_pages=907-919.; "><meta name="citation_reference" content="citation_title=Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.;  citation_authors=Drent  ML; Larsson  I; William-Olsson  T;  citation_journal_title=Int J Obes Relat Metab Disord.;  citation_year=1995;  citation_volume=19;  citation_pages=221-226.; "><meta name="citation_reference" content="citation_title=Beneficial health effects of modest weight loss.;  citation_author=Goldstein  DJ;  citation_journal_title=Int J Obes Relat Metab Disord.;  citation_year=1992;  citation_volume=16;  citation_pages=397-415.; "><meta name="citation_reference" content="citation_title=Intentional weight loss.;  citation_author=Williamson  D;  citation_journal_title=Int J Obes Relat Metab Disord.;  citation_year=1997;  citation_volume=21(suppl 1);  citation_pages=S14-S19.; "><meta name="citation_reference" content="citation_org=National Diabetes Data Group; citation_title=Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.;  citation_journal_title=Diabetes.;  citation_year=1979;  citation_volume=28;  citation_pages=1039-1057.; "><meta name="citation_reference" content="citation_title=Improving the quality of reporting of randomized controlled trials.;  citation_authors=Begg  C; Cho  M; Eastwood  S;  citation_journal_title=JAMA.;  citation_year=1996;  citation_volume=276;  citation_pages=637-639.; "><meta name="citation_reference" content="citation_title=Statistical Principles in Experimental Design.;  citation_author=Winer  BJ;  citation_text=2nd ed. New York, NY: McGraw-Hill Book Co; 1971.; "><meta name="citation_reference" content="citation_title=Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients.;  citation_authors=Sjöström  L; Rissanen  A; Andersen  T;  citation_journal_title=Lancet.;  citation_year=1998;  citation_volume=352;  citation_pages=167-173.; "><meta name="citation_reference" content="citation_title=Changes in energy expenditure resulting from altered body weight.;  citation_authors=Leibel  RL; Rosenbaum  M; Hirsch  J;  citation_journal_title=N Engl J Med.;  citation_year=1995;  citation_volume=332;  citation_pages=621-628.; "><meta name="citation_reference" content="citation_title=Evaluation of drugs for treating obesity.;  citation_author=Bray  G;  citation_journal_title=Obes Res.;  citation_year=1995;  citation_volume=3(suppl 4);  citation_pages=425S-434S.; "><meta name="citation_reference" content="citation_title=Sibutramine.;  citation_author=Lean  M;  citation_journal_title=Int J Obes Relat Metab Disord.;  citation_year=1997;  citation_volume=21(suppl 1);  citation_pages=S30-S36.; "><meta name="citation_reference" content="citation_title=Long-term weight control study, V (weeks 190 to 210).;  citation_authors=Weintraub  M; Sundaresan  PR; Schuster  B; Averbuch  M; Stein  EC; Byrne  L;  citation_journal_title=Clin Pharmacol Ther.;  citation_year=1992;  citation_volume=51;  citation_pages=615-618.; "><meta name="citation_reference" content="citation_title=Long-term weight control study: conclusions.;  citation_author=Weintraub  M;  citation_journal_title=Clin Pharmacol Ther.;  citation_year=1992;  citation_volume=51;  citation_pages=642-646.; "><meta name="citation_reference" content="citation_title=Lifestyle intervention in overweight individuals with a family history of diabetes.;  citation_authors=Wing  R; Venditti  E; Jakicic  J;  citation_journal_title=Diabetes Care.;  citation_year=1998;  citation_volume=21;  citation_pages=350-360.; "><meta name="citation_reference" content="citation_title=Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients.;  citation_authors=Wing  R; Blair  E; Bononi  P;  citation_journal_title=Diabetes Care.;  citation_year=1994;  citation_volume=17;  citation_pages=30-36.; "><meta name="citation_reference" content="citation_title=Mode of action of orlistat.;  citation_author=Guerciolini  R;  citation_journal_title=Int J Obes Relat Metab Disord.;  citation_year=1997;  citation_volume=21(suppl 3);  citation_pages=S12-S23.; "><meta name="citation_reference" content="citation_title=Atherogenic dyslipidemia and the metabolic syndrome.;  citation_author=Grundy  S;  citation_text=In: Gotto AJ, ed. Drugs Affecting Lipid Metabolism. Norwell, Mass: Kluwer Academic Publishers; 1996:237-247.; "><meta name="citation_reference" content="citation_title=Hyperinsulinemia as an independent risk factor for ischemic heart disease.;  citation_authors=Despres  J; Lamarche  B; Mauriege  P;  citation_journal_title=N Engl J Med.;  citation_year=1996;  citation_volume=334;  citation_pages=952-957.; "><meta name="citation_reference" content="citation_title=Hyperinsulinemia.;  citation_author=Landsberg  L;  citation_journal_title=Hypertension.;  citation_year=1992;  citation_volume=(suppl)19;  citation_pages=161-166.; "><meta name="citation_reference" content="citation_title=High attrition rates in commercial weight reduction patterns programs.;  citation_authors=Volkmar  FR; Stunkard  AJ; Woolston  J; Bailey  RA;  citation_journal_title=Arch Intern Med.;  citation_year=1981;  citation_volume=141;  citation_pages=426-428.; "><meta name="citation_reference" content="citation_org=Food and Drug Administration, Center for Drug Evaluation and Research; citation_title=NDA 20-766, Xenical (Orlistat).;  citation_text=Presented at: Endocrinologic and Metabolic Drugs Advisory Committee Meeting 69; March 1998; Gaithersburg, Md.; "><meta name="citation_reference" content="citation_title=Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers.;  citation_authors=Zhi  J; Melia  AT; Eggers  H; Joly  R; Patel  IH;  citation_journal_title=J Clin Pharmacol.;  citation_year=1995;  citation_volume=35;  citation_pages=1103-1108.; "><meta name="citation_reference" content="citation_title=Design and analysis of obesity treatment and prevention trials.;  citation_authors=Allison  DB; Cappelleri  JC; Carpenter  KM;  citation_text=In: Dalton S, ed. Overweight and Weight Management. Gaithersburg, Md: Aspen Publishers Inc; 1997:557-597.; "><meta name="citation_reference" content="citation_title=Intent-to-treat analysis for longitudinal studies with dropouts.;  citation_authors=Little  R; Yau  L;  citation_journal_title=Biometrics.;  citation_year=1996;  citation_volume=52;  citation_pages=1324-1333.; "><meta name="citation_fulltext_world_readable" content=""><meta name="citation_pdf_url" content="https://jamanetwork.com/journals/jama/articlepdf/188381/joc80835.pdf">

    
        <title>Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial. | Cardiology | JAMA | JAMA Network</title>    

    <meta name="description" content="ContextOrlistat, a gastrointestinal lipase
inhibitor that reduces dietary fat absorption by approximately 30%,
may promote weight loss and reduce cardiovascul">


    <link rel="canonical" href="https://jamanetwork.com/journals/jama/fullarticle/188381">



    
    <script type="text/javascript" async="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/analytics.js.download"></script><script async="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/gtm.js(1).download"></script><script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/config" type="text/javascript" async=""></script><script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/head.min.js.download"></script>
    
    
     <script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/hermes.js.download" type="text/javascript" async=""></script>  <!-- Optimizely script --> <script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/2785501806.js.download"></script> <!-- End Optimizely script -->    <meta class="foundation-data-attribute-namespace"><meta class="foundation-mq-xxlarge"><meta class="foundation-mq-xlarge-only"><meta class="foundation-mq-xlarge"><meta class="foundation-mq-large-only"><meta class="foundation-mq-large"><meta class="foundation-mq-medium-only"><meta class="foundation-mq-medium"><meta class="foundation-mq-small-only"><meta class="foundation-mq-small"><style></style><script id="altmetric-embed-js" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/altmetric_badges-71f30fc33c.download"></script><style type="text/css">.at-icon{fill:#fff;border:0}.at-icon-wrapper{display:inline-block;overflow:hidden}a .at-icon-wrapper{cursor:pointer}.at-rounded,.at-rounded-element .at-icon-wrapper{border-radius:12%}.at-circular,.at-circular-element .at-icon-wrapper{border-radius:50%}.addthis_32x32_style .at-icon{width:2pc;height:2pc}.addthis_24x24_style .at-icon{width:24px;height:24px}.addthis_20x20_style .at-icon{width:20px;height:20px}.addthis_16x16_style .at-icon{width:1pc;height:1pc}#at16lb{display:none;position:absolute;top:0;left:0;width:100%;height:100%;z-index:1001;background-color:#000;opacity:.001}#at_complete,#at_error,#at_share,#at_success{position:static!important}.at15dn{display:none}#at15s,#at16p,#at16p form input,#at16p label,#at16p textarea,#at_share .at_item{font-family:arial,helvetica,tahoma,verdana,sans-serif!important;font-size:9pt!important;outline-style:none;outline-width:0;line-height:1em}* html #at15s.mmborder{position:absolute!important}#at15s.mmborder{position:fixed!important;width:250px!important}#at15s{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);float:none;line-height:1em;margin:0;overflow:visible;padding:5px;text-align:left;position:absolute}#at15s a,#at15s span{outline:0;direction:ltr;text-transform:none}#at15s .at-label{margin-left:5px}#at15s .at-icon-wrapper{width:1pc;height:1pc;vertical-align:middle}#at15s .at-icon{width:1pc;height:1pc}.at4-icon{display:inline-block;background-repeat:no-repeat;background-position:top left;margin:0;overflow:hidden;cursor:pointer}.addthis_16x16_style .at4-icon,.addthis_default_style .at4-icon,.at4-icon,.at-16x16{width:1pc;height:1pc;line-height:1pc;background-size:1pc!important}.addthis_32x32_style .at4-icon,.at-32x32{width:2pc;height:2pc;line-height:2pc;background-size:2pc!important}.addthis_24x24_style .at4-icon,.at-24x24{width:24px;height:24px;line-height:24px;background-size:24px!important}.addthis_20x20_style .at4-icon,.at-20x20{width:20px;height:20px;line-height:20px;background-size:20px!important}.at4-icon.circular,.circular .at4-icon,.circular.aticon{border-radius:50%}.at4-icon.rounded,.rounded .at4-icon{border-radius:4px}.at4-icon-left{float:left}#at15s .at4-icon{text-indent:20px;padding:0;overflow:visible;white-space:nowrap;background-size:1pc;width:1pc;height:1pc;background-position:top left;display:inline-block;line-height:1pc}.addthis_vertical_style .at4-icon,.at4-follow-container .at4-icon{margin-right:5px}html>body #at15s{width:250px!important}#at15s.atm{background:none!important;padding:0!important;width:10pc!important}#at15s_inner{background:#fff;border:1px solid #fff;margin:0}#at15s_head{position:relative;background:#f2f2f2;padding:4px;cursor:default;border-bottom:1px solid #e5e5e5}.at15s_head_success{background:#cafd99!important;border-bottom:1px solid #a9d582!important}.at15s_head_success a,.at15s_head_success span{color:#000!important;text-decoration:none}#at15s_brand,#at15sptx,#at16_brand{position:absolute}#at15s_brand{top:4px;right:4px}.at15s_brandx{right:20px!important}a#at15sptx{top:4px;right:4px;text-decoration:none;color:#4c4c4c;font-weight:700}#at15sptx:hover{text-decoration:underline}#at16_brand{top:5px;right:30px;cursor:default}#at_hover{padding:4px}#at_hover .at_item,#at_share .at_item{background:#fff!important;float:left!important;color:#4c4c4c!important}#at_share .at_item .at-icon-wrapper{margin-right:5px}#at_hover .at_bold{font-weight:700;color:#000!important}#at_hover .at_item{width:7pc!important;padding:2px 3px!important;margin:1px;text-decoration:none!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover{margin:0!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover,#at_share .at_item.athov,#at_share .at_item:hover{background:#f2f2f2!important;border:1px solid #e5e5e5;color:#000!important;text-decoration:none}.ipad #at_hover .at_item:focus{background:#fff!important;border:1px solid #fff}.at15t{display:block!important;height:1pc!important;line-height:1pc!important;padding-left:20px!important;background-position:0 0;text-align:left}.addthis_button,.at15t{cursor:pointer}.addthis_toolbox a.at300b,.addthis_toolbox a.at300m{width:auto}.addthis_toolbox a{margin-bottom:5px;line-height:initial}.addthis_toolbox.addthis_vertical_style{width:200px}.addthis_button_facebook_like .fb_iframe_widget{line-height:100%}.addthis_button_facebook_like iframe.fb_iframe_widget_lift{max-width:none}.addthis_toolbox a.addthis_button_counter,.addthis_toolbox a.addthis_button_facebook_like,.addthis_toolbox a.addthis_button_facebook_send,.addthis_toolbox a.addthis_button_facebook_share,.addthis_toolbox a.addthis_button_foursquare,.addthis_toolbox a.addthis_button_linkedin_counter,.addthis_toolbox a.addthis_button_pinterest_pinit,.addthis_toolbox a.addthis_button_tweet{display:inline-block}.addthis_toolbox span.addthis_follow_label{display:none}.addthis_toolbox.addthis_vertical_style span.addthis_follow_label{display:block;white-space:nowrap}.addthis_toolbox.addthis_vertical_style a{display:block}.addthis_toolbox.addthis_vertical_style.addthis_32x32_style a{line-height:2pc;height:2pc}.addthis_toolbox.addthis_vertical_style .at300bs{margin-right:4px;float:left}.addthis_toolbox.addthis_20x20_style span{line-height:20px}.addthis_toolbox.addthis_32x32_style span{line-height:2pc}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact,.addthis_toolbox.addthis_pill_combo_style a{float:left}.addthis_toolbox.addthis_pill_combo_style a.addthis_button_tweet{margin-top:-2px}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact{margin-right:4px}.addthis_default_style .addthis_separator{margin:0 5px;display:inline}div.atclear{clear:both}.addthis_default_style .addthis_separator,.addthis_default_style .at4-icon,.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300bs,.addthis_default_style .at300m{float:left}.at300b img,.at300bo img{border:0}a.at300b .at4-icon,a.at300m .at4-icon{display:block}.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300m{padding:0 2px}.at300b,.at300bo,.at300bs,.at300m{cursor:pointer}.addthis_button_facebook_like.at300b:hover,.addthis_button_facebook_like.at300bs:hover,.addthis_button_facebook_send.at300b:hover,.addthis_button_facebook_send.at300bs:hover{opacity:1}.addthis_20x20_style .at15t,.addthis_20x20_style .at300bs{overflow:hidden;display:block;height:20px!important;width:20px!important;line-height:20px!important}.addthis_32x32_style .at15t,.addthis_32x32_style .at300bs{overflow:hidden;display:block;height:2pc!important;width:2pc!important;line-height:2pc!important}.at300bs{overflow:hidden;display:block;background-position:0 0;height:1pc;width:1pc;line-height:1pc!important}.addthis_default_style .at15t_compact,.addthis_default_style .at15t_expanded{margin-right:4px}#at_share .at_item{width:123px!important;padding:4px;margin-right:2px;border:1px solid #fff}#at16p{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);z-index:10000001;position:absolute;top:50%;left:50%;width:300px;padding:10px;margin:0 auto;margin-top:-185px;margin-left:-155px;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#5e5e5e}#at_share{margin:0;padding:0}#at16pt{position:relative;background:#f2f2f2;height:13px;padding:5px 10px}#at16pt a,#at16pt h4{font-weight:700}#at16pt h4{display:inline;margin:0;padding:0;font-size:9pt;color:#4c4c4c;cursor:default}#at16pt a{position:absolute;top:5px;right:10px;color:#4c4c4c;text-decoration:none;padding:2px}#at15sptx:focus,#at16pt a:focus{outline:thin dotted}#at15s #at16pf a{top:1px}#_atssh{width:1px!important;height:1px!important;border:0!important}.atm{width:10pc!important;padding:0;margin:0;line-height:9pt;letter-spacing:normal;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#444;background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);padding:4px}.atm-f{text-align:right;border-top:1px solid #ddd;padding:5px 8px}.atm-i{background:#fff;border:1px solid #d5d6d6;padding:0;margin:0;box-shadow:1px 1px 5px rgba(0,0,0,.15)}.atm-s{margin:0!important;padding:0!important}.atm-s a:focus{border:transparent;outline:0;transition:none}#at_hover.atm-s a,.atm-s a{display:block;text-decoration:none;padding:4px 10px;color:#235dab!important;font-weight:400;font-style:normal;transition:none}#at_hover.atm-s .at_bold{color:#235dab!important}#at_hover.atm-s a:hover,.atm-s a:hover{background:#2095f0;text-decoration:none;color:#fff!important}#at_hover.atm-s .at_bold{font-weight:700}#at_hover.atm-s a:hover .at_bold{color:#fff!important}.atm-s a .at-label{vertical-align:middle;margin-left:5px;direction:ltr}.at_PinItButton{display:block;width:40px;height:20px;padding:0;margin:0;background-image:url(//s7.addthis.com/static/t00/pinit00.png);background-repeat:no-repeat}.at_PinItButton:hover{background-position:0 -20px}.addthis_toolbox .addthis_button_pinterest_pinit{position:relative}.at-share-tbx-element .fb_iframe_widget span{vertical-align:baseline!important}#at16pf{height:auto;text-align:right;padding:4px 8px}.at-privacy-info{position:absolute;left:7px;bottom:7px;cursor:pointer;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:10px;line-height:9pt;letter-spacing:.2px;color:#666}.at-privacy-info:hover{color:#000}.body .wsb-social-share .wsb-social-share-button-vert{padding-top:0;padding-bottom:0}.body .wsb-social-share.addthis_counter_style .addthis_button_tweet.wsb-social-share-button{padding-top:40px}.body .wsb-social-share.addthis_counter_style .addthis_button_facebook_like.wsb-social-share-button{padding-top:21px}@media print{#at4-follow,#at4-share,#at4-thankyou,#at4-whatsnext,#at4m-mobile,#at15s,.at4,.at4-recommended{display:none!important}}@media screen and (max-width:400px){.at4win{width:100%}}@media screen and (max-height:700px) and (max-width:400px){.at4-thankyou-inner .at4-recommended-container{height:122px;overflow:hidden}.at4-thankyou-inner .at4-recommended .at4-recommended-item:first-child{border-bottom:1px solid #c5c5c5}}</style><style type="text/css">.at-branding-logo{font-family:helvetica,arial,sans-serif;text-decoration:none;font-size:10px;display:inline-block;margin:2px 0;letter-spacing:.2px}.at-branding-logo .at-branding-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAMAAAC67D+PAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAAZQTFRF////+GlNUkcc1QAAAB1JREFUeNpiYIQDBjQmAwMmkwEM0JnY1WIxFyDAABGeAFEudiZsAAAAAElFTkSuQmCC")}.at-branding-logo .at-branding-icon,.at-branding-logo .at-privacy-icon{display:inline-block;height:10px;width:10px;margin-left:4px;margin-right:3px;margin-bottom:-1px;background-repeat:no-repeat}.at-branding-logo .at-privacy-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAkAAAAKCAMAAABR24SMAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABhQTFRF8fr9ot/xXcfn2/P5AKva////////AKTWodjhjAAAAAd0Uk5T////////ABpLA0YAAAA6SURBVHjaJMzBDQAwCAJAQaj7b9xifV0kUKJ9ciWxlzWEWI5gMF65KUTv0VKkjVeTerqE/x7+9BVgAEXbAWI8QDcfAAAAAElFTkSuQmCC")}.at-branding-logo span{text-decoration:none}.at-branding-logo .at-branding-addthis,.at-branding-logo .at-branding-powered-by{color:#666}.at-branding-logo .at-branding-addthis:hover{color:#333}.at-cv-with-image .at-branding-addthis,.at-cv-with-image .at-branding-addthis:hover{color:#fff}a.at-branding-logo:visited{color:initial}.at-branding-info{display:inline-block;padding:0 5px;color:#666;border:1px solid #666;border-radius:50%;font-size:10px;line-height:9pt;opacity:.7;transition:all .3s ease;text-decoration:none}.at-branding-info span{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}.at-branding-info:before{content:'i';font-family:Times New Roman}.at-branding-info:hover{color:#0780df;border-color:#0780df}</style><script type="text/javascript" charset="utf-8" async="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/layers.53666936c94ded42f169.download"></script><link rel="preload" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/f.txt" as="script"><script type="text/javascript" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/f.txt"></script><script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/pubads_impl_2019041801.js.download" async=""></script><style type="text/css">.at-share-dock.atss{top:auto;left:0;right:0;bottom:0;width:100%;max-width:100%;z-index:1000200;box-shadow:0 0 1px 1px #e2dfe2}.at-share-dock.at-share-dock-zindex-hide{z-index:-1!important}.at-share-dock.atss-top{bottom:auto;top:0}.at-share-dock a{width:auto;transition:none;color:#fff;text-decoration:none;box-sizing:content-box;-webkit-box-sizing:content-box;-moz-box-sizing:content-box}.at-share-dock a:hover{width:auto}.at-share-dock .at4-count{height:43px;padding:5px 0 0;line-height:20px;background:#fff;font-family:Helvetica neue,arial}.at-share-dock .at4-count span{width:100%}.at-share-dock .at4-count .at4-share-label{color:#848484;font-size:10px;letter-spacing:1px}.at-share-dock .at4-count .at4-counter{top:2px;position:relative;display:block;color:#222;font-size:22px}.at-share-dock.at-shfs-medium .at4-count{height:36px;line-height:1pc;padding-top:4px}.at-share-dock.at-shfs-medium .at4-count .at4-counter{font-size:18px}.at-share-dock.at-shfs-medium .at-share-btn .at-icon-wrapper,.at-share-dock.at-shfs-medium a .at-icon-wrapper{padding:6px 0}.at-share-dock.at-shfs-small .at4-count{height:26px;line-height:1;padding-top:3px}.at-share-dock.at-shfs-small .at4-count .at4-share-label{font-size:8px}.at-share-dock.at-shfs-small .at4-count .at4-counter{font-size:14px}.at-share-dock.at-shfs-small .at-share-btn .at-icon-wrapper,.at-share-dock.at-shfs-small a .at-icon-wrapper{padding:4px 0}</style><style type="text/css">div.at-share-close-control.ats-dark,div.at-share-open-control-left.ats-dark,div.at-share-open-control-right.ats-dark{background:#262b30}div.at-share-close-control.ats-light,div.at-share-open-control-left.ats-light,div.at-share-open-control-right.ats-light{background:#fff}div.at-share-close-control.ats-gray,div.at-share-open-control-left.ats-gray,div.at-share-open-control-right.ats-gray{background:#f2f2f2}.atss{position:fixed;top:20%;width:3pc;z-index:100020;background:none}.at-share-close-control{position:relative;width:3pc;overflow:auto}.at-share-open-control-left{position:fixed;top:20%;z-index:100020;left:0;width:22px}.at-share-close-control .at4-arrow.at-left{float:right}.atss-left{left:0;float:left;right:auto}.atss-right{left:auto;float:right;right:0}.atss-right.at-share-close-control .at4-arrow.at-right{position:relative;right:0;overflow:auto}.atss-right.at-share-close-control .at4-arrow{float:left}.at-share-open-control-right{position:fixed;top:20%;z-index:100020;right:0;width:22px;float:right}.atss-right .at-share-close-control .at4-arrow{float:left}.atss.atss-right a{float:right}.atss.atss-right .at4-share-title{float:right;overflow:hidden}.atss .at-share-btn,.atss a{position:relative;display:block;width:3pc;margin:0;outline-offset:-1px;text-align:center;float:left;transition:width .15s ease-in-out;overflow:hidden;background:#e8e8e8;z-index:100030;cursor:pointer}.at-share-btn::-moz-focus-inner{border:0;padding:0}.atss-right .at-share-btn{float:right}.atss .at-share-btn{border:0;padding:0}.atss .at-share-btn:focus,.atss .at-share-btn:hover,.atss a:focus,.atss a:hover{width:4pc}.atss .at-share-btn .at-icon-wrapper,.atss a .at-icon-wrapper{display:block;padding:8px 0}.atss .at-share-btn:last-child,.atss a:last-child{border:none}.atss .at-share-btn span .at-icon,.atss a span .at-icon{position:relative;top:0;left:0;display:block;background-repeat:no-repeat;background-position:50% 50%;width:2pc;height:2pc;line-height:2pc;border:none;padding:0;margin:0 auto;overflow:hidden;cursor:pointer;cursor:hand}.at4-share .at-custom-sidebar-counter{font-family:Helvetica neue,arial;vertical-align:top;margin-right:4px;display:inline-block;text-align:center}.at4-share .at-custom-sidebar-count{font-size:17px;line-height:1.25em;color:#222}.at4-share .at-custom-sidebar-text{font-size:9px;line-height:1.25em;color:#888;letter-spacing:1px}.at4-share .at4-share-count-container{position:absolute;left:0;right:auto;top:auto;bottom:0;width:100%;color:#fff;background:inherit}.at4-share .at4-share-count,.at4-share .at4-share-count-container{line-height:1pc;font-size:10px}.at4-share .at4-share-count{text-indent:0;font-family:Arial,Helvetica Neue,Helvetica,sans-serif;font-weight:200;width:100%;height:1pc}.at4-share .at4-share-count-anchor{padding-bottom:8px;text-decoration:none;transition:padding .15s ease-in-out .15s,width .15s ease-in-out}</style><style type="text/css">#at4-drawer-outer-container{top:0;width:20pc;position:fixed}#at4-drawer-outer-container.at4-drawer-inline{position:relative}#at4-drawer-outer-container.at4-drawer-inline.at4-drawer-right{float:right;right:0;left:auto}#at4-drawer-outer-container.at4-drawer-inline.at4-drawer-left{float:left;left:0;right:auto}#at4-drawer-outer-container.at4-drawer-shown,#at4-drawer-outer-container.at4-drawer-shown *{z-index:999999}#at4-drawer-outer-container,#at4-drawer-outer-container .at4-drawer-outer,#at-drawer{height:100%;overflow-y:auto;overflow-x:hidden}.at4-drawer-push-content-right-back{position:relative;right:0}.at4-drawer-push-content-right{position:relative;left:20pc!important}.at4-drawer-push-content-left-back{position:relative;left:0}.at4-drawer-push-content-left{position:relative;right:20pc!important}#at4-drawer-outer-container.at4-drawer-right{left:auto;right:-20pc}#at4-drawer-outer-container.at4-drawer-left{right:auto;left:-20pc}#at4-drawer-outer-container.at4-drawer-shown.at4-drawer-right{left:auto;right:0}#at4-drawer-outer-container.at4-drawer-shown.at4-drawer-left{right:auto;left:0}#at-drawer{top:0;z-index:9999999;height:100%;animation-duration:.4s}#at-drawer.drawer-push.at-right{right:-20pc}#at-drawer.drawer-push.at-left{left:-20pc}#at-drawer .at-recommended-label{padding:0 0 0 20px;color:#999;line-height:3pc;font-size:18px;font-weight:300;cursor:default}#at-drawer-arrow{width:30px;height:5pc}#at-drawer-arrow.ats-dark{background:#262b30}#at-drawer-arrow.ats-gray{background:#f2f2f2}#at-drawer-open-arrow{background-image:url(data:image/png;base64,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);background-repeat:no-repeat;width:13px;height:23px;margin:28px 0 0 8px}.at-left #at-drawer-open-arrow{background-position:0 -46px}.ats-dark #at-drawer-open-arrow{background-position:0 -23px}.ats-dark.at-left #at-drawer-open-arrow{background-position:0 -69px}#at-drawer-arrow.at4-drawer-modern-browsers{position:fixed;top:40%;background-repeat:no-repeat;background-position:0 0!important;z-index:9999999}.at4-drawer-inline #at-drawer-arrow{position:absolute}#at-drawer-arrow.at4-drawer-modern-browsers.at-right{right:0}#at-drawer-arrow.at4-drawer-modern-browsers.at-left{left:0}.at4-drawer-push-animation-left{transition:left .4s ease-in-out .15s}.at4-drawer-push-animation-right{transition:right .4s ease-in-out .15s}#at-drawer.drawer-push.at4-drawer-push-animation-right{right:0}#at-drawer.drawer-push.at4-drawer-push-animation-right-back{right:-20pc!important}#at-drawer.drawer-push.at4-drawer-push-animation-left{left:0}#at-drawer.drawer-push.at4-drawer-push-animation-left-back{left:-20pc!important}#at-drawer .at4-closebutton.drawer-close{content:'X';color:#999;display:block;position:absolute;margin:0;top:0;right:0;width:3pc;height:45px;line-height:45px;overflow:hidden;opacity:.5}#at-drawer.ats-dark .at4-closebutton.drawer-close{color:#fff}#at-drawer .at4-closebutton.drawer-close:hover{opacity:1}#at-drawer.ats-dark.at4-recommended .at4-logo-container a{color:#666}#at-drawer.at4-recommended .at4-recommended-vertical{padding:0}#at-drawer.at4-recommended .at4-recommended-item .sponsored-label{margin:2px 0 0 21px;color:#ddd}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item{position:relative;padding:0;width:20pc;height:180px;margin:0}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img a:after{content:'';position:absolute;top:0;left:0;right:0;bottom:0;background:rgba(0,0,0,.65);z-index:1000000;transition:all .2s ease-in-out}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item.at-hover .at4-recommended-item-img a:after{background:rgba(0,0,0,.8)}#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img,#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img a,#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img img{width:20pc;height:180px;float:none}#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption{width:100%;position:absolute;bottom:0;left:0;height:70px}#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4{color:#fff;position:absolute;height:52px;top:0;left:20px;right:20px;margin:0;padding:0;line-height:25px;font-size:20px;font-weight:600;z-index:1000001;text-decoration:none;text-transform:none}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4 a:hover{text-decoration:none}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4 a:link{color:#fff}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption small{position:absolute;top:auto;bottom:10px;left:20px;width:auto;color:#ccc}#at-drawer.at4-recommended .at4-logo-container{margin-left:20px}#at-drawer.ats-dark.at4-recommended .at4-logo-container a:hover{color:#fff}#at-drawer.at4-recommended .at-logo{margin:0}</style><style type="text/css">.at4-follow.at-mobile{display:none!important}.at4-follow{position:fixed;top:0;right:0;font-weight:400;color:#666;cursor:default;z-index:10001}.at4-follow .at4-follow-inner{position:relative;padding:10px 24px 10px 15px}.at4-follow-inner,.at-follow-open-control{border:0 solid #c5c5c5;border-width:1px 0 1px 1px;margin-top:-1px}.at4-follow .at4-follow-container{margin-left:9pt}.at4-follow.at4-follow-24 .at4-follow-container{height:24px;line-height:23px;font-size:13px}.at4-follow.at4-follow-32 .at4-follow-container{width:15pc;height:2pc;line-height:2pc;font-size:14px}.at4-follow .at4-follow-container .at-follow-label{display:inline-block;height:24px;line-height:24px;margin-right:10px;padding:0;cursor:default;float:left}.at4-follow .at4-follow-container .at-icon-wrapper{height:24px;width:24px}.at4-follow.ats-transparent .at4-follow-inner,.at-follow-open-control.ats-transparent{border-color:transparent}.at4-follow.ats-dark .at4-follow-inner,.at-follow-open-control.ats-dark{background:#262b30;border-color:#000;color:#fff}.at4-follow.ats-dark .at-follow-close-control{background-color:#262b30}.at4-follow.ats-light .at4-follow-inner{background:#fff;border-color:#c5c5c5}.at4-follow.ats-gray .at4-follow-inner,.at-follow-open-control.ats-gray{background:#f2f2f2;border-color:#c5c5c5}.at4-follow.ats-light .at4-follow-close-control,.at-follow-open-control.ats-light{background:#e5e5e5}.at4-follow .at4-follow-inner .at4-follow-close-control{position:absolute;top:0;bottom:0;left:0;width:20px;cursor:pointer;display:none}.at4-follow .at4-follow-inner .at4-follow-close-control div{display:block;line-height:20px;text-indent:-9999em;margin-top:calc(50% + 1px);overflow:hidden}.at-follow-open-control div.at4-arrow.at-left{background-position:0 -2px}.at-follow-open-control{position:fixed;height:35px;top:0;right:0;padding-top:10px;z-index:10002}.at-follow-btn{margin:0 5px 5px 0;padding:0;outline-offset:-1px;display:inline-block;box-sizing:content-box;transition:all .2s ease-in-out}.at-follow-btn:focus,.at-follow-btn:hover{transform:translateY(-4px)}.at4-follow-24 .at-follow-btn{height:25px;line-height:0;width:25px}</style><style type="text/css">.at-follow-tbx-element .at300b,.at-follow-tbx-element .at300m{display:inline-block;width:auto;padding:0;margin:0 2px 5px;outline-offset:-1px;transition:all .2s ease-in-out}.at-follow-tbx-element .at300b:focus,.at-follow-tbx-element .at300b:hover,.at-follow-tbx-element .at300m:focus,.at-follow-tbx-element .at300m:hover{transform:translateY(-4px)}.at-follow-tbx-element .addthis_vertical_style .at300b,.at-follow-tbx-element .addthis_vertical_style .at300m{display:block}.at-follow-tbx-element .addthis_vertical_style .at300b .addthis_follow_label,.at-follow-tbx-element .addthis_vertical_style .at300b .at-icon-wrapper,.at-follow-tbx-element .addthis_vertical_style .at300m .addthis_follow_label,.at-follow-tbx-element .addthis_vertical_style .at300m .at-icon-wrapper{display:inline-block;vertical-align:middle;margin-right:5px}.at-follow-tbx-element .addthis_vertical_style .at300b:focus,.at-follow-tbx-element .addthis_vertical_style .at300b:hover,.at-follow-tbx-element .addthis_vertical_style .at300m:focus,.at-follow-tbx-element .addthis_vertical_style .at300m:hover{transform:none}</style><style type="text/css">.at4-jumboshare .at-share-btn{display:inline-block;margin-right:13px;margin-top:13px}.at4-jumboshare .at-share-btn .at-icon{float:left}.at4-jumboshare .at-share-btn .at300bs{display:inline-block;float:left;cursor:pointer}.at4-jumboshare .at4-mobile .at-share-btn .at-icon,.at4-jumboshare .at4-mobile .at-share-btn .at-icon-wrapper{margin:0;padding:0}.at4-jumboshare .at4-mobile .at-share-btn{padding:0}.at4-jumboshare .at4-mobile .at-share-btn .at-label{display:none}.at4-jumboshare .at4-count{font-size:60px;line-height:60px;font-family:Helvetica neue,arial;font-weight:700}.at4-jumboshare .at4-count-container{display:table-cell;text-align:center;min-width:200px;vertical-align:middle;border-right:1px solid #ccc;padding-right:20px}.at4-jumboshare .at4-share-container{display:table-cell;vertical-align:middle;padding-left:20px}.at4-jumboshare .at4-share-container.at-share-tbx-element{padding-top:0}.at4-jumboshare .at4-title{position:relative;font-size:18px;line-height:18px;bottom:2px}.at4-jumboshare .at4-spacer{height:1px;display:block;visibility:hidden;opacity:0}.at4-jumboshare .at-share-btn{display:inline-block;margin:0 2px;line-height:0;padding:0;overflow:hidden;text-decoration:none;text-transform:none;color:#fff;cursor:pointer;transition:all .2s ease-in-out;border:0;background-color:transparent}.at4-jumboshare .at-share-btn:focus,.at4-jumboshare .at-share-btn:hover{transform:translateY(-4px);color:#fff;text-decoration:none}.at4-jumboshare .at-label{font-family:helvetica neue,helvetica,arial,sans-serif;font-size:9pt;padding:0 15px 0 0;margin:0;height:2pc;line-height:2pc;background:none}.at4-jumboshare .at-share-btn:hover,.at4-jumboshare .at-share-btn:link{text-decoration:none}.at4-jumboshare .at-share-btn::-moz-focus-inner{border:0;padding:0}.at4-jumboshare.at-mobile .at-label{display:none}</style><style type="text/css">.at4-recommendedbox-outer-container{display:inline}.at4-recommended-outer{position:static}.at4-recommended{top:20%;margin:0;text-align:center;font-weight:400;font-size:13px;line-height:17px;color:#666}.at4-recommended.at-inline .at4-recommended-horizontal{text-align:left}.at4-recommended-recommendedbox{padding:0;z-index:inherit}.at4-recommended-recommended{padding:40px 0}.at4-recommended-horizontal{max-height:340px}.at4-recommended.at-medium .at4-recommended-horizontal{max-height:15pc}.at4-recommended.at4-minimal.at-medium .at4-recommended-horizontal{padding-top:10px;max-height:230px}.at4-recommended-text-only .at4-recommended-horizontal{max-height:130px}.at4-recommended-horizontal{padding-top:5px;overflow-y:hidden}.at4-minimal{background:none;color:#000;border:none!important;box-shadow:none!important}@media screen and (max-width:900px){.at4-recommended-horizontal .at4-recommended-item,.at4-recommended-horizontal .at4-recommended-item .at4-recommended-item-img{width:15pc}}.at4-recommended.at4-minimal .at4-recommended-horizontal .at4-recommended-item .at4-recommended-item-caption{padding:0 0 10px}.at4-recommended.at4-minimal .at4-recommended-horizontal .at4-recommended-item-caption{padding:20px 0 0!important}.addthis-smartlayers .at4-recommended .at-h3.at-recommended-label{margin:0;padding:0;font-weight:300;font-size:18px;line-height:24px;color:#464646;width:100%;display:inline-block;zoom:1}.addthis-smartlayers .at4-recommended.at-inline .at-h3.at-recommended-label{text-align:left}#at4-thankyou .addthis-smartlayers .at4-recommended.at-inline .at-h3.at-recommended-label{text-align:center}.at4-recommended .at4-recommended-item{display:inline-block;zoom:1;position:relative;background:#fff;border:1px solid #c5c5c5;width:200px;margin:10px}.addthis_recommended_horizontal .at4-recommended-item{border:none}.at4-recommended .at4-recommended-item .sponsored-label{color:#666;font-size:9px;position:absolute;top:-20px}.at4-recommended .at4-recommended-item-img .at-tli,.at4-recommended .at4-recommended-item-img a{position:absolute;left:0}.at4-recommended.at-inline .at4-recommended-horizontal .at4-recommended-item{margin:10px 20px 0 0}.at4-recommended.at-medium .at4-recommended-horizontal .at4-recommended-item{margin:10px 10px 0 0}.at4-recommended.at-medium .at4-recommended-item{width:140px;overflow:hidden}.at4-recommended .at4-recommended-item .at4-recommended-item-img{position:relative;text-align:center;width:100%;height:200px;line-height:0;overflow:hidden}.at4-recommended .at4-recommended-item .at4-recommended-item-img a{display:block;width:100%;height:200px}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-img,.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-img a{height:140px}.at4-recommended .at4-recommended-item .at4-recommended-item-img img{position:absolute;top:0;left:0;min-height:0;min-width:0;max-height:none;max-width:none;margin:0;padding:0}.at4-recommended .at4-recommended-item .at4-recommended-item-caption{height:74px;overflow:hidden;padding:20px;text-align:left;-ms-box-sizing:content-box;-o-box-sizing:content-box;box-sizing:content-box}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-caption{height:50px;padding:15px}.at4-recommended .at4-recommended-item .at4-recommended-item-caption .at-h4{height:54px;margin:0 0 5px;padding:0;overflow:hidden;word-wrap:break-word;font-size:14px;font-weight:400;line-height:18px;text-align:left}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-caption .at-h4{font-size:9pt;line-height:1pc;height:33px}.at4-recommended .at4-recommended-item:hover .at4-recommended-item-caption .at-h4{text-decoration:underline}.at4-recommended a:link,.at4-recommended a:visited{text-decoration:none;color:#464646}.at4-recommended .at4-recommended-item .at4-recommended-item-caption .at-h4 a:hover{text-decoration:underline;color:#000}.at4-recommended .at4-recommended-item .at4-recommended-item-caption small{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:11px;color:#666}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-caption small{font-size:9px}.at4-recommended .at4-recommended-vertical{padding:15px 0 0}.at4-recommended .at4-recommended-vertical .at4-recommended-item{display:block;width:auto;max-width:100%;height:60px;border:none;margin:0 0 15px;box-shadow:none;background:none}.at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img,.at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img img{width:60px;height:60px;float:left}.at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption{border-top:none;margin:0;height:60px;padding:3px 5px}.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4{height:38px;margin:0}.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption small{position:absolute;bottom:0}.at4-recommended .at-recommended-label.at-vertical{text-align:left}.at4-no-image-light-recommended,.at4-no-image-minimal-recommended{background-color:#f2f2f2!important}.at4-no-image-gray-recommended{background-color:#e6e6e5!important}.at4-no-image-dark-recommended{background-color:#4e555e!important}.at4-recommended .at4-recommended-item-placeholder-img{background-repeat:no-repeat!important;background-position:center!important;width:100%!important;height:100%!important}.at4-recommended-horizontal .at4-no-image-dark-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}.at4-recommended-vertical .at4-no-image-dark-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}.at4-recommended-horizontal .at4-no-image-gray-recommended .at4-recommended-item-placeholder-img,.at4-recommended-horizontal .at4-no-image-light-recommended .at4-recommended-item-placeholder-img,.at4-recommended-horizontal .at4-no-image-minimal-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}.at4-recommended-vertical .at4-no-image-gray-recommended .at4-recommended-item-placeholder-img,.at4-recommended-vertical .at4-no-image-light-recommended .at4-recommended-item-placeholder-img,.at4-recommended-vertical .at4-no-image-minimal-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}#at-drawer.ats-dark,.at4-recommended.ats-dark .at4-recommended-horizontal .at4-recommended-item-caption,.at4-recommended.ats-dark .at4-recommended-vertical .at4-recommended-item-caption{background:#262b30}#at-drawer.ats-gray,.at4-recommended.ats-gray .at4-recommended-horizontal .at4-recommended-item-caption{background:#f2f2f2}#at-drawer.ats-light,.at4-recommended.ats-light .at4-recommended-horizontal .at4-recommended-item-caption{background:#fff}.at4-recommended.ats-dark .at4-recommended-vertical .at4-recommended-item{background:none}.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption a:hover,.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption a:link,.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption a:visited,.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption small,.at4-recommended.ats-dark .at4-recommended-item-caption,.at4-recommended.ats-dark .at-logo a:hover,.at4-recommended.ats-dark .at-recommended-label.at-vertical{color:#fff}.at4-recommended-vertical-logo{padding-top:0;text-align:left}.at4-recommended-vertical-logo .at4-logo-container{line-height:10px}.at4-recommended-horizontal-logo{text-align:center}.at4-recommended.at-inline .at4-recommended-horizontal-logo{text-align:left}#at4-thankyou .at4-recommended.at-inline .at4-recommended-horizontal{text-align:center}.at4-recommended .at-logo{margin:10px 0 0;padding:0;height:25px;overflow:auto;-ms-box-sizing:content-box;-o-box-sizing:content-box;box-sizing:content-box}.at4-recommended.at-inline .at4-recommended-horizontal .at-logo{text-align:left}.at4-recommended .at4-logo-container a.at-sponsored-link{color:#666}.at4-recommended-class .at4-logo-container a:hover,.at4-recommendedbox-outer-container .at4-recommended-recommendedbox .at4-logo-container a:hover{color:#000}</style><style type="text/css">.at-recommendedjumbo-outer-container{margin:0;padding:0;border:0;background:none;color:#000}.at-recommendedjumbo-footer{position:relative;width:100%;height:510px;overflow:hidden;transition:all .3s ease-in-out}.at-mobile .at-recommendedjumbo-footer{height:250px}.at-recommendedjumbo-footer #bg-link:after{content:'';position:absolute;top:0;left:0;right:0;bottom:0;background:rgba(0,0,0,.75)}.at-recommendedjumbo-footer:hover #bg-link:after{background:rgba(0,0,0,.85)}.at-recommendedjumbo-footer *,.at-recommendedjumbo-footer :after,.at-recommendedjumbo-footer :before{box-sizing:border-box}.at-recommendedjumbo-footer:hover #at-recommendedjumbo-footer-bg{animation:atRecommendedJumboAnimatedBackground 1s ease-in-out 1;animation-fill-mode:forwards}.at-recommendedjumbo-footer #at-recommendedjumbo-top-holder{position:absolute;top:0;padding:0 40px;width:100%}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-top-holder{padding:0 20px}.at-recommendedjumbo-footer .at-recommendedjumbo-footer-inner{position:relative;text-align:center;font-family:helvetica,arial,sans-serif;z-index:2;width:100%}.at-recommendedjumbo-footer #at-recommendedjumbo-label-holder{margin:40px 0 0;max-height:30px}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-label-holder{margin:20px 0 0;max-height:20px}.at-recommendedjumbo-footer #at-recommendedjumbo-label{font-weight:300;font-size:24px;line-height:24px;color:#fff;margin:0}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-label{font-weight:150;font-size:14px;line-height:14px}.at-recommendedjumbo-footer #at-recommendedjumbo-title-holder{margin:20px 0 0;min-height:3pc;max-height:78pt}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-title-holder{margin:10px 0 0;min-height:24px;max-height:54px}.at-recommendedjumbo-footer #at-recommendedjumbo-content-title{font-size:3pc;line-height:52px;font-weight:700;margin:0}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-content-title{font-size:24px;line-height:27px}.at-recommendedjumbo-footer a{text-decoration:none;color:#fff}.at-recommendedjumbo-footer a:visited{color:#fff}.at-recommendedjumbo-footer small{margin:20px 0 0;display:inline-block;height:2pc;line-height:2pc;font-size:14px;color:#ccc;cursor:default}.at-mobile .at-recommendedjumbo-footer small{margin:10px 0 0;height:14px;line-height:14px;font-size:9pt}.at-recommendedjumbo-footer .at-logo-container{position:absolute;bottom:20px;margin:auto;left:0;right:0}.at-mobile .at-recommendedjumbo-footer .at-logo-container{bottom:10px}.at-recommendedjumbo-footer a.at-sponsored-link{color:#ccc}.at-recommendedjumbo-footer div #at-recommendedjumbo-logo-link{padding:2px 0 0 11px;text-decoration:none;line-height:20px;font-family:helvetica,arial,sans-serif;font-size:9px;color:#ccc}@keyframes atRecommendedJumboAnimatedBackground{0%{transform:scale(1,1)}to{transform:scale(1.1,1.1)}}</style><style type="text/css">.at-resp-share-element{position:relative;padding:0;margin:0;font-size:0;line-height:0}.at-resp-share-element:after,.at-resp-share-element:before{content:" ";display:table}.at-resp-share-element.at-mobile .at4-share-count-container,.at-resp-share-element.at-mobile .at-label{display:none}.at-resp-share-element .at-share-btn{display:inline-block;*display:inline;*zoom:1;margin:0 2px 5px;padding:0;overflow:hidden;line-height:0;text-decoration:none;text-transform:none;color:#fff;cursor:pointer;transition:all .2s ease-in-out;border:0;font-family:helvetica neue,helvetica,arial,sans-serif;background-color:transparent}.at-resp-share-element .at-share-btn::-moz-focus-inner{border:0;padding:0}.at-resp-share-element .at-share-btn:focus,.at-resp-share-element .at-share-btn:hover{transform:translateY(-4px);color:#fff;text-decoration:none}.at-resp-share-element .at-share-btn .at-icon-wrapper{float:left}.at-resp-share-element .at-share-btn.at-share-btn.at-svc-compact:hover{transform:none}.at-resp-share-element .at-share-btn .at-label{font-family:helvetica neue,helvetica,arial,sans-serif;font-size:9pt;padding:0 15px 0 0;margin:0 0 0 5px;height:2pc;line-height:2pc;background:none}.at-resp-share-element .at-icon,.at-resp-share-element .at-label{cursor:pointer}.at-resp-share-element .at4-share-count-container{text-decoration:none;float:right;padding-right:15px;font-size:9pt}.at-mobile .at-resp-share-element .at-label{display:none}.at-resp-share-element.at-mobile .at-share-btn{margin-right:5px}.at-mobile .at-resp-share-element .at-share-btn{padding:5px;margin-right:5px}</style><style type="text/css">.at-share-tbx-element{position:relative;margin:0;color:#fff;font-size:0}.at-share-tbx-element,.at-share-tbx-element .at-share-btn{font-family:helvetica neue,helvetica,arial,sans-serif;padding:0;line-height:0}.at-share-tbx-element .at-share-btn{cursor:pointer;margin:0 5px 5px 0;display:inline-block;overflow:hidden;border:0;text-decoration:none;text-transform:none;background-color:transparent;color:inherit;transition:all .2s ease-in-out}.at-share-tbx-element .at-share-btn:focus,.at-share-tbx-element .at-share-btn:hover{transform:translateY(-4px);outline-offset:-1px;color:inherit}.at-share-tbx-element .at-share-btn::-moz-focus-inner{border:0;padding:0}.at-share-tbx-element .at-share-btn.at-share-btn.at-svc-compact:hover{transform:none}.at-share-tbx-element .at-icon-wrapper{vertical-align:middle}.at-share-tbx-element .at4-share-count,.at-share-tbx-element .at-label{margin:0 7.5px 0 2.5px;text-decoration:none;vertical-align:middle;display:inline-block;background:none;height:0;font-size:inherit;line-height:inherit;color:inherit}.at-share-tbx-element.at-mobile .at4-share-count,.at-share-tbx-element.at-mobile .at-label{display:none}.at-share-tbx-element .at_native_button{vertical-align:middle}.at-share-tbx-element .addthis_counter.addthis_bubble_style{margin:0 2px;vertical-align:middle;display:inline-block}.at-share-tbx-element .fb_iframe_widget{display:block}.at-share-tbx-element.at-share-tbx-native .at300b{vertical-align:middle}.at-style-responsive .at-share-btn{padding:5px}.at-style-jumbo{display:table}.at-style-jumbo .at4-spacer{height:1px;display:block;visibility:hidden;opacity:0}.at-style-jumbo .at4-count-container{display:table-cell;text-align:center;min-width:200px;vertical-align:middle;border-right:1px solid #ccc;padding-right:20px}.at-style-jumbo .at4-count{font-size:60px;line-height:60px;font-weight:700}.at-style-jumbo .at4-count-title{position:relative;font-size:18px;line-height:18px;bottom:2px}.at-style-jumbo .at-share-btn-elements{display:table-cell;vertical-align:middle;padding-left:20px}.at_flat_counter{cursor:pointer;font-family:helvetica,arial,sans-serif;font-weight:700;text-transform:uppercase;display:inline-block;position:relative;vertical-align:top;height:auto;margin:0 5px;padding:0 6px;left:-1px;background:#ebebeb;color:#32363b;transition:all .2s ease}.at_flat_counter:after{top:30%;left:-4px;content:"";position:absolute;border-width:5px 8px 5px 0;border-style:solid;border-color:transparent #ebebeb transparent transparent;display:block;width:0;height:0;transform:translateY(360deg)}.at_flat_counter:hover{background:#e1e2e2}</style><style type="text/css">.at4-thankyou-background{top:0;right:0;left:0;bottom:0;-webkit-overflow-scrolling:touch;z-index:9999999;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpizCuu/sRABGBiIBKMKqSOQoAAAwC8KgJipENhxwAAAABJRU5ErkJggg==);background:hsla(217,6%,46%,.95)}.at4-thankyou-background.at-thankyou-shown{position:fixed}.at4-thankyou-inner{position:absolute;width:100%;top:10%;left:50%;margin-left:-50%;text-align:center}.at4-thankyou-mobile .at4-thankyou-inner{top:5%}.thankyou-description{font-weight:400}.at4-thankyou-background .at4lb-inner{position:relative;width:100%;height:100%}.at4-thankyou-background .at4lb-inner .at4x{position:absolute;top:15px;right:15px;display:block;width:20px;height:20px;padding:20px;margin:0;cursor:pointer;transition:opacity .25s ease-in;opacity:.4;background:url("data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAUCAYAAACNiR0NAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAABx0RVh0U29mdHdhcmUAQWRvYmUgRmlyZXdvcmtzIENTNui8sowAAAAWdEVYdENyZWF0aW9uIFRpbWUAMTEvMTMvMTKswDp5AAAAd0lEQVQ4jb2VQRLAIAgDE///Z3qqY1FAhalHMCsCIkVEAIAkkVgvp2lDBgYAnAyHkWotLccNrEd4A7X2TqIdqLfnWBAdaF5rJdyJfjtPH5GT37CaGhoVq3nOm/XflUuLUto2pY1d+vRKh0Pp+MrAVtDe2JkvYNQ+jVSEEFmOkggAAAAASUVORK5CYII=") no-repeat center center;overflow:hidden;text-indent:-99999em;border:1px solid transparent}.at4-thankyou-background .at4lb-inner .at4x:focus,.at4-thankyou-background .at4lb-inner .at4x:hover{border:1px solid #fff;border-radius:50%;outline:0}.at4-thankyou-background .at4lb-inner #at4-palogo{position:absolute;bottom:10px;display:inline-block;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:11px;cursor:pointer;-webkit-transition:opacity .25s ease-in;moz-transition:opacity .25s ease-in;transition:opacity .25s ease-in;opacity:.5;z-index:100020;color:#fff;padding:2px 0 0 13px}.at4-thankyou-background .at4lb-inner #at4-palogo .at-branding-addthis,.at4-thankyou-background .at4lb-inner #at4-palogo .at-branding-info{color:#fff}.at4-thankyou-background .at4lb-inner #at4-palogo:hover,.at4-thankyou-background.ats-dark .at4lb-inner a#at4-palogo:hover{text-decoration:none;color:#fff;opacity:1}.at4-thankyou-background.ats-dark{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgeMZABGBiIBKMKqSOQoAAAwB+cQD6hqlbCwAAAABJRU5ErkJggg==");background:rgba(0,0,0,.85)}.at4-thankyou-background .thankyou-title{color:#fff;font-size:38.5px;margin:10px 20px;line-height:38.5px;font-family:helvetica neue,helvetica,arial,sans-serif;font-weight:300}.at4-thankyou-background.ats-dark .thankyou-description,.at4-thankyou-background.ats-dark .thankyou-title{color:#fff}.at4-thankyou-background .thankyou-description{color:#fff;font-size:18px;margin:10px 0;line-height:24px;padding:0;font-family:helvetica neue,helvetica,arial,sans-serif;font-weight:300}.at4-thankyou-background .at4-thanks-icons{padding-top:10px}.at4-thankyou-mobile *{-webkit-overflow-scrolling:touch}#at4-thankyou .at4-recommended-recommendedbox .at-logo{display:none}.at4-thankyou .at-h3{height:49px;line-height:49px;margin:0 50px 0 20px;padding:1px 0 0;font-family:helvetica neue,helvetica,arial,sans-serif;font-size:1pc;font-weight:700;color:#fff;text-shadow:0 1px #000}.at4-thanks{padding-top:50px;text-align:center}.at4-thanks label{display:block;margin:0 0 15px;font-size:1pc;line-height:1pc}.at4-thanks .at4-h2{background:none;border:none;margin:0 0 10px;padding:0;font-family:helvetica neue,helvetica,arial,sans-serif;font-size:28px;font-weight:300;color:#000}.at4-thanks .at4-thanks-icons{position:relative;height:2pc}.at4-thanks .at4-thanks-icons .at-thankyou-label{display:block;padding-bottom:10px;font-size:14px;color:#666}.at4-thankyou-layer .at-follow .at-icon-wrapper{width:2pc;height:2pc}</style><style type="text/css">.at4-recommended-toaster{position:fixed;top:auto;bottom:0;right:0;z-index:100021}.at4-recommended-toaster.ats-light{border:1px solid #c5c5c5;background:#fff}.at4-recommended-toaster.ats-gray{border:1px solid #c5c5c5;background:#f2f2f2}.at4-recommended-toaster.ats-dark{background:#262b30;color:#fff}.at4-recommended-toaster .at4-recommended-container{padding-top:0;margin:0}.at4-recommended.at4-recommended-toaster div.at-recommended-label{line-height:1pc;font-size:1pc;text-align:left;padding:20px 0 0 20px}.at4-toaster-outer .at4-recommended .at4-recommended-item .at4-recommended-item-caption .at-h4{font-size:11px;line-height:11px;margin:10px 0 6px;height:30px}.at4-recommended.at4-recommended-toaster div.at-recommended-label.ats-gray,.at4-recommended.at4-recommended-toaster div.at-recommended-label.ats-light{color:#464646}.at4-recommended.at4-recommended-toaster div.at-recommended-label.ats-dark{color:#fff}.at4-toaster-close-control{position:absolute;top:0;right:0;display:block;width:20px;height:20px;line-height:20px;margin:5px 5px 0 0;padding:0;text-indent:-9999em}.at4-toaster-open-control{position:fixed;right:0;bottom:0;z-index:100020}.at4-toaster-outer .at4-recommended-item{width:90pt;border:0;margin:9px 10px 0}.at4-toaster-outer .at4-recommended-item:first-child{margin-left:20px}.at4-toaster-outer .at4-recommended-item:last-child{margin-right:20px}.at4-toaster-outer .at4-recommended-item .at4-recommended-item-img{max-height:90pt;max-width:90pt}.at4-toaster-outer .at4-recommended-item .at4-recommended-item-img img{height:90pt;width:90pt}.at4-toaster-outer .at4-recommended-item .at4-recommended-item-caption{height:30px;padding:0;margin:0;height:initial}.at4-toaster-outer .ats-dark .at4-recommended-item .at4-recommended-item-caption{background:#262b30}.at4-toaster-outer .at4-recommended .at4-recommended-item .at4-recommended-item-caption small{width:auto;line-height:14px;margin:0}.at4-toaster-outer .at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption small{color:#fff}.at4-recommended-toaster .at-logo{margin:0 0 3px 20px;text-align:left}.at4-recommended-toaster .at-logo .at4-logo-container.at-sponsored-logo{position:relative}.at4-toaster-outer .at4-recommended-item .sponsored-label{text-align:right;font-size:10px;color:#666;float:right;position:fixed;bottom:6px;right:20px;top:initial;z-index:99999}</style><style type="text/css">.at4-whatsnext{position:fixed;bottom:0!important;right:0;background:#fff;border:1px solid #c5c5c5;margin:-1px;width:390px;height:90pt;overflow:hidden;font-size:9pt;font-weight:400;color:#000;z-index:1800000000}.at4-whatsnext a{color:#666}.at4-whatsnext .at-whatsnext-content{height:90pt;position:relative}.at4-whatsnext .at-whatsnext-content .at-branding{position:absolute;bottom:15px;right:10px;padding-left:9px;text-decoration:none;line-height:10px;font-family:helvetica,arial,sans-serif;font-size:10px;color:#666}.at4-whatsnext .at-whatsnext-content .at-whatsnext-content-inner{position:absolute;top:15px;right:20px;bottom:15px;left:140px;text-align:left;height:105px}.at4-whatsnext .at-whatsnext-content-inner a{display:inline-block}.at4-whatsnext .at-whatsnext-content-inner div.at-h6{text-align:left;margin:0;padding:0 0 3px;font-size:11px;color:#666;cursor:default}.at4-whatsnext .at-whatsnext-content .at-h3{text-align:left;margin:5px 0;padding:0;line-height:1.2em;font-weight:400;font-size:14px;height:3pc}.at4-whatsnext .at-whatsnext-content-inner a:link,.at4-whatsnext .at-whatsnext-content-inner a:visited{text-decoration:none;font-weight:400;color:#464646}.at4-whatsnext .at-whatsnext-content-inner a:hover{color:#000}.at4-whatsnext .at-whatsnext-content-inner small{position:absolute;bottom:15px;line-height:10px;font-size:11px;color:#666;cursor:default;text-align:left}.at4-whatsnext .at-whatsnext-content .at-whatsnext-content-img{position:absolute;top:0;left:0;width:90pt;height:90pt;overflow:hidden}.at4-whatsnext .at-whatsnext-content .at-whatsnext-content-img img{position:absolute;top:0;left:0;max-height:none;max-width:none}.at4-whatsnext .at-whatsnext-close-control{position:absolute;top:0;right:0;display:block;width:20px;height:20px;line-height:20px;margin:0 5px 0 0;padding:0;text-indent:-9999em}.at-whatsnext-open-control{position:fixed;right:0;bottom:0;z-index:100020}.at4-whatsnext.ats-dark{background:#262b30}.at4-whatsnext.ats-dark .at-whatsnext-content .at-h3,.at4-whatsnext.ats-dark .at-whatsnext-content a.at4-logo:hover,.at4-whatsnext.ats-dark .at-whatsnext-content-inner a:link,.at4-whatsnext.ats-dark .at-whatsnext-content-inner a:visited{color:#fff}.at4-whatsnext.ats-light{background:#fff}.at4-whatsnext.ats-gray{background:#f2f2f2}.at4-whatsnext.at-whatsnext-nophoto{width:270px}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content-img{display:none}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner{top:15px;right:0;left:20px}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner.addthis_32x32_style{top:0;right:0;left:0;padding:45px 20px 0;font-size:20px}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner .at4-icon,.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner .at4-icon-fw,.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner .whatsnext-msg{vertical-align:middle}.at-whatsnext-img,.at-whatsnext-img-lnk{position:absolute;left:0}</style><style type="text/css">.at4-whatsnextmobile{position:fixed;bottom:0;right:0;left:0;background:#fff;z-index:9999998;height:170px;font-size:28px}.at4-whatsnextmobile .col-2{height:100%;font-size:1em}.at4-whatsnextmobile .col-2:first-child{max-width:200px;display:inline-block;float:left}.at4-whatsnextmobile .col-2:last-child{position:absolute;left:200px;right:50px;top:0;bottom:0;display:inline-block}.at4-whatsnextmobile .at-whatsnext-content-inner{font-size:1em}.at4-whatsnextmobile .at-whatsnext-content-img img{height:100%;width:100%}.at4-whatsnextmobile .at-close-control{font-size:1em;position:absolute;top:0;right:0;width:50px;height:50px}.at4-whatsnextmobile .at-close-control button{width:100%;height:100%;font-size:1em;font-weight:400;text-decoration:none;opacity:.5;padding:0;cursor:pointer;background:0 0;border:0;-webkit-appearance:none}.at4-whatsnextmobile .at-h3,.at4-whatsnextmobile .at-h6{font-size:1em;margin:0;color:#a1a1a1;margin-left:2.5%;margin-top:25px}.at4-whatsnextmobile .at-h3{font-size:1em;line-height:1em;font-weight:500;height:50%}.at4-whatsnextmobile .at-h3 a{font-size:1em;text-decoration:none}.at4-whatsnextmobile .at-h6{font-size:.8em;line-height:.8em;font-weight:500}.at4-whatsnextmobile .footer{position:absolute;bottom:2px;left:200px;right:0;padding-left:2.5%;font-size:1em;line-height:.6em}.at4-whatsnextmobile .footer small{font-size:.6em;color:#a1a1a1}.at4-whatsnextmobile .footer small:first-child{margin-right:5%;float:left}.at4-whatsnextmobile .footer small:last-child{margin-right:2.5%;float:right}.at4-whatsnextmobile .at-whatsnext-content{height:100%}.at4-whatsnextmobile.ats-dark{background:#262b30;color:#fff}.at4-whatsnextmobile .at-close-control button{color:#bfbfbf}.at4-whatsnextmobile.ats-dark a:link,.at4-whatsnextmobile.ats-dark a:visited{color:#fff}.at4-whatsnextmobile.ats-gray{background:#f2f2f2;color:#262b30}.at4-whatsnextmobile.ats-light{background:#fff;color:#262b30}.at4-whatsnextmobile.ats-dark .footer a:link,.at4-whatsnextmobile.ats-dark .footer a:visited,.at4-whatsnextmobile.ats-gray .footer a:link,.at4-whatsnextmobile.ats-gray .footer a:visited,.at4-whatsnextmobile.ats-light .footer a:link,.at4-whatsnextmobile.ats-light .footer a:visited{color:#a1a1a1}.at4-whatsnextmobile.ats-gray a:link,.at4-whatsnextmobile.ats-gray a:visited,.at4-whatsnextmobile.ats-light a:link,.at4-whatsnextmobile.ats-light a:visited{color:#262b30}@media only screen and (min-device-width:320px) and (max-device-width:480px){.at4-whatsnextmobile{height:85px;font-size:14px}.at4-whatsnextmobile .col-2:first-child{width:75pt}.at4-whatsnextmobile .col-2:last-child{right:25px;left:75pt}.at4-whatsnextmobile .footer{left:75pt}.at4-whatsnextmobile .at-close-control{width:25px;height:25px}.at4-whatsnextmobile .at-h3,.at4-whatsnextmobile .at-h6{margin-top:12.5px}}</style><style type="text/css">.at-custom-mobile-bar{left:0;right:0;width:100%;height:56px;position:fixed;text-align:center;z-index:100020;background:#fff;overflow:hidden;box-shadow:0 0 10px 0 rgba(0,0,0,.2);font:initial;line-height:normal;top:auto;bottom:0}.at-custom-mobile-bar.at-custom-mobile-bar-zindex-hide{z-index:-1!important}.at-custom-mobile-bar.atss-top{top:0;bottom:auto}.at-custom-mobile-bar.atss-bottom{top:auto;bottom:0}.at-custom-mobile-bar .at-custom-mobile-bar-btns{display:inline-block;text-align:center}.at-custom-mobile-bar .at-custom-mobile-bar-counter,.at-custom-mobile-bar .at-share-btn{margin-top:4px}.at-custom-mobile-bar .at-share-btn{display:inline-block;text-decoration:none;transition:none;box-sizing:content-box}.at-custom-mobile-bar .at-custom-mobile-bar-counter{font-family:Helvetica neue,arial;vertical-align:top;margin-left:4px;margin-right:4px;display:inline-block}.at-custom-mobile-bar .at-custom-mobile-bar-count{font-size:26px;line-height:1.25em;color:#222}.at-custom-mobile-bar .at-custom-mobile-bar-text{font-size:9pt;line-height:1.25em;color:#888;letter-spacing:1px}.at-custom-mobile-bar .at-icon-wrapper{text-align:center;height:3pc;width:3pc;margin:0 4px}.at-custom-mobile-bar .at-icon{vertical-align:top;margin:8px;width:2pc;height:2pc}.at-custom-mobile-bar.at-shfs-medium{height:3pc}.at-custom-mobile-bar.at-shfs-medium .at-custom-mobile-bar-counter{margin-top:6px}.at-custom-mobile-bar.at-shfs-medium .at-custom-mobile-bar-count{font-size:18px}.at-custom-mobile-bar.at-shfs-medium .at-custom-mobile-bar-text{font-size:10px}.at-custom-mobile-bar.at-shfs-medium .at-icon-wrapper{height:40px;width:40px}.at-custom-mobile-bar.at-shfs-medium .at-icon{margin:6px;width:28px;height:28px}.at-custom-mobile-bar.at-shfs-small{height:40px}.at-custom-mobile-bar.at-shfs-small .at-custom-mobile-bar-counter{margin-top:3px}.at-custom-mobile-bar.at-shfs-small .at-custom-mobile-bar-count{font-size:1pc}.at-custom-mobile-bar.at-shfs-small .at-custom-mobile-bar-text{font-size:10px}.at-custom-mobile-bar.at-shfs-small .at-icon-wrapper{height:2pc;width:2pc}.at-custom-mobile-bar.at-shfs-small .at-icon{margin:4px;width:24px;height:24px}</style><style type="text/css">.at-custom-sidebar{top:20%;width:58px;position:fixed;text-align:center;z-index:100020;background:#fff;overflow:hidden;box-shadow:0 0 10px 0 rgba(0,0,0,.2);font:initial;line-height:normal;top:auto;bottom:0}.at-custom-sidebar.at-custom-sidebar-zindex-hide{z-index:-1!important}.at-custom-sidebar.atss-left{left:0;right:auto;float:left;border-radius:0 4px 4px 0}.at-custom-sidebar.atss-right{left:auto;right:0;float:right;border-radius:4px 0 0 4px}.at-custom-sidebar .at-custom-sidebar-btns{display:inline-block;text-align:center;padding-top:4px}.at-custom-sidebar .at-custom-sidebar-counter{margin-bottom:8px}.at-custom-sidebar .at-share-btn{display:inline-block;text-decoration:none;transition:none;box-sizing:content-box}.at-custom-sidebar .at-custom-sidebar-counter{font-family:Helvetica neue,arial;vertical-align:top;margin-left:4px;margin-right:4px;display:inline-block}.at-custom-sidebar .at-custom-sidebar-count{font-size:21px;line-height:1.25em;color:#222}.at-custom-sidebar .at-custom-sidebar-text{font-size:10px;line-height:1.25em;color:#888;letter-spacing:1px}.at-custom-sidebar .at-icon-wrapper{text-align:center;margin:0 4px}.at-custom-sidebar .at-icon{vertical-align:top;margin:9px;width:2pc;height:2pc}.at-custom-sidebar .at-icon-wrapper{position:relative}.at-custom-sidebar .at4-share-count,.at-custom-sidebar .at4-share-count-container{line-height:1pc;font-size:10px}.at-custom-sidebar .at4-share-count{text-indent:0;font-family:Arial,Helvetica Neue,Helvetica,sans-serif;font-weight:200;width:100%;height:1pc}.at-custom-sidebar .at4-share-count-anchor .at-icon{margin-top:3px}.at-custom-sidebar .at4-share-count-container{position:absolute;left:0;right:auto;top:auto;bottom:0;width:100%;color:#fff;background:inherit}</style><style type="text/css">.at-image-sharing-mobile-icon{position:absolute;background:#000 url(//s7.addthis.com/static/44a36d35bafef33aa9455b7d3039a771.png) no-repeat top center;background-color:rgba(0,0,0,.9);background-image:url(//s7.addthis.com/static/10db525181ee0bbe1a515001be1c7818.svg),none;border-radius:3px;width:50px;height:40px;top:-9999px;left:-9999px}.at-image-sharing-tool{display:block;position:absolute;text-align:center;z-index:9001;background:none;overflow:hidden;top:-9999px;left:-9999px;font:initial;line-height:0}.at-image-sharing-tool.addthis-animated{animation-duration:.15s}.at-image-sharing-tool.at-orientation-vertical .at-share-btn{display:block}.at-image-sharing-tool.at-orientation-horizontal .at-share-btn{display:inline-block}.at-image-sharing-tool.at-image-sharing-tool-size-big .at-icon{width:43px;height:43px}.at-image-sharing-tool.at-image-sharing-tool-size-mobile .at-share-btn{margin:0!important}.at-image-sharing-tool.at-image-sharing-tool-size-mobile .at-icon-wrapper{height:60px;width:100%;border-radius:0!important}.at-image-sharing-tool.at-image-sharing-tool-size-mobile .at-icon{max-width:100%;height:54px!important;width:54px!important}.at-image-sharing-tool .at-custom-shape.at-image-sharing-tool-btns{margin-right:8px;margin-bottom:8px}.at-image-sharing-tool .at-custom-shape .at-share-btn{margin-top:8px;margin-left:8px}.at-image-sharing-tool .at-share-btn{line-height:0;text-decoration:none;transition:none;box-sizing:content-box}.at-image-sharing-tool .at-icon-wrapper{text-align:center;height:100%;width:100%}.at-image-sharing-tool .at-icon{vertical-align:top;width:2pc;height:2pc;margin:3px}</style><style type="text/css">.at-expanding-share-button{box-sizing:border-box;position:fixed;z-index:9999}.at-expanding-share-button[data-position=bottom-right]{bottom:10px;right:10px}.at-expanding-share-button[data-position=bottom-right] .at-expanding-share-button-toggle-bg,.at-expanding-share-button[data-position=bottom-right] .at-expanding-share-button-toggle-btn[data-name]:after,.at-expanding-share-button[data-position=bottom-right] .at-icon-wrapper,.at-expanding-share-button[data-position=bottom-right] [data-name]:after{float:right}.at-expanding-share-button[data-position=bottom-right] [data-name]:after{margin-right:10px}.at-expanding-share-button[data-position=bottom-right] .at-expanding-share-button-toggle-btn[data-name]:after{margin-right:5px}.at-expanding-share-button[data-position=bottom-right] .at-icon-wrapper{margin-right:-3px}.at-expanding-share-button[data-position=bottom-left]{bottom:10px;left:10px}.at-expanding-share-button[data-position=bottom-left] .at-expanding-share-button-toggle-bg,.at-expanding-share-button[data-position=bottom-left] .at-expanding-share-button-toggle-btn[data-name]:after,.at-expanding-share-button[data-position=bottom-left] .at-icon-wrapper,.at-expanding-share-button[data-position=bottom-left] [data-name]:after{float:left}.at-expanding-share-button[data-position=bottom-left] [data-name]:after{margin-left:10px}.at-expanding-share-button[data-position=bottom-left] .at-expanding-share-button-toggle-btn[data-name]:after{margin-left:5px}.at-expanding-share-button *,.at-expanding-share-button :after,.at-expanding-share-button :before{box-sizing:border-box}.at-expanding-share-button .at-expanding-share-button-services-list{display:none;list-style:none;margin:0 5px;overflow:visible;padding:0}.at-expanding-share-button .at-expanding-share-button-services-list>li{display:block;height:45px;position:relative;overflow:visible}.at-expanding-share-button .at-expanding-share-button-toggle-btn,.at-expanding-share-button .at-share-btn{transition:.1s;text-decoration:none}.at-expanding-share-button .at-share-btn{display:block;height:40px;padding:0 3px 0 0}.at-expanding-share-button .at-expanding-share-button-toggle-btn{position:relative;overflow:auto}.at-expanding-share-button .at-expanding-share-button-toggle-btn.at-expanding-share-button-hidden[data-name]:after{display:none}.at-expanding-share-button .at-expanding-share-button-toggle-bg{box-shadow:0 2px 4px 0 rgba(0,0,0,.3);border-radius:50%;position:relative}.at-expanding-share-button .at-expanding-share-button-toggle-bg>span{background-image:url("data:image/svg+xml,%3Csvg%20width%3D%2232px%22%20height%3D%2232px%22%20viewBox%3D%220%200%2032%2032%22%20version%3D%221.1%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Ctitle%3Eshare%3C%2Ftitle%3E%3Cg%20stroke%3D%22none%22%20stroke-width%3D%221%22%20fill%3D%22none%22%20fill-rule%3D%22evenodd%22%3E%3Cg%20fill%3D%22%23FFFFFF%22%3E%3Cpath%20d%3D%22M26%2C13.4285714%20C26%2C13.6220248%2025.9293162%2C13.7894338%2025.7879464%2C13.9308036%20L20.0736607%2C19.6450893%20C19.932291%2C19.786459%2019.7648819%2C19.8571429%2019.5714286%2C19.8571429%20C19.3779752%2C19.8571429%2019.2105662%2C19.786459%2019.0691964%2C19.6450893%20C18.9278267%2C19.5037195%2018.8571429%2C19.3363105%2018.8571429%2C19.1428571%20L18.8571429%2C16.2857143%20L16.3571429%2C16.2857143%20C15.6279725%2C16.2857143%2014.9750773%2C16.3080355%2014.3984375%2C16.3526786%20C13.8217977%2C16.3973217%2013.2488868%2C16.477306%2012.6796875%2C16.5926339%20C12.1104882%2C16.7079619%2011.6157015%2C16.8660704%2011.1953125%2C17.0669643%20C10.7749235%2C17.2678581%2010.3824423%2C17.5264121%2010.0178571%2C17.8426339%20C9.65327199%2C18.1588557%209.35565592%2C18.534596%209.125%2C18.9698661%20C8.89434408%2C19.4051361%208.71391434%2C19.9203839%208.58370536%2C20.515625%20C8.45349637%2C21.1108661%208.38839286%2C21.7842224%208.38839286%2C22.5357143%20C8.38839286%2C22.9449425%208.40699386%2C23.4025272%208.44419643%2C23.9084821%20C8.44419643%2C23.9531252%208.45349693%2C24.0405499%208.47209821%2C24.1707589%20C8.4906995%2C24.3009679%208.5%2C24.3995532%208.5%2C24.4665179%20C8.5%2C24.5781256%208.46837829%2C24.6711306%208.40513393%2C24.7455357%20C8.34188956%2C24.8199408%208.25446484%2C24.8571429%208.14285714%2C24.8571429%20C8.02380893%2C24.8571429%207.9196433%2C24.7938994%207.83035714%2C24.6674107%20C7.77827355%2C24.6004461%207.72991094%2C24.5186017%207.68526786%2C24.421875%20C7.64062478%2C24.3251483%207.59040206%2C24.2135423%207.53459821%2C24.0870536%20C7.47879436%2C23.9605648%207.43973225%2C23.87128%207.41741071%2C23.8191964%20C6.47246551%2C21.6986501%206%2C20.0208395%206%2C18.7857143%20C6%2C17.3050521%206.19717065%2C16.0662252%206.59151786%2C15.0691964%20C7.79688103%2C12.0706695%2011.0520568%2C10.5714286%2016.3571429%2C10.5714286%20L18.8571429%2C10.5714286%20L18.8571429%2C7.71428571%20C18.8571429%2C7.52083237%2018.9278267%2C7.35342333%2019.0691964%2C7.21205357%20C19.2105662%2C7.07068382%2019.3779752%2C7%2019.5714286%2C7%20C19.7648819%2C7%2019.932291%2C7.07068382%2020.0736607%2C7.21205357%20L25.7879464%2C12.9263393%20C25.9293162%2C13.067709%2026%2C13.2351181%2026%2C13.4285714%20L26%2C13.4285714%20Z%22%3E%3C%2Fpath%3E%3C%2Fg%3E%3C%2Fg%3E%3C%2Fsvg%3E");background-position:center center;background-repeat:no-repeat;transition:transform .4s ease;border-radius:50%;display:block}.at-expanding-share-button .at-icon-wrapper{box-shadow:0 2px 4px 0 rgba(0,0,0,.3);border-radius:50%;display:inline-block;height:40px;line-height:40px;text-align:center;width:40px}.at-expanding-share-button .at-icon{display:inline-block;height:34px;margin:3px 0;vertical-align:top;width:34px}.at-expanding-share-button [data-name]:after{box-shadow:0 2px 4px 0 rgba(0,0,0,.3);transform:translate(0, -50%);transition:.4s;background-color:#fff;border-radius:3px;color:#666;content:attr(data-name);font-family:Helvetica Neue,Helvetica,Arial,sans-serif;font-size:9pt;line-height:9pt;font-weight:500;opacity:0;padding:3px 5px;position:relative;top:20px;white-space:nowrap}.at-expanding-share-button.at-expanding-share-button-show-icons .at-expanding-share-button-services-list{display:block}.at-expanding-share-button.at-expanding-share-button-animate-in .at-expanding-share-button-toggle-bg>span{transform:rotate(270deg);background-image:url("data:image/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20xmlns%3Axlink%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2Fxlink%22%20viewBox%3D%220%200%2032%2032%22%3E%3Cg%3E%3Cpath%20d%3D%22M18%2014V8h-4v6H8v4h6v6h4v-6h6v-4h-6z%22%20fill-rule%3D%22evenodd%22%20fill%3D%22white%22%3E%3C%2Fpath%3E%3C%2Fg%3E%3C%2Fsvg%3E");background-position:center center;background-repeat:no-repeat}.at-expanding-share-button.at-expanding-share-button-animate-in [data-name]:after{opacity:1}.at-expanding-share-button.at-hide-label [data-name]:after{display:none}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle{height:50px}.at-expanding-share-button.at-expanding-share-button-desktop .at-icon-wrapper:hover{box-shadow:0 2px 5px 0 rgba(0,0,0,.5)}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg{height:50px;line-height:50px;width:50px}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg>span{height:50px;width:50px}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg:after{box-shadow:0 2px 5px 0 rgba(0,0,0,.2);transition:opacity .2s ease;border-radius:50%;content:'';height:100%;opacity:0;position:absolute;top:0;left:0;width:100%}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg:hover:after{opacity:1}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-btn[data-name]:after{top:25px}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-services-list{margin:0}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle-btn,.at-expanding-share-button.at-expanding-share-button-mobile .at-share-btn{outline:0}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle{height:40px;-webkit-tap-highlight-color:transparent}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle-bg,.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle-bg span{height:40px;line-height:40px;width:40px}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-click-flash{transform:scale(0);transition:transform ease,opacity ease-in;background-color:hsla(0,0%,100%,.3);border-radius:50%;height:40px;opacity:1;position:absolute;width:40px;z-index:10000}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-click-flash.at-expanding-share-button-click-flash-animate{transform:scale(1);opacity:0}.at-expanding-share-button.at-expanding-share-button-mobile+.at-expanding-share-button-mobile-overlay{transition:opacity ease;bottom:0;background-color:hsla(0,0%,87%,.7);display:block;height:auto;left:0;opacity:0;position:fixed;right:0;top:0;width:auto;z-index:9998}.at-expanding-share-button.at-expanding-share-button-mobile+.at-expanding-share-button-mobile-overlay.at-expanding-share-button-hidden{height:0;width:0;z-index:-10000}.at-expanding-share-button.at-expanding-share-button-mobile.at-expanding-share-button-animate-in+.at-expanding-share-button-mobile-overlay{transition:opacity ease;opacity:1}</style><style type="text/css">.at-tjin-element .at300b,.at-tjin-element .at300m{display:inline-block;width:auto;padding:0;margin:0 2px 5px;outline-offset:-1px;transition:all .2s ease-in-out}.at-tjin-element .at300b:focus,.at-tjin-element .at300b:hover,.at-tjin-element .at300m:focus,.at-tjin-element .at300m:hover{transform:translateY(-4px)}.at-tjin-element .addthis_tjin_label{display:none}.at-tjin-element .addthis_vertical_style .at300b,.at-tjin-element .addthis_vertical_style .at300m{display:block}.at-tjin-element .addthis_vertical_style .at300b .addthis_tjin_label,.at-tjin-element .addthis_vertical_style .at300b .at-icon-wrapper,.at-tjin-element .addthis_vertical_style .at300m .addthis_tjin_label,.at-tjin-element .addthis_vertical_style .at300m .at-icon-wrapper{display:inline-block;vertical-align:middle;margin-right:5px}.at-tjin-element .addthis_vertical_style .at300b:focus,.at-tjin-element .addthis_vertical_style .at300b:hover,.at-tjin-element .addthis_vertical_style .at300m:focus,.at-tjin-element .addthis_vertical_style .at300m:hover{transform:none}.at-tjin-element .at-tjin-btn{margin:0 5px 5px 0;padding:0;outline-offset:-1px;display:inline-block;box-sizing:content-box;transition:all .2s ease-in-out}.at-tjin-element .at-tjin-btn:focus,.at-tjin-element .at-tjin-btn:hover{transform:translateY(-4px)}.at-tjin-element .at-tjin-title{margin:0 0 15px}</style><style type="text/css">#addthissmartlayerscssready{color:#bada55!important}.addthis-smartlayers,div#at4-follow,div#at4-share,div#at4-thankyou,div#at4-whatsnext{padding:0;margin:0}#at4-follow-label,#at4-share-label,#at4-whatsnext-label,.at4-recommended-label.hidden{padding:0;border:none;background:none;position:absolute;top:0;left:0;height:0;width:0;overflow:hidden;text-indent:-9999em}.addthis-smartlayers .at4-arrow:hover{cursor:pointer}.addthis-smartlayers .at4-arrow:after,.addthis-smartlayers .at4-arrow:before{content:none}a.at4-logo{background:url(data:image/gif;base64,R0lGODlhBwAHAJEAAP9uQf///wAAAAAAACH5BAkKAAIALAAAAAAHAAcAAAILFH6Ge8EBH2MKiQIAOw==) no-repeat left center}.at4-minimal a.at4-logo{background:url(data:image/gif;base64,R0lGODlhBwAHAJEAAP9uQf///wAAAAAAACH5BAkKAAIALAAAAAAHAAcAAAILFH6Ge8EBH2MKiQIAOw==) no-repeat left center!important}button.at4-closebutton{position:absolute;top:0;right:0;padding:0;margin-right:10px;cursor:pointer;background:transparent;border:0;-webkit-appearance:none;font-size:19px;line-height:1;color:#000;text-shadow:0 1px 0 #fff;opacity:.2}button.at4-closebutton:hover{color:#000;text-decoration:none;cursor:pointer;opacity:.5}div.at4-arrow{background-image:url(data:image/png;base64,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);background-repeat:no-repeat;width:20px;height:20px;margin:0;padding:0;overflow:hidden;text-indent:-9999em;text-align:left;cursor:pointer}#at4-recommendedpanel-outer-container .at4-arrow.at-right,div.at4-arrow.at-right{background-position:-20px 0}#at4-recommendedpanel-outer-container .at4-arrow.at-left,div.at4-arrow.at-left{background-position:0 0}div.at4-arrow.at-down{background-position:-60px 0}div.at4-arrow.at-up{background-position:-40px 0}.ats-dark div.at4-arrow.at-right{background-position:-20px -20px}.ats-dark div.at4-arrow.at-left{background-position:0 -20px}.ats-dark div.at4-arrow.at-down{background-position:-60px -20px}.ats-dark div.at4-arrow.at-up{background-position:-40px -20}.at4-opacity-hidden{opacity:0!important}.at4-opacity-visible{opacity:1!important}.at4-visually-hidden{position:absolute;clip:rect(1px,1px,1px,1px);padding:0;border:0;overflow:hidden}.at4-hidden-off-screen,.at4-hidden-off-screen *{position:absolute!important;top:-9999px!important;left:-9999px!important}.at4-show{display:block!important;opacity:1!important}.at4-show-content{opacity:1!important;visibility:visible}.at4-hide{display:none!important;opacity:0!important}.at4-hide-content{opacity:0!important;visibility:hidden}.at4-visible{display:block!important;opacity:0!important}.at-wordpress-hide{display:none!important;opacity:0!important}.addthis-animated{animation-fill-mode:both;animation-timing-function:ease-out;animation-duration:.3s}.slideInDown.addthis-animated,.slideInLeft.addthis-animated,.slideInRight.addthis-animated,.slideInUp.addthis-animated,.slideOutDown.addthis-animated,.slideOutLeft.addthis-animated,.slideOutRight.addthis-animated,.slideOutUp.addthis-animated{animation-duration:.4s}@keyframes fadeIn{0%{opacity:0}to{opacity:1}}.fadeIn{animation-name:fadeIn}@keyframes fadeInUp{0%{opacity:0;transform:translateY(20px)}to{opacity:1;transform:translateY(0)}}.fadeInUp{animation-name:fadeInUp}@keyframes fadeInDown{0%{opacity:0;transform:translateY(-20px)}to{opacity:1;transform:translateY(0)}}.fadeInDown{animation-name:fadeInDown}@keyframes fadeInLeft{0%{opacity:0;transform:translateX(-20px)}to{opacity:1;transform:translateX(0)}}.fadeInLeft{animation-name:fadeInLeft}@keyframes fadeInRight{0%{opacity:0;transform:translateX(20px)}to{opacity:1;transform:translateX(0)}}.fadeInRight{animation-name:fadeInRight}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}.fadeOut{animation-name:fadeOut}@keyframes fadeOutUp{0%{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(-20px)}}.fadeOutUp{animation-name:fadeOutUp}@keyframes fadeOutDown{0%{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(20px)}}.fadeOutDown{animation-name:fadeOutDown}@keyframes fadeOutLeft{0%{opacity:1;transform:translateX(0)}to{opacity:0;transform:translateX(-20px)}}.fadeOutLeft{animation-name:fadeOutLeft}@keyframes fadeOutRight{0%{opacity:1;transform:translateX(0)}to{opacity:0;transform:translateX(20px)}}.fadeOutRight{animation-name:fadeOutRight}@keyframes slideInUp{0%{transform:translateY(1500px)}0%,to{opacity:1}to{transform:translateY(0)}}.slideInUp{animation-name:slideInUp}.slideInUp.addthis-animated{animation-duration:.4s}@keyframes slideInDown{0%{transform:translateY(-850px)}0%,to{opacity:1}to{transform:translateY(0)}}.slideInDown{animation-name:slideInDown}@keyframes slideOutUp{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(-250px)}}.slideOutUp{animation-name:slideOutUp}@keyframes slideOutUpFast{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(-1250px)}}#at4m-menu.slideOutUp{animation-name:slideOutUpFast}@keyframes slideOutDown{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(350px)}}.slideOutDown{animation-name:slideOutDown}@keyframes slideOutDownFast{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(1250px)}}#at4m-menu.slideOutDown{animation-name:slideOutDownFast}@keyframes slideInLeft{0%{opacity:0;transform:translateX(-850px)}to{transform:translateX(0)}}.slideInLeft{animation-name:slideInLeft}@keyframes slideInRight{0%{opacity:0;transform:translateX(1250px)}to{transform:translateX(0)}}.slideInRight{animation-name:slideInRight}@keyframes slideOutLeft{0%{transform:translateX(0)}to{opacity:0;transform:translateX(-350px)}}.slideOutLeft{animation-name:slideOutLeft}@keyframes slideOutRight{0%{transform:translateX(0)}to{opacity:0;transform:translateX(350px)}}.slideOutRight{animation-name:slideOutRight}.at4win{margin:0 auto;background:#fff;border:1px solid #ebeced;width:25pc;box-shadow:0 0 10px rgba(0,0,0,.3);border-radius:8px;font-family:helvetica neue,helvetica,arial,sans-serif;text-align:left;z-index:9999}.at4win .at4win-header{position:relative;border-bottom:1px solid #f2f2f2;background:#fff;height:49px;-webkit-border-top-left-radius:8px;-webkit-border-top-right-radius:8px;-moz-border-radius-topleft:8px;-moz-border-radius-topright:8px;border-top-left-radius:8px;border-top-right-radius:8px;cursor:default}.at4win .at4win-header .at-h3,.at4win .at4win-header h3{height:49px;line-height:49px;margin:0 50px 0 0;padding:1px 0 0;margin-left:20px;font-family:helvetica neue,helvetica,arial,sans-serif;font-size:1pc;font-weight:700;text-shadow:0 1px #fff;color:#333}.at4win .at4win-header .at-h3 img,.at4win .at4win-header h3 img{display:inline-block;margin-right:4px}.at4win .at4win-header .at4-close{display:block;position:absolute;top:0;right:0;background:url("data:image/gif;base64,R0lGODlhFAAUAIABAAAAAP///yH5BAEAAAEALAAAAAAUABQAAAIzBIKpG+YMm5Enpodw1HlCfnkKOIqU1VXk55goVb2hi7Y0q95lfG70uurNaqLgTviyyUoFADs=") no-repeat center center;background-repeat:no-repeat;background-position:center center;border-left:1px solid #d2d2d1;width:49px;height:49px;line-height:49px;overflow:hidden;text-indent:-9999px;text-shadow:none;cursor:pointer;opacity:.5;border:0;transition:opacity .15s ease-in}.at4win .at4win-header .at4-close::-moz-focus-inner{border:0;padding:0}.at4win .at4win-header .at4-close:hover{opacity:1;background-color:#ebeced;border-top-right-radius:7px}.at4win .at4win-content{position:relative;background:#fff;min-height:220px}#at4win-footer{position:relative;background:#fff;border-top:1px solid #d2d2d1;-webkit-border-bottom-right-radius:8px;-webkit-border-bottom-left-radius:8px;-moz-border-radius-bottomright:8px;-moz-border-radius-bottomleft:8px;border-bottom-right-radius:8px;border-bottom-left-radius:8px;height:11px;line-height:11px;padding:5px 20px;font-size:11px;color:#666;-ms-box-sizing:content-box;-o-box-sizing:content-box;box-sizing:content-box}#at4win-footer a{margin-right:10px;text-decoration:none;color:#666}#at4win-footer a:hover{text-decoration:none;color:#000}#at4win-footer a.at4-logo{top:5px;padding-left:10px}#at4win-footer a.at4-privacy{position:absolute;top:5px;right:10px;padding-right:14px}.at4win.ats-dark{border-color:#555;box-shadow:none}.at4win.ats-dark .at4win-header{background:#1b1b1b;-webkit-border-top-left-radius:6px;-webkit-border-top-right-radius:6px;-moz-border-radius-topleft:6px;-moz-border-radius-topright:6px;border-top-left-radius:6px;border-top-right-radius:6px}.at4win.ats-dark .at4win-header .at4-close{background:url("data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAUCAYAAACNiR0NAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAABx0RVh0U29mdHdhcmUAQWRvYmUgRmlyZXdvcmtzIENTNui8sowAAAAWdEVYdENyZWF0aW9uIFRpbWUAMTEvMTMvMTKswDp5AAAAd0lEQVQ4jb2VQRLAIAgDE///Z3qqY1FAhalHMCsCIkVEAIAkkVgvp2lDBgYAnAyHkWotLccNrEd4A7X2TqIdqLfnWBAdaF5rJdyJfjtPH5GT37CaGhoVq3nOm/XflUuLUto2pY1d+vRKh0Pp+MrAVtDe2JkvYNQ+jVSEEFmOkggAAAAASUVORK5CYII=") no-repeat center center;background-image:url(//s7.addthis.com/static/fb08f6d50887bd0caacc86a62bcdcf68.svg),none;border-color:#333}.at4win.ats-dark .at4win-header .at4-close:hover{background-color:#000}.at4win.ats-dark .at4win-header .at-h3,.at4win.ats-dark .at4win-header h3{color:#fff;text-shadow:0 1px #000}.at4win.ats-gray .at4win-header{background:#fff;border-color:#d2d2d1;-webkit-border-top-left-radius:6px;-webkit-border-top-right-radius:6px;-moz-border-radius-topleft:6px;-moz-border-radius-topright:6px;border-top-left-radius:6px;border-top-right-radius:6px}.at4win.ats-gray .at4win-header a.at4-close{border-color:#d2d2d1}.at4win.ats-gray .at4win-header a.at4-close:hover{background-color:#ebeced}.at4win.ats-gray #at4win-footer{border-color:#ebeced}.at4win .clear{clear:both}.at4win ::selection{background:#fe6d4c;color:#fff}.at4win ::-moz-selection{background:#fe6d4c;color:#fff}.at4-icon-fw{display:inline-block;background-repeat:no-repeat;background-position:0 0;margin:0 5px 0 0;overflow:hidden;text-indent:-9999em;cursor:pointer;padding:0;border-radius:50%;-moz-border-radius:50%;-webkit-border-radius:50%}.at44-follow-container a.aticon{height:2pc;margin:0 5px 5px 0}.at44-follow-container .at4-icon-fw{margin:0}</style><link rel="stylesheet" type="text/css" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/trendmd.min.css" media="all"><style type="text/css">.fb_hidden{position:absolute;top:-10000px;z-index:10001}.fb_reposition{overflow:hidden;position:relative}.fb_invisible{display:none}.fb_reset{background:none;border:0;border-spacing:0;color:#000;cursor:auto;direction:ltr;font-family:"lucida grande", tahoma, verdana, arial, sans-serif;font-size:11px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:1;margin:0;overflow:visible;padding:0;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;visibility:visible;white-space:normal;word-spacing:normal}.fb_reset>div{overflow:hidden}@keyframes fb_transform{from{opacity:0;transform:scale(.95)}to{opacity:1;transform:scale(1)}}.fb_animate{animation:fb_transform .3s forwards}
.fb_dialog{background:rgba(82, 82, 82, .7);position:absolute;top:-10000px;z-index:10001}.fb_dialog_advanced{border-radius:8px;padding:10px}.fb_dialog_content{background:#fff;color:#373737}.fb_dialog_close_icon{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 0 transparent;cursor:pointer;display:block;height:15px;position:absolute;right:18px;top:17px;width:15px}.fb_dialog_mobile .fb_dialog_close_icon{left:5px;right:auto;top:5px}.fb_dialog_padding{background-color:transparent;position:absolute;width:1px;z-index:-1}.fb_dialog_close_icon:hover{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -15px transparent}.fb_dialog_close_icon:active{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yq/r/IE9JII6Z1Ys.png) no-repeat scroll 0 -30px transparent}.fb_dialog_iframe{line-height:0}.fb_dialog_content .dialog_title{background:#6d84b4;border:1px solid #365899;color:#fff;font-size:14px;font-weight:bold;margin:0}.fb_dialog_content .dialog_title>span{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/yd/r/Cou7n-nqK52.gif) no-repeat 5px 50%;float:left;padding:5px 0 7px 26px}body.fb_hidden{height:100%;left:0;margin:0;overflow:visible;position:absolute;top:-10000px;transform:none;width:100%}.fb_dialog.fb_dialog_mobile.loading{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/ya/r/3rhSv5V8j3o.gif) white no-repeat 50% 50%;min-height:100%;min-width:100%;overflow:hidden;position:absolute;top:0;z-index:10001}.fb_dialog.fb_dialog_mobile.loading.centered{background:none;height:auto;min-height:initial;min-width:initial;width:auto}.fb_dialog.fb_dialog_mobile.loading.centered #fb_dialog_loader_spinner{width:100%}.fb_dialog.fb_dialog_mobile.loading.centered .fb_dialog_content{background:none}.loading.centered #fb_dialog_loader_close{clear:both;color:#fff;display:block;font-size:18px;padding-top:20px}#fb-root #fb_dialog_ipad_overlay{background:rgba(0, 0, 0, .4);bottom:0;left:0;min-height:100%;position:absolute;right:0;top:0;width:100%;z-index:10000}#fb-root #fb_dialog_ipad_overlay.hidden{display:none}.fb_dialog.fb_dialog_mobile.loading iframe{visibility:hidden}.fb_dialog_mobile .fb_dialog_iframe{position:sticky;top:0}.fb_dialog_content .dialog_header{background:linear-gradient(from(#738aba), to(#2c4987));border-bottom:1px solid;border-color:#1d3c78;box-shadow:white 0 1px 1px -1px inset;color:#fff;font:bold 14px Helvetica, sans-serif;text-overflow:ellipsis;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0;vertical-align:middle;white-space:nowrap}.fb_dialog_content .dialog_header table{height:43px;width:100%}.fb_dialog_content .dialog_header td.header_left{font-size:12px;padding-left:5px;vertical-align:middle;width:60px}.fb_dialog_content .dialog_header td.header_right{font-size:12px;padding-right:5px;vertical-align:middle;width:60px}.fb_dialog_content .touchable_button{background:linear-gradient(from(#4267B2), to(#2a4887));background-clip:padding-box;border:1px solid #29487d;border-radius:3px;display:inline-block;line-height:18px;margin-top:3px;max-width:85px;padding:4px 12px;position:relative}.fb_dialog_content .dialog_header .touchable_button input{background:none;border:none;color:#fff;font:bold 12px Helvetica, sans-serif;margin:2px -12px;padding:2px 6px 3px 6px;text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog_content .dialog_header .header_center{color:#fff;font-size:16px;font-weight:bold;line-height:18px;text-align:center;vertical-align:middle}.fb_dialog_content .dialog_content{background:url(https://static.xx.fbcdn.net/rsrc.php/v3/y9/r/jKEcVPZFk-2.gif) no-repeat 50% 50%;border:1px solid #4a4a4a;border-bottom:0;border-top:0;height:150px}.fb_dialog_content .dialog_footer{background:#f5f6f7;border:1px solid #4a4a4a;border-top-color:#ccc;height:40px}#fb_dialog_loader_close{float:left}.fb_dialog.fb_dialog_mobile .fb_dialog_close_button{text-shadow:rgba(0, 30, 84, .296875) 0 -1px 0}.fb_dialog.fb_dialog_mobile .fb_dialog_close_icon{visibility:hidden}#fb_dialog_loader_spinner{animation:rotateSpinner 1.2s linear infinite;background-color:transparent;background-image:url(https://static.xx.fbcdn.net/rsrc.php/v3/yD/r/t-wz8gw1xG1.png);background-position:50% 50%;background-repeat:no-repeat;height:24px;width:24px}@keyframes rotateSpinner{0%{transform:rotate(0deg)}100%{transform:rotate(360deg)}}
.fb_iframe_widget{display:inline-block;position:relative}.fb_iframe_widget span{display:inline-block;position:relative;text-align:justify}.fb_iframe_widget iframe{position:absolute}.fb_iframe_widget_fluid_desktop,.fb_iframe_widget_fluid_desktop span,.fb_iframe_widget_fluid_desktop iframe{max-width:100%}.fb_iframe_widget_fluid_desktop iframe{min-width:220px;position:relative}.fb_iframe_widget_lift{z-index:1}.fb_iframe_widget_fluid{display:inline}.fb_iframe_widget_fluid span{width:100%}</style></head><body data-sitename="jama" class="pg_article split-screen" data-thm="jama" data-gr-c-s-loaded="true">        <script>
      var SCM = SCM || {};
      if (SCM.AMA && SCM.AMA.DataLayerAsync) {
        SCM.AMA.DataLayerAsync.push("arrSisAffinity", "Adolescent+Medicine,Bariatric+Surgery,Cardiology,Cerebrovascular+Disease,Depressive+Disorders,Guidelines,Lifestyle+Behaviors,Obesity,Pediatrics,Physical+Activity,Psychiatry,Psychotherapy,Surgery,Diet,Hepatobiliary+Disease,Cardiovascular+Risk+Factors,Ischemic+Heart+Disease,Gastroenterology+and+Hepatology,Nutrition%2C+Obesity%2C+Exercise,United+States+Preventive+Services+Task+Force", "array");
        SCM.AMA.DataLayerAsync.push("SubStatus", "no", "string");
      }

      var googletag = googletag || {};
      googletag.cmd = googletag.cmd || [];

      
      if (!googletag.pubads) {
        (function () {
          var gads = document.createElement('script');
          var useSSL = 'https:' == document.location.protocol;
          gads.src = (useSSL ? 'https:' : 'http:') +
            '//www.googletagservices.com/tag/js/gpt.js';
          var node = document.getElementsByTagName('script')[0];
          node.parentNode.insertBefore(gads, node);
        })();

        var App = App || {};
        App.Ads = App.Ads || {};
        App.Ads.adPath = App.Ads.adPath || '/6479/' + 'ama.jama';
        App.Ads.Mappings = App.Ads.Mappings || {};
        App.Ads.slots = App.Ads.slots || [];
        App.Ads.fromGoogle = !('no' === 'yes');

        App.isCollection = App.isCollection || !!document.getElementsByClassName('pg_collection').length;


        googletag.cmd.push(function () {

          googletag.pubads()
            .setTargeting('environment', ['newjama'])
            .setTargeting('site', ['ama.jama'])
            .setTargeting('sect', ['scholarly'])
            .setTargeting('sub', ['no'])
            .setTargeting('device', ['Mozilla%2F5.0%20(Windows%20NT%206.1%3B%20Win64%3B%20x64)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.108%20Safari%2F537.36'])
            .setTargeting('usaphys', ['no'])
            .setTargeting('memberstat', ['no'])
            .setTargeting('pracset', [''])
            .setTargeting('specialty', ['other'])
            .setTargeting('occupation', [''])
            .setTargeting('useraffinity', ['5495,5526,5548,5553,5595,5672,5720,5791,5843,5854,5871,5875,5923,42055,42094,42101,42118,44012,44027,44068'])
            .setTargeting('direct', ['no'])
            .setTargeting('bot', [''])
            .setTargeting('datacenter', ['no'])
            .setTargeting('selfMPA', [''])
            .setTargeting('selfSpecialty', ['']);

          if (App.isCollection) {
            googletag.pubads().setTargeting('collection', ['']);
          }

          var testParam = getQueryVariable('test');

          if (testParam) {
            googletag.pubads().setTargeting('test', [testParam]);
          }

          function getQueryVariable(variable) {
            var query = window.location.search.substring(1);
            var vars = query.split('&');
            for (var i = 0; i < vars.length; i++) {
              var pair = vars[i].split('=');
              if (decodeURIComponent(pair[0]) == variable) {
                return decodeURIComponent(pair[1]);
              }
            }
            console.log('Query variable %s not found', variable);
          }

          googletag.pubads().disableInitialLoad();
          googletag.enableServices();
        });
      }
        </script>




    
    <script>
        
        var App = App || {};
        App.suppressAds = App.suppressAds || !!document.getElementsByClassName('suppress-ads').length;
    </script>

    

    
    <a class="accessible" href="https://jamanetwork.com/journals/jama/article-abstract/188381#skip-to-content">[Skip to Content]</a>
    
    <!-- Google Tag Manager --><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-WNKSNP" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WNKSNP');</script><!-- End Google Tag Manager -->

    
    
    <span class="hide tagmanagervalue" data-attribute="journalName" data-value="JAMA" data-type="string"></span>
    <form method="post" action="https://jamanetwork.com/journals/jama/article-abstract/188381" id="webform" class="m0" novalidate="novalidate">
<div class="aspNetHidden">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUKLTYwMDU3MTgxOWRkWZLOAorjvbiftuJ1TLkb1DVSXUk=">
</div>

<div class="aspNetHidden">

	<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="2173C2F0">
	<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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">
</div>
        
        <input id="hdnSiteID" type="hidden" value="3">
        <input id="hdnDomain" type="hidden" value=".jamanetwork.com">

        
        


        
        

    <section class="master-header">
        
<nav id="nav" class="nav">
    <div class="nav-journal-level">
        <a href="https://jamanetwork.com/journals/jama" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_0" class="home">Home</a><a href="https://jamanetwork.com/journals/jama/newonline" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_1" class="new-online">New Online</a><a href="https://jamanetwork.com/journals/jama/currentissue" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_2" class="current-issue">Current Issue</a><a href="https://jamanetwork.com/journals/jama/pages/for-authors" id="BodyContent_Header_rptMicrositeHeaders_aItemResourceList_3" class="for-authors">For Authors</a>
    </div>
    <div class="nav-journals">
        <h2 id="BodyContent_Header_JournalHeader" class="nav-heading">Journals</h2>
        <a href="https://jamanetwork.com/journals/jama" id="BodyContent_Header_rptJournals_aItemResourceList_0" class="theme-jama">JAMA</a><a href="https://jamanetwork.com/journals/jamanetworkopen" id="BodyContent_Header_rptJournals_aItemResourceList_1" class="theme-jama-network-open">JAMA Network Open</a><a href="https://jamanetwork.com/journals/jamacardiology" id="BodyContent_Header_rptJournals_aItemResourceList_2" class="theme-jama-cardiology">JAMA Cardiology</a><a href="https://jamanetwork.com/journals/jamadermatology" id="BodyContent_Header_rptJournals_aItemResourceList_3" class="theme-jama-dermatology">JAMA Dermatology</a><a href="https://jamanetwork.com/journals/jamafacialplasticsurgery" id="BodyContent_Header_rptJournals_aItemResourceList_4" class="theme-jama-facial-plastic-surgery">JAMA Facial Plastic Surgery</a><a href="https://jamanetwork.com/journals/jamainternalmedicine" id="BodyContent_Header_rptJournals_aItemResourceList_5" class="theme-jama-internal-medicine">JAMA Internal Medicine</a><a href="https://jamanetwork.com/journals/jamaneurology" id="BodyContent_Header_rptJournals_aItemResourceList_6" class="theme-jama-neurology">JAMA Neurology</a><a href="https://jamanetwork.com/journals/jamaoncology" id="BodyContent_Header_rptJournals_aItemResourceList_7" class="theme-jama-oncology">JAMA Oncology</a><a href="https://jamanetwork.com/journals/jamaophthalmology" id="BodyContent_Header_rptJournals_aItemResourceList_8" class="theme-jama-ophthalmology">JAMA Ophthalmology</a><a href="https://jamanetwork.com/journals/jamaotolaryngology" id="BodyContent_Header_rptJournals_aItemResourceList_9" class="theme-jama-otolaryngology-head-neck-surgery">JAMA Otolaryngology–Head &amp; Neck Surgery</a><a href="https://jamanetwork.com/journals/jamapediatrics" id="BodyContent_Header_rptJournals_aItemResourceList_10" class="theme-jama-pediatrics">JAMA Pediatrics</a><a href="https://jamanetwork.com/journals/jamapsychiatry" id="BodyContent_Header_rptJournals_aItemResourceList_11" class="theme-jama-psychiatry">JAMA Psychiatry</a><a href="https://jamanetwork.com/journals/jamasurgery" id="BodyContent_Header_rptJournals_aItemResourceList_12" class="theme-jama-surgery">JAMA Surgery</a><a href="https://jamanetwork.com/journals/archneurpsyc" id="BodyContent_Header_rptJournals_aItemResourceList_13" class="theme-archives-of-neurology-psychiatry-1919-1959-">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
    </div>
    <div class="nav-network-other">
        <a href="https://edhub.ama-assn.org/jn-learning" id="BodyContent_Header_rptOtherResources_aItemResourceList_0" class="is-b link-jn-learning" target="_blank">JN Learning</a><a href="https://store.jamanetwork.com/" id="BodyContent_Header_rptOtherResources_aItemResourceList_1" class="is-b link-subscribe" target="_blank">Subscribe</a><a href="https://jamanetwork.com/pages/apps/" id="BodyContent_Header_rptOtherResources_aItemResourceList_2" class="is-b link-apps">Apps</a><a href="https://careers.jamanetwork.com/" id="BodyContent_Header_rptOtherResources_aItemResourceList_3" class="is-b link-jobs" target="_blank">Jobs</a><a href="https://jamanetwork.com/pages/institutions-and-librarians" id="BodyContent_Header_rptOtherResources_aItemResourceList_4" class="is-b link-institutions-librarians">Institutions / Librarians</a><a href="https://jamanetwork.com/pages/reprints-and-permissions" id="BodyContent_Header_rptOtherResources_aItemResourceList_5" class="is-b link-reprints-permissions" rel="nofollow">Reprints &amp; Permissions</a>
    </div>
    <div class="white text-xxs">
        <div class="p05 ml4 mr3 mb1 mt10 flex hamburger-menu-legal">
            <a href="https://jamanetwork.com/pages/conditions-of-use" class="p0" rel="nofollow">Terms of Use</a>
            <span class="pl1 pr1">| </span>
            <a href="https://jamanetwork.com/pages/privacy-policy" class="p0" rel="nofollow">Privacy Policy</a>
            <span class="pl1 pr1">| </span>
            <a href="https://jamanetwork.com/pages/accessibility-statement" class="p0" rel="nofollow">Accessibility Statement</a>
        </div>
        <div class="ta-c">
            <span class="pb1">2019 American Medical Association. All Rights Reserved</span>
        </div>
    </div>
</nav>

<script type="text/javascript">
    var App = App || {};
    App.LoginUserInfo = {
        isInstLoggedIn: [0],
        currentSessionId: 'huq2ygoiua0u3ghrlit3i0jd'
    };
</script>



<input name="ctl00$ctl00$BodyContent$Header$hfGlobalSearchSiteURL" type="hidden" id="hfGlobalSearchSiteURL" value="https://jamanetwork.com/">

<input name="ctl00$ctl00$BodyContent$Header$hfAppIsPaidUser" type="hidden" id="hfAppIsPaidUser" value="false">
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsMember" type="hidden" id="hfAppIsMember" value="false">
<input name="ctl00$ctl00$BodyContent$Header$hfAppSubscribedTo" type="hidden" id="hfAppSubscribedTo">
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsIndividual" type="hidden" id="hfAppIsIndividual" value="false">
<input name="ctl00$ctl00$BodyContent$Header$hfAppHasAccess" type="hidden" id="hfAppHasAccess" value="false">
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsReferredFromGoogle" type="hidden" id="hfAppIsReferredFromGoogle" value="True">
<input name="ctl00$ctl00$BodyContent$Header$hfSolrAutoSuggestMinimumCharactersLength" type="hidden" id="hfSolrAutoSuggestMinimumCharactersLength" value="2">
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalName" type="hidden" id="hfSolrJournalName" value="JAMA">
<input name="ctl00$ctl00$BodyContent$Header$hfSolrJournalID" type="hidden" id="hfSolrJournalID" value="J67">
<input name="ctl00$ctl00$BodyContent$Header$hfAppIsLucy" type="hidden" id="hfAppIsLucy" value="false">


<div class="header-wrap">
    <header class="header">
        <div class="network-bar">
            <a class="jama-network" href="https://jamanetwork.com/" title="JAMA Network Home">
                <img alt="JAMA Network Home" class="title-image" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/Jama_Network_Logo.svg">
            </a>
            
        </div>

        <a class="nav-toggler" href="https://jamanetwork.com/journals/jama/article-abstract/188381#nav">
            <div class="nav-toggler-indicator">
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
                <span class="indicator-stroke"></span>
            </div>
            <div class="nav-toggler-site">
                <span id="BodyContent_Header_siteFullNamenav" class="nav-toggler-microsite"><span class="network">JAMA</span></span>
            </div>
        </a>


        
        <div id="BodyContent_Header_GlobalSignIn_auth" class="auth">
            <a class="auth--trigger is-b is-a">
                <span id="BodyContent_Header_GlobalSignIn_spnUserFullName" class="user-full-name">Sign In</span>
            </a>

            <div class="auth--dropdown">
                
                <div class="auth--option auth--ind">
                    
                    <div id="BodyContent_Header_GlobalSignIn_divUserFullName" class="auth--ind-user"></div>                    
                    
                    <div id="BodyContent_Header_GlobalSignIn_divIndSignIn" class="auth--ind-auth">
                        <div class="auth--title">Individual Sign In</div>
                        <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="BodyContent_Header_GlobalSignIn_oauthSignInLink" rel="nofollow" class="auth--ind-sign-in">Sign in</a><a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="BodyContent_Header_GlobalSignIn_oauthSignUpLink" rel="nofollow" class="auth--ind-create">Create an Account</a>
                    </div>
                </div>

                
                <div id="BodyContent_Header_GlobalSignIn_divInstSignIn" class="auth--option auth--inst">

                    
                    <div class="auth--inst-auth">
                        <div class="auth--title">Institutional Sign In</div>
                        <a id="BodyContent_Header_GlobalSignIn_openAthensSignIn_lnkAuthensLogin" class="auth--athens" rel="nofollow" href="https://jamanetwork.com/PageRedirectHandler.ashx?returnurl=https://jamanetwork.com/journals/jama/fullarticle/188381&amp;redirectpage=openathens">OpenAthens</a>
                        <a rel="nofollow" class="auth--shib" href="https://jamanetwork.com/signinshibboleth">Shibboleth</a>
                    </div>
                </div>
 
                                               
                

                
                <div id="BodyContent_Header_GlobalSignIn_divPurchaseOptions" class="auth--option auth--purchase">
                    <div class="auth--title">Purchase Options:</div>
                    
                    <a id="BodyContent_Header_GlobalSignIn_lnkSubscribeJournal" class="auth--subscribe" href="https://store.jamanetwork.com/productDetails.aspx?journalId=67">Subscribe to the JAMA journal</a>
                </div>

                
                

                
                
                
            </div>
        </div>





        
        <a class="toolbar-search-trigger is-b" data-mobile-tog-target=".site-search"></a>

        
        <div id="site-search" class="site-search">
            <div class="site-search-bar"><div class="cs-select cs-skin-border" tabindex="0"><span class="cs-placeholder is-a">Journals</span><div class="cs-options"><ul><li data-option="" data-value="J*"><span>Journals</span></li><li data-option="" data-value="J67"><span>JAMA</span></li><li data-option="" data-value="J187"><span>JAMA Network Open</span></li><li data-option="" data-value="J184"><span>JAMA Cardiology</span></li><li data-option="" data-value="J68"><span>JAMA Dermatology</span></li><li data-option="" data-value="J69"><span>JAMA Facial Plastic Surgery</span></li><li data-option="" data-value="J71"><span>JAMA Internal Medicine</span></li><li data-option="" data-value="J72"><span>JAMA Neurology</span></li><li data-option="" data-value="J174"><span>JAMA Oncology</span></li><li data-option="" data-value="J73"><span>JAMA Ophthalmology</span></li><li data-option="" data-value="J74"><span>JAMA Otolaryngology–Head &amp; Neck Surgery</span></li><li data-option="" data-value="J75"><span>JAMA Pediatrics</span></li><li data-option="" data-value="J70"><span>JAMA Psychiatry</span></li><li data-option="" data-value="J76"><span>JAMA Surgery</span></li><li data-option="" data-value="J91"><span>Archives of Neurology &amp; Psychiatry</span></li></ul></div><select name="ctl00$ctl00$BodyContent$Header$ddlForSearch" id="BodyContent_Header_ddlForSearch" class="cs-select cs-skin-border" title="Search Site Selector">
	<option value="J*">Journals</option>
	<option value="J67">JAMA</option>
	<option value="J187">JAMA Network Open</option>
	<option value="J184">JAMA Cardiology</option>
	<option value="J68">JAMA Dermatology</option>
	<option value="J69">JAMA Facial Plastic Surgery</option>
	<option value="J71">JAMA Internal Medicine</option>
	<option value="J72">JAMA Neurology</option>
	<option value="J174">JAMA Oncology</option>
	<option value="J73">JAMA Ophthalmology</option>
	<option value="J74">JAMA Otolaryngology–Head &amp; Neck Surgery</option>
	<option value="J75">JAMA Pediatrics</option>
	<option value="J70">JAMA Psychiatry</option>
	<option value="J76">JAMA Surgery</option>
	<option value="J91">Archives of Neurology &amp; Psychiatry</option>

</select></div>
                
                

                
                <div class="search-input-container">

                    <input id="search-term" class="search-term" type="text" placeholder="Enter Search Term" maxlength="255" title="Enter Search Term">


                    <input class="searchTerm" type="text" id="umbrellaSiteSearchInputHint" autocomplete="off">

                    <ul id="umbrellaSiteAutoCompleteResults" class="term-list hidden"></ul>


                </div>
                <!-- /.search-input-container -->
                
                <a class="search-button is-b"></a>
            </div>
        </div>
    </header>
</div>



<div class="editors-choice-header">
</div>

<div id="BodyContent_Header_divAds" class="header-ad-wrap">
    <div class="leader-ad desktop-only">
        
            

    </div>
</div>
<!-- /.header-ad-wrap -->


    </section>


    <section class="master-main">
        <a id="skip-to-content" class="hide">[Skip to Content Landing]</a>
        
	    <div class="widget-UserContentAccessWrite widget-instance-AMA_LocalStorage_Article">
        <div class="SCM-SharedWidgets-LocalStorage-UserContentAccessWrite" data-values="{&quot;id&quot;:&quot;188381&quot;,&quot;type&quot;:&quot;Article&quot;,&quot;date&quot;:&quot;4/29/2019 5:10:18 AM&quot;}"></div>
 
    </div>
<div itemscope="" itemtype="http://schema.org/Article">
    <meta itemprop="inLanguage" content="en-US">
    <meta itemprop="name headline" content="Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat : A Randomized Controlled Trial">
    <meta itemprop="description" content="Context Orlistat, a gastrointestinal lipase inhibitor that reduces dietary fat absorption by approximately 30%, may promote weight loss and reduce cardiovascular risk factors. Objective To test the hypothesis that orlistat combined with dietary intervention is more effective than placebo plus diet for weight loss and maintenance over 2 years. Design...">
    <meta itemprop="author" content="Michael H. Davidson, MD">
    <meta itemprop="url" content="https://jamanetwork.com/journals/jama/fullarticle/188381">
    <meta itemprop="datePublished" datetime="1999-01-20" content="1999-01-20">
        <meta itemprop="image" content="https://jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f1.gif">
        <meta itemprop="image" content="https://jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t1.png">
        <meta itemprop="image" content="https://jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t2.png">
        <meta itemprop="image" content="https://jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f2.gif">
        <meta itemprop="image" content="https://jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t3.png">
        <meta itemprop="image" content="https://jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f3.gif">
            <meta itemprop="articleSection" content="Abstract">
        <meta itemprop="articleSection" content="Methods">
        <meta itemprop="articleSection" content="Subjects">
        <meta itemprop="articleSection" content="Study Design">
        <meta itemprop="articleSection" content="Assessments">
        <meta itemprop="articleSection" content="Statistical Analysis">
        <meta itemprop="articleSection" content="Results">
        <meta itemprop="articleSection" content="Participation">
        <meta itemprop="articleSection" content="Table 1. Demographic Data From Start of Placebo Lead-in Period*">
        <meta itemprop="articleSection" content="Table 2. Summary of Reasons for Study Withdrawal*">
        <meta itemprop="articleSection" content="Weight Loss">
        <meta itemprop="articleSection" content="Obesity-Related Risk Factors">
        <meta itemprop="articleSection" content="Table 3. Results of Serum Lipid Studies">
        <meta itemprop="articleSection" content="Table 4. Results of Fasting Serum Glucose and Insulin Studies">
        <meta itemprop="articleSection" content="Comment">
        <meta itemprop="articleSection" content="Weight Loss Effects">
        <meta itemprop="articleSection" content="Risk Factor Reduction">
        <meta itemprop="articleSection" content="Adverse Effects">
        <meta itemprop="articleSection" content="Study Limitations">
        <meta itemprop="articleSection" content="References">
    <meta itemprop="keywords" content="obesity, orlistat, body weight decreased, weight maintenance regimen, diet">
</div>    <div class="widget-ArticleToggleView widget-instance-AMA_ArticleToggleView">
        
    <div class="widget-ArticleFullView widget-instance-AMA_ArticleFullView">
        
<script>
    (function () {
        var bodyElem = document.querySelector('body');
        var className = 'split-screen';

        if (bodyElem.classList) {
            bodyElem.classList.add(className);
        } else {
            el.className += ' ' + className;
        }
    })();
</script>


<div id="resources-panel" class="resources-panel">
            <span class="hide tagmanagervalue" data-attribute="articleTemplate" data-value="splitscreen" data-type="string"></span>

   
<div class="tab-nav is_stuck" style="position: fixed; top: 100px; width: 582px;">
    <a class="tab-nav-trigger tab-nav-full-text tablet-down" href="https://jamanetwork.com/journals/jama/article-abstract/188381#full-text-tab">
        <i class="icon-full_text"><span class="sr-t">full text icon</span></i>
        <div class="tab-nav-tab-name">Full Text</div>
    </a>
    <a class="tab-nav-trigger tab-nav-contents target-tab-active" href="https://jamanetwork.com/journals/jama/article-abstract/188381#contents-tab">
        <i class="icon-contents"><span class="sr-t">contents icon</span></i>
        <div class="tab-nav-tab-name">Contents</div>
    </a>
    <a class="tab-nav-trigger tab-nav-figure-table" href="https://jamanetwork.com/journals/jama/article-abstract/188381#figure-table-tab">
        <i class="icon-figures"><span class="sr-t">figure icon</span></i>
        <div class="tab-nav-tab-name">Figures / <br> Tables</div>
    </a>
    <a class="tab-nav-trigger tab-nav-multimedia tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#multimedia-tab" style="display: none!important">
        <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
        <div class="tab-nav-tab-name">Multimedia</div>
    </a>
    <a class="tab-nav-trigger tab-nav-supplemental tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#supplemental-tab" style="display: none!important">
        <i class="icon-attach"><span class="sr-t">attach icon</span></i>
        <div class="tab-nav-tab-name">Supplemental <br> Content</div>
    </a>
    <a class="tab-nav-trigger tab-nav-references" href="https://jamanetwork.com/journals/jama/article-abstract/188381#references-tab">
        <i class="icon-references"><span class="sr-t">references icon</span></i>
        <div class="tab-nav-tab-name">References</div>
    </a>
    <a class="tab-nav-trigger tab-nav-related" href="https://jamanetwork.com/journals/jama/article-abstract/188381#related-tab">
        <i class="icon-related"><span class="sr-t">related icon</span></i>
        <div class="tab-nav-tab-name">Related</div>
    </a>
    <a class="tab-nav-trigger tab-nav-comments tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#comments-tab" style="display: none!important">
        <i class="icon-user-comments"><span class="sr-t">comments icon</span></i>
        <div class="tab-nav-tab-name">Comments</div>
    </a>
</div><div style="position: relative; width: 582px; height: 92px; display: block; vertical-align: baseline; float: none;"></div>

<div class="resource-tabs">
<div id="contents-tab" class="resource-tab contents-tab tab-active">
    <div class="contents-tab-contents">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="188381" data-article-url="/journals/jama/articlepdf/188381/joc80835.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>
    <div class="widget-ArticleJumpLinks widget-instance-AMA_ArticleJumpLinks_Widget">
            <a href="https://jamanetwork.com/journals/jama/article-abstract/188381#top" class="section-jump-link contents-tab-jump-link top-of-article" data-tab-toggle=".tab-nav-full-text">Top of Article</a>
    <ul class="section-jump-links bullet ml2 pl1">
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="https://jamanetwork.com/journals/jama/article-abstract/188381#24723301" data-tab-toggle=".tab-nav-full-text">Abstract</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="https://jamanetwork.com/journals/jama/article-abstract/188381#24723305" data-tab-toggle=".tab-nav-full-text">Methods</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="https://jamanetwork.com/journals/jama/article-abstract/188381#24723322" data-tab-toggle=".tab-nav-full-text">Results</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="https://jamanetwork.com/journals/jama/article-abstract/188381#24723345" data-tab-toggle=".tab-nav-full-text">Comment</a></li>
                <li><a class="section-jump-link contents-tab-jump-link scroll-to head-1" href="https://jamanetwork.com/journals/jama/article-abstract/188381#24723368" data-tab-toggle=".tab-nav-full-text">References</a></li>
    </ul>
 
    </div>
    <div class="widget-SelfServeContent widget-instance-AMA_Contents_Tab_SelfServe">
         
    </div>

    </div>
    <div class="contents-tab-ad">
        <div id="split-screen-contab">        <div id="ad-article-contents-sky" class="ad-article-contents-sky advertisement" data-slot="50">
            <script>
          googletag.cmd.push(function() {
            if (!App.suppressAds && ((App.isCurrentIssue || App.isPastIssues || App.isNewOnline) || (App.isSplitScreen && App.isFreeArticle && !App.hasAccess && !App.Ads.fromGoogle))) {
              App.Ads.Mappings.sky = googletag.sizeMapping()
                .addSize([1024, 600], [[120, 600], [160, 600], [300, 250], [300, 600]])
                .addSize([1024, 0], [[120, 600], [160, 600], [300, 250], [300, 600]])
                .addSize([0, 600], [[120, 600], [160, 600], [300, 250], [300, 600]])
                .addSize([0, 0], [300, 250])
                .build();
              App.Ads.slots[50] = googletag.defineSlot(App.Ads.adPath + '/scholarly', [300, 250], 'ad-article-contents-sky')
                .setTargeting('pos', ['contab'])
                .defineSizeMapping(App.Ads.Mappings.sky)
                .addService(googletag.pubads());
              googletag.display('ad-article-contents-sky');
            } else {
              $(".ad-article-contents-sky").removeClass("ad-text");
            }
          });
            </script>
        </div>
</div>
    </div>
</div>


<div id="figure-table-tab" class="resource-tab figure-table-tab need-jobs-ad">
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Figures_Tab">
        <div class="figure-table-wrapper figure-no-label thm-bd-top">Figure 1. Flow and Disposition of Subjects Entered Into the
Study<a id="Joc80835f1" class="figure-table-anchor"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="Joc80835f1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f1.gif?Expires=2147483647&amp;Signature=T0KfzbG19l-~zD9B9XANH9XoLkAXZqYFzIOzHQNepqqfS1SW0G5aGuUsyiy5YJhGSe2hed54slu4nO5t9olnMZ~JFkGShmBHX6PFhF3cSWzGnFWdz3FqV~wIuKSd47~f6LlOkC1WPmubVhMKnfT4PelpXXHM5X2kNCw4k4jkyfbr5RoqNVCRpgFRcEa5iSbG8Elh4mKcSK9y3wS4rVPSlHRYPpbnIhPt00Ja5XuIEeN-tR0Wh1IMWKqF4Xxtd4JWn9gIJ4-3wK-GDn517C-SyXa8-WbTzRBB-ZcE~zXHh1o0VFJSc~b3kPI8nJbsBMLR-wBnaH7vaPU9XpQPJxNxZQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="Joc80835f1" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f1.gif?Expires=2147483647&amp;Signature=T0KfzbG19l-~zD9B9XANH9XoLkAXZqYFzIOzHQNepqqfS1SW0G5aGuUsyiy5YJhGSe2hed54slu4nO5t9olnMZ~JFkGShmBHX6PFhF3cSWzGnFWdz3FqV~wIuKSd47~f6LlOkC1WPmubVhMKnfT4PelpXXHM5X2kNCw4k4jkyfbr5RoqNVCRpgFRcEa5iSbG8Elh4mKcSK9y3wS4rVPSlHRYPpbnIhPt00Ja5XuIEeN-tR0Wh1IMWKqF4Xxtd4JWn9gIJ4-3wK-GDn517C-SyXa8-WbTzRBB-ZcE~zXHh1o0VFJSc~b3kPI8nJbsBMLR-wBnaH7vaPU9XpQPJxNxZQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723326&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f1.gif?Expires=2147483647&amp;Signature=T0KfzbG19l-~zD9B9XANH9XoLkAXZqYFzIOzHQNepqqfS1SW0G5aGuUsyiy5YJhGSe2hed54slu4nO5t9olnMZ~JFkGShmBHX6PFhF3cSWzGnFWdz3FqV~wIuKSd47~f6LlOkC1WPmubVhMKnfT4PelpXXHM5X2kNCw4k4jkyfbr5RoqNVCRpgFRcEa5iSbG8Elh4mKcSK9y3wS4rVPSlHRYPpbnIhPt00Ja5XuIEeN-tR0Wh1IMWKqF4Xxtd4JWn9gIJ4-3wK-GDn517C-SyXa8-WbTzRBB-ZcE~zXHh1o0VFJSc~b3kPI8nJbsBMLR-wBnaH7vaPU9XpQPJxNxZQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="Joc80835f1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835f1.gif?Expires=2147483647&amp;Signature=OtyC4pDtHjySqczf4IKKt-Cj8QpThNoTC8R~L2oCch96vPUVwj5Jodd2Vjebz2iGEy3Yd-iI25XEtxOgAY7mfigE9FWp1tqhY-hN5Hou8C3x6YNCD6ZyiHl4afM1MBVeM0BXJJLD7mFdu6OtKt8CUdcS0IOlZbW29Jf7WGK~6s9aUYAL72OS9qEqpx3NAJ~GGAbJE1CbGlm-D58bF-ePGJE3Mvf-oKZ5xG2vAs~85JP5H1jw2x6B85F2tjfFDGXFEnoT~8KQX1uARIW3OuhwE4TSc2WIPIJ7l~0uCqkN5DegcFZmDovipks~t-5oS9iZfKkcYwcL1HBZc262ozcxxg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="Joc80835f1"></a></div></div></div><div class="figure-table-wrapper figure-no-label thm-bd-top">Figure 2. Mean Body Weight Change (±SEM) During 2
Years of Double-Blind Treatment*<a id="Joc80835f2" class="figure-table-anchor"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="Joc80835f2" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f2.gif?Expires=2147483647&amp;Signature=tRZ5tIxBT7F2~GJC7Eiqqw-xlef8b2qQ7IRX1IVXuWAOpzEbmaFFvstCdPwIdcTfmzzAuFQ5lpBC0~bne0qg6SPv-vUDrFRQh~P8w61DICrpLr7oEyb~0RvlXMJYxObQx-42VPFyIGxnfnuN84HgIuSW76sdnY4XL-w8Hw9a3Gsk8ibMsCcuPPkmeHPoJLA0emU1-houEmSj~8qMy7HsjZCRrjHWIENEokTxpSlZ4nP7ZGn6rtoBcM4KdOcUX2pMulTdCndtewWqYgHuZ7zE-YgIvKCeConVcdGWr46CSJYusBRykzu615w2SJF6fzVGwEBO2SmZ-HGaeuTnyxXceg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="Joc80835f2" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f2.gif?Expires=2147483647&amp;Signature=tRZ5tIxBT7F2~GJC7Eiqqw-xlef8b2qQ7IRX1IVXuWAOpzEbmaFFvstCdPwIdcTfmzzAuFQ5lpBC0~bne0qg6SPv-vUDrFRQh~P8w61DICrpLr7oEyb~0RvlXMJYxObQx-42VPFyIGxnfnuN84HgIuSW76sdnY4XL-w8Hw9a3Gsk8ibMsCcuPPkmeHPoJLA0emU1-houEmSj~8qMy7HsjZCRrjHWIENEokTxpSlZ4nP7ZGn6rtoBcM4KdOcUX2pMulTdCndtewWqYgHuZ7zE-YgIvKCeConVcdGWr46CSJYusBRykzu615w2SJF6fzVGwEBO2SmZ-HGaeuTnyxXceg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723332&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f2.gif?Expires=2147483647&amp;Signature=tRZ5tIxBT7F2~GJC7Eiqqw-xlef8b2qQ7IRX1IVXuWAOpzEbmaFFvstCdPwIdcTfmzzAuFQ5lpBC0~bne0qg6SPv-vUDrFRQh~P8w61DICrpLr7oEyb~0RvlXMJYxObQx-42VPFyIGxnfnuN84HgIuSW76sdnY4XL-w8Hw9a3Gsk8ibMsCcuPPkmeHPoJLA0emU1-houEmSj~8qMy7HsjZCRrjHWIENEokTxpSlZ4nP7ZGn6rtoBcM4KdOcUX2pMulTdCndtewWqYgHuZ7zE-YgIvKCeConVcdGWr46CSJYusBRykzu615w2SJF6fzVGwEBO2SmZ-HGaeuTnyxXceg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="Joc80835f2" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835f2.gif?Expires=2147483647&amp;Signature=acDyDDbPSewowZVjaAaYb-fDD6j~0R5XRTsCaAJCg-E90M2FnXJTpJR2WmwBnm6idigAQ2gW33UUJcG0A5FUmvANDR25AEhRJBtvAUTs3SqvPYESfQPfl~~OhhjeqXmQTrVWvuEkSItk0GkjkWPxr3AA8H5hXkjmsHp0gCq5ZyFKqtqzpWHWvDU82nqvNoJ3mB9g6~IZOKtaVRZ4nnG1ZZC-0QkcySM4gRjxheGM9JVNSjyPQ5VZtKqMdWNYreL83QegnVh4dZbeV9C66-6m879483-ha3S-RhCLlEDsbpwHzUXtxk9gxiKPPgM1GBOWAIk~9APrFPTzPTkEY0ZJPg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="Joc80835f2"></a></div></div><div class="figure-caption clip-last-child">*Numbers in parentheses are number of subjects at each time
point.</div></div><div class="figure-table-wrapper figure-no-label thm-bd-top">Figure 3. Changes in Fasting Serum Insulin and Lipid
Levels During 1 Year of Double-Blind Treatment Plus Hypocaloric
Diet<a id="Joc80835f3" class="figure-table-anchor"> </a><div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="Joc80835f3" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f3.gif?Expires=2147483647&amp;Signature=DI45E0nzmdj8cAWB7D4g2Hlg9jmkbYW5vPM8eOPbC3Qez2GseMjrNVOf-0XV16Y8I14xJcRBnu4XFwsoBdXEmFsqh818qZynZHtHrVHvsOntFZuuAeXzTIdzMkP~ELtREYU9zD~PQI5BlTwYUwei1PSkRlhkRPwa-PZGHbaW588uXEcLpaTxaUiBYkFRnhMK7IUvG0mChHLH9~GxPgS-S4oV1Sab5Z5lXB4xBneKK~BqOr0V~zsZigPqwY-ZwNX2RsJ4dmn9iU1gBQ5K8RfIC~NG6N8rpLyqude8PVGPg2QwZzrBUd2psc54nEZszmdFfVDH8OSxQvYr3nupGuNlxQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="Joc80835f3" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f3.gif?Expires=2147483647&amp;Signature=DI45E0nzmdj8cAWB7D4g2Hlg9jmkbYW5vPM8eOPbC3Qez2GseMjrNVOf-0XV16Y8I14xJcRBnu4XFwsoBdXEmFsqh818qZynZHtHrVHvsOntFZuuAeXzTIdzMkP~ELtREYU9zD~PQI5BlTwYUwei1PSkRlhkRPwa-PZGHbaW588uXEcLpaTxaUiBYkFRnhMK7IUvG0mChHLH9~GxPgS-S4oV1Sab5Z5lXB4xBneKK~BqOr0V~zsZigPqwY-ZwNX2RsJ4dmn9iU1gBQ5K8RfIC~NG6N8rpLyqude8PVGPg2QwZzrBUd2psc54nEZszmdFfVDH8OSxQvYr3nupGuNlxQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723338&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835f3.gif?Expires=2147483647&amp;Signature=DI45E0nzmdj8cAWB7D4g2Hlg9jmkbYW5vPM8eOPbC3Qez2GseMjrNVOf-0XV16Y8I14xJcRBnu4XFwsoBdXEmFsqh818qZynZHtHrVHvsOntFZuuAeXzTIdzMkP~ELtREYU9zD~PQI5BlTwYUwei1PSkRlhkRPwa-PZGHbaW588uXEcLpaTxaUiBYkFRnhMK7IUvG0mChHLH9~GxPgS-S4oV1Sab5Z5lXB4xBneKK~BqOr0V~zsZigPqwY-ZwNX2RsJ4dmn9iU1gBQ5K8RfIC~NG6N8rpLyqude8PVGPg2QwZzrBUd2psc54nEZszmdFfVDH8OSxQvYr3nupGuNlxQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="Joc80835f3" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835f3.gif?Expires=2147483647&amp;Signature=JGjLV4n230OEkogT0f4wQUZoRSKQJEFwtRkOKPSe-MWk44sDRW9rXm~b~Q2OuKRpXHTVRoNApCmSruIs7GUrL5kd6KPWMMnIq0roYozyGTegG5p1FpexCNacr9~Gm8dtLWliIkX~-S3czI65oOV66-vpO2O4tMIYrrcTUmdsQCx8w5KDYW48v5uZpw8x5ow80oW5-4KF8RGWDH~ZZ4kdVh3~ubTo-MwtLGqsvnGs5i57t9JAlWpjxowGL6KBN7kUxZOmo6zXnhZfhdpV8Y4Z4q~9YiEKAfO~2uuPtbv1Q9TJpC7JylMsH9zsvMIcAIn7BuK9AHwBVMu7zZ1qQJWZGw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="Joc80835f3"></a></div></div><div class="figure-caption clip-last-child">A, Mean (±SEM) fasting serum insulin levels from randomization.
<em>P</em>=.11 for placebo vs orlistat. B, Mean fasting serum
low-density lipoprotein cholesterol levels from initial value.
<em>P</em>&lt;.05 for placebo vs orlistat. C, Mean (±SEM) total
cholesterol levels from initial value. The numbers above the plot
points are the number of subjects.</div></div> 
    </div>
    <div class="widget-ArticleFiguresAndTables widget-instance-AMA_Article_Tables_Tab">
        <div class="figure-table-wrapper figure-no-label thm-bd-top"><a id="JOC80835T1" class="figure-table-anchor"> </a>Table 1. Demographic Data From Start of Placebo Lead-in Period*<div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="JOC80835T1" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t1.png?Expires=2147483647&amp;Signature=ZjkRR1bCEyN0xKTzYQp91HmgwK~IL2Wn~HvV1nbN9na2n-SMAx7oDt8eD9qz-dj3-2wIdJ8lXwBtG4QI5J0vL9JlDSICoy3aNBsdNNJucSBTuI7L46OdzpAyJaXBG54-Xo3oO0XEh~UuksqK81X1JDxUJ~higzi6xEhsmTRrrYWmCtdDiOA2OGyaDfWfXYXkkSN5hP3KAlPS4QroWcb7djyxt2lxOvf81Nuiuktl7XgSmr1pulIbIFuBCwqbG9Xn79JHU~LWtqqg3ZNNbzHBLLDAInmANUkm~WcHpCodEU2cp75n9AnxNce2oE5c~FNdEIy0tzTVLHMnwaLrobA6gg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="JOC80835T1" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t1.png?Expires=2147483647&amp;Signature=ZjkRR1bCEyN0xKTzYQp91HmgwK~IL2Wn~HvV1nbN9na2n-SMAx7oDt8eD9qz-dj3-2wIdJ8lXwBtG4QI5J0vL9JlDSICoy3aNBsdNNJucSBTuI7L46OdzpAyJaXBG54-Xo3oO0XEh~UuksqK81X1JDxUJ~higzi6xEhsmTRrrYWmCtdDiOA2OGyaDfWfXYXkkSN5hP3KAlPS4QroWcb7djyxt2lxOvf81Nuiuktl7XgSmr1pulIbIFuBCwqbG9Xn79JHU~LWtqqg3ZNNbzHBLLDAInmANUkm~WcHpCodEU2cp75n9AnxNce2oE5c~FNdEIy0tzTVLHMnwaLrobA6gg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723327&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t1.png?Expires=2147483647&amp;Signature=ZjkRR1bCEyN0xKTzYQp91HmgwK~IL2Wn~HvV1nbN9na2n-SMAx7oDt8eD9qz-dj3-2wIdJ8lXwBtG4QI5J0vL9JlDSICoy3aNBsdNNJucSBTuI7L46OdzpAyJaXBG54-Xo3oO0XEh~UuksqK81X1JDxUJ~higzi6xEhsmTRrrYWmCtdDiOA2OGyaDfWfXYXkkSN5hP3KAlPS4QroWcb7djyxt2lxOvf81Nuiuktl7XgSmr1pulIbIFuBCwqbG9Xn79JHU~LWtqqg3ZNNbzHBLLDAInmANUkm~WcHpCodEU2cp75n9AnxNce2oE5c~FNdEIy0tzTVLHMnwaLrobA6gg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="JOC80835T1" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835t1.png?Expires=2147483647&amp;Signature=lLNVzrFZyY4O2OSCC6SmbfimNW1SXnRuWch4h9IQPhsNJVEmgO9wSgr3KGJNIiDWMo7pONUgI5AGgIMRVABsLPCHpga~OwRzQd1xf6dholxP0UOpOdeEC~2dts-eydBMlpmjyGWvYh~a4amdr7sgTjuFfr8o0Bds~UvNoPQjwfVfduP6n38TNLZIX8nPrEDWn2gNagM5BG690LCZkS2nMnqoDnUK98eUM7U80cnIQmJbrGC2fH309OX5gQCcO~G85f1lZB5kxpUwtPFRDCpAv4qOWrfn~vVz4VnmVQBN0Qyo4BPrEkcpZ4dfToweVV1cHDKwbUCQToeR-MjM03KbEA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="JOC80835T1"></a></div></div></div><div class="figure-table-wrapper figure-no-label thm-bd-top"><a id="JOC80835T2" class="figure-table-anchor"> </a>Table 2. Summary of Reasons for Study Withdrawal*<div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="JOC80835T2" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t2.png?Expires=2147483647&amp;Signature=ciSEzICv3U1y7XL6BzZkrbo~ZqqxIZIpNb2d5Yt8sUohRLx3yr6SXbyBl4QBK1~1sdlVC~MJpsXCe2Zy2ZnpkWvG2Y3g9dqXSvm56JR8PI6n9tgGPeyIs5jmepvLuJVUSZV67PYuff~j5tSKR-x0YQmPBP8DHoVuxIbdq887mZnOz76h46s43ugHpEoAhsifhX7pSkW0sxCPX4su1tCLBFFClI0J8F1pj-MENLUJzXd1niN834GU48BYw4EeuJZMjSifgX4tNRFkLuhWVvTRfRqntew6CZCtry-zllCFDadRbFTekdBOPGnHNcZhWeCOWk1KOalomfw1uZFPNEhyaA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="JOC80835T2" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t2.png?Expires=2147483647&amp;Signature=ciSEzICv3U1y7XL6BzZkrbo~ZqqxIZIpNb2d5Yt8sUohRLx3yr6SXbyBl4QBK1~1sdlVC~MJpsXCe2Zy2ZnpkWvG2Y3g9dqXSvm56JR8PI6n9tgGPeyIs5jmepvLuJVUSZV67PYuff~j5tSKR-x0YQmPBP8DHoVuxIbdq887mZnOz76h46s43ugHpEoAhsifhX7pSkW0sxCPX4su1tCLBFFClI0J8F1pj-MENLUJzXd1niN834GU48BYw4EeuJZMjSifgX4tNRFkLuhWVvTRfRqntew6CZCtry-zllCFDadRbFTekdBOPGnHNcZhWeCOWk1KOalomfw1uZFPNEhyaA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723329&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t2.png?Expires=2147483647&amp;Signature=ciSEzICv3U1y7XL6BzZkrbo~ZqqxIZIpNb2d5Yt8sUohRLx3yr6SXbyBl4QBK1~1sdlVC~MJpsXCe2Zy2ZnpkWvG2Y3g9dqXSvm56JR8PI6n9tgGPeyIs5jmepvLuJVUSZV67PYuff~j5tSKR-x0YQmPBP8DHoVuxIbdq887mZnOz76h46s43ugHpEoAhsifhX7pSkW0sxCPX4su1tCLBFFClI0J8F1pj-MENLUJzXd1niN834GU48BYw4EeuJZMjSifgX4tNRFkLuhWVvTRfRqntew6CZCtry-zllCFDadRbFTekdBOPGnHNcZhWeCOWk1KOalomfw1uZFPNEhyaA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="JOC80835T2" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835t2.png?Expires=2147483647&amp;Signature=QFwSWsKcw1yadMLdRJIcHvnQRgDIsTMS0LiFThVNOFPgnT7rJkKyrnvZO98jNuwxPh4S9rOh~9bkvBkfmERgbzaJIRiPPHjwvCHLTP3WjPM8K1XrT405d6aYo9IuzZ3i-E~HswBQ99UA50xEehwm5YQHfV2q~nu5YKGBd8DsAwQrQ~WHQzdSNmSo0KxJhXSZjSkFHbZBhOT89axlhE4RCKPHpc8FMG7ShfovVnCIgGQTh6RLS0s8KWGePC9cT~8CxBfliGt2aMvFBhCO-L-o77e7620IihmcsYa8SskDf0keCuQ-eCgaXpbLqrZWVDa46lj7bYq1rUVmlKvgrB6bgw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="JOC80835T2"></a></div></div></div><div class="figure-table-wrapper figure-no-label thm-bd-top"><a id="JOC80835T3" class="figure-table-anchor"> </a>Table 3. Results of Serum Lipid Studies<div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="JOC80835T3" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t3.png?Expires=2147483647&amp;Signature=wESrFzDSOmQ5HKPu-pBqNgmL0cpUM1uFBdanq3v4g1SzHZFsIR-m1SRh~bxInFhxMEe99wozrqCVa5Rhc4Fegp1Uv2GjMctZfF~hVhoCTllU9whXhcbz0n50f7Tii-MWkH6Y79eJwvS-vcsXU-JQ1HS-bvyMgwbLAfkxoSCbgbISvEWRe23X6I-PRUG0ckvniihK~TklkLZIOPSjeHEh4~wHGqytHa4a1PDRmTS201ozHa-WgpTvpIWh-WkoGyYwhkMFIeGR2DRoiils1SM3lhVq7ySPd4gf8iWHWWPp-rMM4zK9XpopuPe8Y0ss272AwD4dIy9EIIHt6e6RUwxMUA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="JOC80835T3" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t3.png?Expires=2147483647&amp;Signature=wESrFzDSOmQ5HKPu-pBqNgmL0cpUM1uFBdanq3v4g1SzHZFsIR-m1SRh~bxInFhxMEe99wozrqCVa5Rhc4Fegp1Uv2GjMctZfF~hVhoCTllU9whXhcbz0n50f7Tii-MWkH6Y79eJwvS-vcsXU-JQ1HS-bvyMgwbLAfkxoSCbgbISvEWRe23X6I-PRUG0ckvniihK~TklkLZIOPSjeHEh4~wHGqytHa4a1PDRmTS201ozHa-WgpTvpIWh-WkoGyYwhkMFIeGR2DRoiils1SM3lhVq7ySPd4gf8iWHWWPp-rMM4zK9XpopuPe8Y0ss272AwD4dIy9EIIHt6e6RUwxMUA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723337&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t3.png?Expires=2147483647&amp;Signature=wESrFzDSOmQ5HKPu-pBqNgmL0cpUM1uFBdanq3v4g1SzHZFsIR-m1SRh~bxInFhxMEe99wozrqCVa5Rhc4Fegp1Uv2GjMctZfF~hVhoCTllU9whXhcbz0n50f7Tii-MWkH6Y79eJwvS-vcsXU-JQ1HS-bvyMgwbLAfkxoSCbgbISvEWRe23X6I-PRUG0ckvniihK~TklkLZIOPSjeHEh4~wHGqytHa4a1PDRmTS201ozHa-WgpTvpIWh-WkoGyYwhkMFIeGR2DRoiils1SM3lhVq7ySPd4gf8iWHWWPp-rMM4zK9XpopuPe8Y0ss272AwD4dIy9EIIHt6e6RUwxMUA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="JOC80835T3" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835t3.png?Expires=2147483647&amp;Signature=KDLgrb75FVDSz1Puh-UcVihCzMiSwPWJ47iRX8Pbtaf1LWzYHh4en6eF96rwnYV4uvtjXn0KF4AjSPzxBn4Tf0EztnC-YgayBtLG4XAXS4H8IodaG75U75JyMQ1hfK6GqTcCjp2VnNydF35k24KSbvKLNILjMG15Iw4LSetiTQ0Kzk1SNji32ijy7GL92xnPM0pn-dCXzN5aDeELeVoEKGEBVhyBAKQvHMq6OQWvUe4QY2JpyzaHDKrU~BK8SZD9yEOPhfMVWWx1I~GN8KPsOaYAym2EEZgCVR5A7PGEoEkF~yEJ5HmRrNXVNi7axzqeq-fu8Ram166lLNmKGvz2DQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="JOC80835T3"></a></div></div></div><div class="figure-table-wrapper figure-no-label thm-bd-top"><a id="JOC80835T4" class="figure-table-anchor"> </a>Table 4. Results of Fasting Serum Glucose and Insulin Studies<div class="figure-table-links right"><a class="view-large figure-table-link is-b desktop-only" path-from-xml="JOC80835T4" href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t4.png?Expires=2147483647&amp;Signature=iDC5gNvDA8BlGN85HQ--alMzzDFjyJLRp6~woHDCtBByrrDrtLVpNe~N0ABZ0Q21BZ-fR2OuIY~oaw~SxxzbGbX~l3JxQLXS7cBfTroHZ5DNpVGksUG8Fk1P3bVO4iO9Lbi6ZajP~YHjkv59wuWwBF9KzDi2wpA5EeXrw4aneX7w3E~~Nd5Mqm-JeyYnXH3OSPgyRocc1vN7UBmIMKr2BntPwQy84kN0rkyf56wzVvIp45EDJJXEEyyX-oiE45ituYAdyDoSALzdxWpmPfrzLYz7ecpc310z0kyVvRzfKzqon-XU3ywJs4y7NlS5RzWbLA1a~xNja~2Idvda556Cpg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" rel="nofollow"><span class="view-large-text">View Large</span></a><a class="download-ppt figure-table-link is-b" path-from-xml="JOC80835T4" href="https://jamanetwork.com/downloadimage.aspx?image=https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t4.png?Expires=2147483647&amp;Signature=iDC5gNvDA8BlGN85HQ--alMzzDFjyJLRp6~woHDCtBByrrDrtLVpNe~N0ABZ0Q21BZ-fR2OuIY~oaw~SxxzbGbX~l3JxQLXS7cBfTroHZ5DNpVGksUG8Fk1P3bVO4iO9Lbi6ZajP~YHjkv59wuWwBF9KzDi2wpA5EeXrw4aneX7w3E~~Nd5Mqm-JeyYnXH3OSPgyRocc1vN7UBmIMKr2BntPwQy84kN0rkyf56wzVvIp45EDJJXEEyyX-oiE45ituYAdyDoSALzdxWpmPfrzLYz7ecpc310z0kyVvRzfKzqon-XU3ywJs4y7NlS5RzWbLA1a~xNja~2Idvda556Cpg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=24723340&amp;ar=188381&amp;imagename=&amp;siteId=3" rel="nofollow"><span class="download-ppt-text">Download</span></a><a class="figure-table-twitter figure-table-link figure-table-social addthis_button_twitter is-b at300b" rel="nofollow" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a><a class="figure-table-facebook figure-table-link figure-table-social addthis_button_facebook is-b at300b" rel="nofollow" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text"> </span></a></div><div class="figure-table cf cb"><div class="figure-table-image"><a href="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/joc80835t4.png?Expires=2147483647&amp;Signature=iDC5gNvDA8BlGN85HQ--alMzzDFjyJLRp6~woHDCtBByrrDrtLVpNe~N0ABZ0Q21BZ-fR2OuIY~oaw~SxxzbGbX~l3JxQLXS7cBfTroHZ5DNpVGksUG8Fk1P3bVO4iO9Lbi6ZajP~YHjkv59wuWwBF9KzDi2wpA5EeXrw4aneX7w3E~~Nd5Mqm-JeyYnXH3OSPgyRocc1vN7UBmIMKr2BntPwQy84kN0rkyf56wzVvIp45EDJJXEEyyX-oiE45ituYAdyDoSALzdxWpmPfrzLYz7ecpc310z0kyVvRzfKzqon-XU3ywJs4y7NlS5RzWbLA1a~xNja~2Idvda556Cpg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" target="_blank" path-from-xml="JOC80835T4" rel="nofollow"><img data-original="https://cdn.jamanetwork.com/ama/content_public/journal/jama/4592/m_joc80835t4.png?Expires=2147483647&amp;Signature=WwrqXDNnHifdM1Ih3W1Cx-rnLNOIW77F0g6Stfs7YVBAxNIrbmxU~Iec85gamvhqzgMNi7wIAjayYya-Sogj54l8KJOsBndof4dp5LS1R74~mlZkGfinazeSluMwoLr6-2KHZv4PPOSiRd4hVHrDuFPozYyXJ6iipjQUHvTYscxrIX0E2GSRtxC9GmLc4yrp6zwKv03-MKqlMuzd7Cx~slEeb1C0iTnYuQXss~lR1OMpqLpFICgBkNPNbrPNjYUTvvkpexJWYv6I8TXUTqcEjedQLbmuVSaqHUSJwwGCT7MCvZODXvrwlIjPpt4IxzLdoqXC~8ULbSv7euzVDS5Rbw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA" alt="Image description not available." class="content-img lazy" path-from-xml="JOC80835T4"></a></div></div></div> 
    </div>

</div>


<div id="multimedia-tab" class="resource-tab multimedia-tab need-jobs-ad" style="display: none!important">

</div>


<div id="supplemental-tab" class="resource-tab supplemental-tab need-jobs-ad" style="display: none!important">

</div>


<div id="references-tab" class="resource-tab references-tab need-jobs-ad">
    <div class="references-wrap">
    <div class="widget-SectionDisplay widget-instance-AMA_References_Tab">
        
<div class="references"><div class="reference"><a class="reference-number" id="ref-joc80835-1">1.</a><div class="reference-content">Flegal&nbsp;K, Carroll&nbsp;M, Kuczmarski&nbsp;R, Johnson&nbsp;C.&nbsp;Overweight and obesity in the United States.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat
Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;22:38-47.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Overweight%20and%20obesity%20in%20the%20United%20States.&amp;author=K%20Flegal&amp;author=M%20Carroll&amp;author=R%20Kuczmarski&amp;author=C%20Johnson&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-2">2.</a><div class="reference-content">Thomas&nbsp;PR.&nbsp;<em>Weighing the Options Criteria for
Evaluating Weight-management Programs.</em>&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">Washington, DC: National
Academy Press; 1995.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-3">3.</a><div class="reference-content">National Task Force on the Prevention and
Treatment of Obesity.&nbsp;&nbsp;Long-term pharmacotherapy in the management of
obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;JAMA.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;276:1907-1915.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20pharmacotherapy%20in%20the%20management%20of%20obesity.&amp;publication_year=&amp;journal=JAMA.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-4">4.</a><div class="reference-content">Eckel&nbsp;RH.&nbsp;Obesity and heart disease.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Circulation.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;96:3248-3250.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Obesity%20and%20heart%20disease.&amp;author=RH%20Eckel&amp;publication_year=&amp;journal=Circulation.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-5">5.</a><div class="reference-content">Meigs&nbsp;J, Nathan&nbsp;D, Wilson&nbsp;P, Cupples&nbsp;L, Singer&nbsp;D.&nbsp;Metabolic risk factors worsen continuously across the spectrum of
nondiabetic glucose tolerance.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Ann Intern Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;128:524-533.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Metabolic%20risk%20factors%20worsen%20continuously%20across%20the%20spectrum%20of%20nondiabetic%20glucose%20tolerance.&amp;author=J%20Meigs&amp;author=D%20Nathan&amp;author=P%20Wilson&amp;author=L%20Cupples&amp;author=D%20Singer&amp;publication_year=&amp;journal=Ann%20Intern%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-6">6.</a><div class="reference-content">Pi-Sunyer&nbsp;FX.&nbsp;Medical hazards of obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Ann
Intern Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1993;19:655-660.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Medical%20hazards%20of%20obesity.&amp;author=FX%20Pi-Sunyer&amp;publication_year=&amp;journal=Ann%20Intern%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-7">7.</a><div class="reference-content">Bray&nbsp;GA.&nbsp;Health hazards of obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Endocrinol
Metab Clin North Am.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;25:907-919.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Health%20hazards%20of%20obesity.&amp;author=GA%20Bray&amp;publication_year=&amp;journal=Endocrinol%20Metab%20Clin%20North%20Am.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-8">8.</a><div class="reference-content">Drent&nbsp;ML, Larsson&nbsp;I, William-Olsson&nbsp;T.
    &nbsp;et al.&nbsp;&nbsp;Orlistat
(Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a
multiple dose study.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;19:221-226.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Orlistat%20(Ro%2018-0647)%2C%20a%20lipase%20inhibitor%2C%20in%20the%20treatment%20of%20human%20obesity%3A%20a%20multiple%20dose%20study.&amp;author=ML%20Drent&amp;author=I%20Larsson&amp;author=T%20William-Olsson&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-9">9.</a><div class="reference-content">Goldstein&nbsp;DJ.&nbsp;Beneficial health effects of
modest weight loss.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;16:397-415.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Beneficial%20health%20effects%20of%20modest%20weight%20loss.&amp;author=DJ%20Goldstein&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-10">10.</a><div class="reference-content">Williamson&nbsp;D.&nbsp;Intentional weight loss.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes
Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;21(suppl 1):S14-S19.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Intentional%20weight%20loss.&amp;author=D%20Williamson&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-11">11.</a><div class="reference-content">National Diabetes Data Group.&nbsp;&nbsp;Classification and
diagnosis of diabetes mellitus and other categories of glucose
intolerance.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Diabetes.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1979;28:1039-1057.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Classification%20and%20diagnosis%20of%20diabetes%20mellitus%20and%20other%20categories%20of%20glucose%20intolerance.&amp;publication_year=&amp;journal=Diabetes.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-12">12.</a><div class="reference-content">Begg&nbsp;C, Cho&nbsp;M, Eastwood&nbsp;S.
    &nbsp;et al.&nbsp;&nbsp;Improving the quality
of reporting of randomized controlled trials.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;JAMA.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;276:637-639.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Improving%20the%20quality%20of%20reporting%20of%20randomized%20controlled%20trials.&amp;author=C%20Begg&amp;author=M%20Cho&amp;author=S%20Eastwood&amp;publication_year=&amp;journal=JAMA.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-13">13.</a><div class="reference-content">Winer&nbsp;BJ.&nbsp;<em>Statistical Principles in
Experimental Design.</em>&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">2nd ed. New York, NY: McGraw-Hill Book Co;
1971.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-14">14.</a><div class="reference-content">Sjöström&nbsp;L, Rissanen&nbsp;A, Andersen&nbsp;T.
    &nbsp;et al.&nbsp;&nbsp;Randomised placebo-controlled trial of orlistat for weight loss and
prevention of weight regain in obese patients.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Lancet.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;352:167-173.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Randomised%20placebo-controlled%20trial%20of%20orlistat%20for%20weight%20loss%20and%20prevention%20of%20weight%20regain%20in%20obese%20patients.&amp;author=L%20Sj%C3%B6str%C3%B6m&amp;author=A%20Rissanen&amp;author=T%20Andersen&amp;publication_year=&amp;journal=Lancet.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-15">15.</a><div class="reference-content">Leibel&nbsp;RL, Rosenbaum&nbsp;M, Hirsch&nbsp;J.&nbsp;Changes in energy
expenditure resulting from altered body weight.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;N Engl J Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;332:621-628.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Changes%20in%20energy%20expenditure%20resulting%20from%20altered%20body%20weight.&amp;author=RL%20Leibel&amp;author=M%20Rosenbaum&amp;author=J%20Hirsch&amp;publication_year=&amp;journal=N%20Engl%20J%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-16">16.</a><div class="reference-content">Bray&nbsp;G.&nbsp;Evaluation of drugs for treating obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Obes Res.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;3(suppl 4):425S-434S.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Evaluation%20of%20drugs%20for%20treating%20obesity.&amp;author=G%20Bray&amp;publication_year=&amp;journal=Obes%20Res.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-17">17.</a><div class="reference-content">Lean&nbsp;M.&nbsp;Sibutramine.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab
Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;21(suppl 1):S30-S36.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Sibutramine.&amp;author=M%20Lean&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-18">18.</a><div class="reference-content">Weintraub&nbsp;M, Sundaresan&nbsp;PR, Schuster&nbsp;B, Averbuch&nbsp;M, Stein&nbsp;EC, Byrne&nbsp;L.&nbsp;Long-term weight control study, V (weeks 190 to
210).&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Clin Pharmacol Ther.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;51:615-618.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20weight%20control%20study%2C%20V%20(weeks%20190%20to%20210).&amp;author=M%20Weintraub&amp;author=PR%20Sundaresan&amp;author=B%20Schuster&amp;author=M%20Averbuch&amp;author=EC%20Stein&amp;author=L%20Byrne&amp;publication_year=&amp;journal=Clin%20Pharmacol%20Ther.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-19">19.</a><div class="reference-content">Weintraub&nbsp;M.&nbsp;Long-term weight control
study: conclusions.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Clin Pharmacol Ther.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;51:642-646.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20weight%20control%20study%3A%20conclusions.&amp;author=M%20Weintraub&amp;publication_year=&amp;journal=Clin%20Pharmacol%20Ther.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-20">20.</a><div class="reference-content">Wing&nbsp;R, Venditti&nbsp;E, Jakicic&nbsp;J.
    &nbsp;et al.&nbsp;&nbsp;Lifestyle
intervention in overweight individuals with a family history of
diabetes.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Diabetes Care.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;21:350-360.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Lifestyle%20intervention%20in%20overweight%20individuals%20with%20a%20family%20history%20of%20diabetes.&amp;author=R%20Wing&amp;author=E%20Venditti&amp;author=J%20Jakicic&amp;publication_year=&amp;journal=Diabetes%20Care.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-21">21.</a><div class="reference-content">Wing&nbsp;R, Blair&nbsp;E, Bononi&nbsp;P.
    &nbsp;et al.&nbsp;&nbsp;Caloric
restriction per se is a significant factor in improvements in glycemic
control and insulin sensitivity during weight loss in obese NIDDM
patients.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Diabetes Care.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1994;17:30-36.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Caloric%20restriction%20per%20se%20is%20a%20significant%20factor%20in%20improvements%20in%20glycemic%20control%20and%20insulin%20sensitivity%20during%20weight%20loss%20in%20obese%20NIDDM%20patients.&amp;author=R%20Wing&amp;author=E%20Blair&amp;author=P%20Bononi&amp;publication_year=&amp;journal=Diabetes%20Care.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-22">22.</a><div class="reference-content">Guerciolini&nbsp;R.&nbsp;Mode of action of orlistat.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;21(suppl 3):S12-S23.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Mode%20of%20action%20of%20orlistat.&amp;author=R%20Guerciolini&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-23">23.</a><div class="reference-content">Grundy&nbsp;S.&nbsp;Atherogenic dyslipidemia and the metabolic
syndrome.&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">In: Gotto AJ, ed. 
<em>Drugs Affecting Lipid Metabolism</em>. 
Norwell, Mass: Kluwer Academic Publishers; 1996:237-247.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-24">24.</a><div class="reference-content">Despres&nbsp;J, Lamarche&nbsp;B, Mauriege&nbsp;P.
    &nbsp;et al.&nbsp;&nbsp;Hyperinsulinemia as an independent risk factor for ischemic heart
disease.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;N Engl J Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;334:952-957.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Hyperinsulinemia%20as%20an%20independent%20risk%20factor%20for%20ischemic%20heart%20disease.&amp;author=J%20Despres&amp;author=B%20Lamarche&amp;author=P%20Mauriege&amp;publication_year=&amp;journal=N%20Engl%20J%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-25">25.</a><div class="reference-content">Landsberg&nbsp;L.&nbsp;Hyperinsulinemia.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Hypertension.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;(suppl)19:161-166.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Hyperinsulinemia.&amp;author=L%20Landsberg&amp;publication_year=&amp;journal=Hypertension.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-26">26.</a><div class="reference-content">Volkmar&nbsp;FR, Stunkard&nbsp;AJ, Woolston&nbsp;J, Bailey&nbsp;RA.&nbsp;High attrition rates in commercial weight reduction patterns programs.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Arch Intern Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1981;141:426-428.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=High%20attrition%20rates%20in%20commercial%20weight%20reduction%20patterns%20programs.&amp;author=FR%20Volkmar&amp;author=AJ%20Stunkard&amp;author=J%20Woolston&amp;author=RA%20Bailey&amp;publication_year=&amp;journal=Arch%20Intern%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-27">27.</a><div class="reference-content">Food and Drug Administration, Center for
Drug Evaluation and Research.&nbsp;&nbsp;NDA 20-766, Xenical (Orlistat).&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">Presented
at: Endocrinologic and Metabolic Drugs Advisory Committee Meeting 69;
March 1998; Gaithersburg, Md.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-28">28.</a><div class="reference-content">Zhi&nbsp;J, Melia&nbsp;AT, Eggers&nbsp;H, Joly&nbsp;R, Patel&nbsp;IH.&nbsp;Review of
limited systemic absorption of orlistat, a lipase inhibitor, in healthy
human volunteers.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;J Clin Pharmacol.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;35:1103-1108.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Review%20of%20limited%20systemic%20absorption%20of%20orlistat%2C%20a%20lipase%20inhibitor%2C%20in%20healthy%20human%20volunteers.&amp;author=J%20Zhi&amp;author=AT%20Melia&amp;author=H%20Eggers&amp;author=R%20Joly&amp;author=IH%20Patel&amp;publication_year=&amp;journal=J%20Clin%20Pharmacol.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-29">29.</a><div class="reference-content">Allison&nbsp;DB, Cappelleri&nbsp;JC, Carpenter&nbsp;KM.&nbsp;Design and
analysis of obesity treatment and prevention trials.&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">In: Dalton S, ed.
<em>Overweight and Weight Management</em>. Gaithersburg, Md: Aspen
Publishers Inc; 1997:557-597.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-30">30.</a><div class="reference-content">Little&nbsp;R, Yau&nbsp;L.&nbsp;Intent-to-treat analysis for
longitudinal studies with dropouts.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Biometrics.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;52:1324-1333.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Intent-to-treat%20analysis%20for%20longitudinal%20studies%20with%20dropouts.&amp;author=R%20Little&amp;author=L%20Yau&amp;publication_year=&amp;journal=Biometrics.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div></div> 
    </div>

    </div>
</div>


<div id="related-tab" class="resource-tab related-tab need-jobs-ad">
    <div class="widget-ArticleLinks widget-instance-AMA_See_Also_Related_Content">
        
 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
         
    </div>
    <div class="widget-RelatedTopics widget-instance-AMA_Related_Topics">
        
    <h4 class="related-topics-heading topic-suggestions-heading">
See More About    </h4>
    <div class="related-topics topic-suggestions">
    <a href="https://jamanetwork.com/collections/5548/cardiology" id="item_Link" class="related-topic topic-suggestion no-wrap">Cardiology</a>    <a href="https://jamanetwork.com/collections/5720/lifestyle-behaviors" id="item_Link_1" class="related-topic topic-suggestion no-wrap">Lifestyle Behaviors</a>    <a href="https://jamanetwork.com/collections/5721/dyslipidemia" id="item_Link_2" class="related-topic topic-suggestion no-wrap">Dyslipidemia</a>    <a href="https://jamanetwork.com/collections/5791/obesity" id="item_Link_3" class="related-topic topic-suggestion no-wrap">Obesity</a>    <a href="https://jamanetwork.com/collections/42055/diet" id="item_Link_4" class="related-topic topic-suggestion no-wrap">Diet</a>    <a href="https://jamanetwork.com/collections/42101/cardiovascular-risk-factors" id="item_Link_5" class="related-topic topic-suggestion no-wrap">Cardiovascular Risk Factors</a>    </div>
 
    </div>
        <div class="ymal--footer">
        <div class="widget-PersonalizedContent widget-instance-AMA_PersonalizedContent_SplitScreenView_Footer">
        

    <div class="row ymal">
        <h4 class="ymal--hed thm-col-sec">
            Trending
        </h4>

        <ul class="ymal--content featured-list--contents">
                <li class="article ymal--item thm-bd-top bd-jama-sec">
                    <a class="article--title d-b mb05" href="https://jamanetwork.com/journals/jama/fullarticle/2729246?widget=personalizedcontent&amp;previousarticle=188381">Practical Suggestions for Obesity Management in Clinical Practice</a>
                        <div class="article--pub-name meta-item">JAMA</div>
                                            <div class="article--type meta-item">Opinion</div>
                                            <div class="article--date meta-item no-wrap">April 9, 2019</div>
                                                                                                </li>
                <li class="article ymal--item thm-bd-top bd-jama-sec">
                    <a class="article--title d-b mb05" href="https://jamanetwork.com/journals/jama/fullarticle/2632510?widget=personalizedcontent&amp;previousarticle=188381">USPSTF Evidence Report: Screening for Obesity in Children and Youth</a>
                        <div class="article--pub-name meta-item">JAMA</div>
                                            <div class="article--type meta-item">Research</div>
                                            <div class="article--date meta-item no-wrap">June 20, 2017</div>
                                                                                                </li>
                <li class="article ymal--item thm-bd-top bd-jama-surgery-sec">
                    <a class="article--title d-b mb05" href="https://jamanetwork.com/journals/jama/fullarticle/2698680?widget=personalizedcontent&amp;previousarticle=188381">Preference for People-First Language Among Patients Seeking Bariatric Surgery</a>
                        <div class="article--pub-name meta-item">JAMA Surgery</div>
                                            <div class="article--type meta-item">Research</div>
                                            <div class="article--date meta-item no-wrap">December 1, 2018</div>
                                                                                                </li>
        </ul>
    </div>
    <script type="text/javascript">SCM.AMA.DataLayerAsync.push("arrYMALbottom", ",,", "array");</script>
 
    </div>


        </div>
        <hr>
        <h4 class="thm-col-sec" align="center">
            Others Also Liked
        </h4>
        <div id="trendmd-suggestions"><div class="trendmd-widget-container trendmd-widget_title-normal trendmd-widget_body-normal" data-trendmd-journal-id="39135" data-trendmd-article-id="13fc8fac-92e6-4616-9750-6221ce5450c9" data-trendmd-swoop="eyJzd2kiOm51bGx9" similar-nonsponsored-merged="true" similar-sponsored-merged="true">
  <div class="trendmd-widget ">
    <div class="trendmd-widget-inner">
        <div class="trendmd-widget-section">
          <div class="trendmd-widget-header"><h3 class="trendmd-widget-header__heading">We recommend</h3></div>
          <ol class="trendmd-widget-list">
            
          <li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="13f6ccb6-4824-4244-8290-277d4fdb0f21" data-trendmd-journal-id="54023" data-trendmd-campaign-id="5888" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B51603%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="true" href="http://www.practiceupdate.com/content/liraglutide-in-obese-non-diabetic-adults/8144?elsca1=TrendMD_CPA" rel="noindex, nofollow" target="_blank">Liraglutide in Obese, Non-Diabetic Adults<span class="trendmd-widget-list-item__link__external"></span></a>
                <div class="trendmd-widget-list-item__meta">
                                                                          PracticeUpdate,                                                         <span class="js_publication_date">2014</span>
                                  </div>
              </li><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="507ab79c-5ec5-403e-8601-ed8f803997a9" data-trendmd-journal-id="54023" data-trendmd-campaign-id="5888" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B51603%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="true" href="http://www.practiceupdate.com/content/the-diogenes-trial-12-month-results/7987?elsca1=TrendMD_CPA" rel="noindex, nofollow" target="_blank">The DIOGENES Trial 12-Month Results<span class="trendmd-widget-list-item__link__external"></span></a>
                <div class="trendmd-widget-list-item__meta">
                                                                          PracticeUpdate,                                                         <span class="js_publication_date">2014</span>
                                  </div>
              </li></ol>
        </div>
      
        <div class="trendmd-widget-section">
          <div class="trendmd-widget-header"><h3 class="trendmd-widget-header__heading">&nbsp;</h3></div>
          <ol class="trendmd-widget-list">
            
          <li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="a81f4951-0968-4146-9937-9ffd60f74dbe" data-trendmd-journal-id="38201" data-trendmd-campaign-id="764" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="true" href="http://dtb.bmj.com/content/55/7/78?utm_campaign=dtb&amp;utm_content=consumer&amp;utm_medium=cpc&amp;utm_source=trendmd&amp;utm_term=1-A" rel="noindex, nofollow" target="_blank">▾ Liraglutide for weight management<span class="trendmd-widget-list-item__link__external"></span></a>
                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">BMJ Publishing Group Ltd,</span>
                                                        DTB,                                                         <span class="js_publication_date">2017</span>
                                  </div>
              </li><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="be1c4d87-27c1-4fb4-94bf-0d5ffa2f269a" data-trendmd-journal-id="53928" data-trendmd-campaign-id="1966" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="true" href="https://www.medicalnewstoday.com/articles/62578.php?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=Medical_News_Today_TrendMD_1" rel="noindex, nofollow" target="_blank">FDA Approves Over The Counter Weight Loss Pills<span class="trendmd-widget-list-item__link__external"></span></a>
                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Catharine Paddock PhD,</span>
                                                        Medical News Today,                                                         <span class="js_publication_date">2007</span>
                                  </div>
              </li></ol>
        </div>
      
    </div>
    <div class="trendmd-widget-footer">
      <div class="trendmd-widget-footer-inner">
        <div class="trendmd-widget-footer-inner-left">
          <a href="https://www.trendmd.com/how-it-works-readers" target="_blank" class="trendmd-widget-brand" title="TrendMD">
            <span class="trendmd-widget-brand__recommended">Powered by</span>
            <span class="trendmd-widget-brand__logo trendmd-widget-brand__logo__normal" style="display: inline-block; width: 93px">
              <svg viewBox="0 0 234 57" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
                <g id="logo">
                  <path d="M227.7,56.9 L149.7,56.9 C146.7,56.9 143.7,53.8 143.7,50.9 L143.7,6.9 C143.7,4 146.7,0.9 149.7,0.9 L227.7,0.9 C230.7,0.9 233.7,4 233.7,6.9 L233.7,50.9 C233.7,53.9 230.6,56.9 227.7,56.9 L227.7,56.9 Z" id="shape0" fill="#CA2127"></path>
                  <g id="group1" transform="translate(0.000000, 14.000000)" fill="#16325c">
                    <path d="M15.8,5.9 L15.8,29.6 L9.2,29.6 L9.2,5.9 L0.9,5.9 L0.9,0.2 L24.1,0.2 L24.1,5.9 L15.8,5.9 L15.8,5.9 Z" id="shape1"></path>
                    <path d="M50.2,10 C50.2,14.7 48.3,17.7 44.6,19.1 L52,29.6 L44,29.6 L37.5,20.2 L33,20.2 L33,29.6 L26.4,29.6 L26.4,0.2 L37.5,0.2 C42.1,0.2 45.3,1 47.3,2.5 C49.2,4.1 50.2,6.6 50.2,10 L50.2,10 Z M42.3,13.5 C43.1,12.8 43.5,11.6 43.5,10 C43.5,8.4 43.1,7.3 42.2,6.7 C41.4,6.1 39.9,5.8 37.8,5.8 L32.9,5.8 L32.9,14.5 L37.7,14.5 C40,14.6 41.5,14.2 42.3,13.5 L42.3,13.5 Z" id="shape2"></path>
                    <path d="M75.6,0.3 L75.6,6.1 L61,6.1 L61,12.1 L74.1,12.1 L74.1,17.7 L61,17.7 L61,23.8 L76,23.8 L76,29.6 L54.4,29.6 L54.4,0.2 L75.6,0.2 L75.6,0.3 Z" id="shape3"></path>
                    <path d="M99.9,0.3 L106.5,0.3 L106.5,29.7 L99.9,29.7 L85.9,11.3 L85.9,29.7 L79.3,29.7 L79.3,0.3 L85.4,0.3 L99.8,19.2 L99.8,0.3 L99.9,0.3 Z" id="shape4"></path>
                    <path d="M133.6,4.1 C136.4,6.7 137.8,10.2 137.8,14.8 C137.8,19.4 136.4,23 133.7,25.6 C131,28.3 126.8,29.6 121.2,29.6 L111.2,29.6 L111.2,0.2 L121.6,0.2 C126.7,0.3 130.8,1.5 133.6,4.1 L133.6,4.1 Z M128.8,21.6 C130.4,20.1 131.2,17.9 131.2,15 C131.2,12.1 130.4,9.9 128.8,8.3 C127.2,6.7 124.7,6 121.4,6 L117.7,6 L117.7,23.9 L121.9,23.9 C124.8,23.8 127.1,23.1 128.8,21.6 L128.8,21.6 Z" id="shape5"></path>
                  </g>
                  <g id="group2" transform="translate(156.000000, 14.000000)" fill="#FFFFFF">
                    <path d="M26.9,11.1 L19,27.1 L15,27.1 L7.1,11.1 L7.1,29.6 L0.5,29.6 L0.5,0.2 L9.4,0.2 L17,16.3 L24.6,0.2 L33.4,0.2 L33.4,29.6 L26.8,29.6 L26.8,11.1 L26.9,11.1 Z" id="shape6"></path>
                    <path d="M60.6,4.1 C63.4,6.7 64.8,10.2 64.8,14.8 C64.8,19.4 63.4,23 60.7,25.6 C58,28.3 53.8,29.6 48.2,29.6 L38.2,29.6 L38.2,0.2 L48.6,0.2 C53.7,0.3 57.8,1.5 60.6,4.1 L60.6,4.1 Z M55.8,21.6 C57.4,20.1 58.2,17.9 58.2,15 C58.2,12.1 57.4,9.9 55.8,8.3 C54.2,6.7 51.7,6 48.4,6 L44.7,6 L44.7,23.9 L48.9,23.9 C51.8,23.8 54.1,23.1 55.8,21.6 L55.8,21.6 Z" id="shape7"></path>
                  </g>
                </g>
              </svg>
            </span>
          </a>
        </div>
        <div class="trendmd-widget-footer-inner-right">
          <div class="trendmd-widget-settings"><span class="trendmd-widget-settings__cog"></span>
            <div class="trendmd-widget-settings__modal">
              <ul class="trendmd-widget-settings__list">
                <li class="trendmd-widget-settings__item">
                  <a href="https://www.trendmd.com/privacy" target="_blank" title="Privacy policy" class="trendmd-widget-settings__link">Privacy policy</a>
                </li>
                <li class="trendmd-widget-settings__item">
                  <a href="https://www.trendmd.com/google-analytics" target="_blank" title="Google Analytics settings" class="trendmd-widget-settings__link">Google Analytics settings</a>
                </li>
              </ul>
            </div>
          </div>
        </div>
        <div class="trendmd-widget-footer-inner-clear"></div>
        <div class="trendmd-widget-footer-inner-bottom">
          <div class="trendmd-widget-cookie-notification">
            <div class="trendmd-widget-cookie-notification__info"><span>I consent to the use of Google Analytics and related cookies across the TrendMD network (widget, website, blog). </span><a href="https://www.trendmd.com/google-analytics" title="Learn more" target="_blank">Learn more</a></div>
            <div class="trendmd-widget-cookie-notification__actions">
              <span></span>
              <button onclick="(function() { window.TrendMD.gdpr().setGaConsent(true); })(); return false;">Yes</button>
              <button onclick="(function() { window.TrendMD.gdpr().setGaConsent(false); })(); return false;">No</button>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>
</div>
        <div class="manage-interest">
            <h4><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#" class="manage-interests-link-no-access thm-col-sec">Select Your Interests</a></h4>
    <div class="widget-ManageCollectionInterests widget-instance-ManageCollectionInterests_SplitScreen">
        <div class="manage-interests-modal reveal-modal small modal" data-reveal="">
<div class="manage-interests--header">
    <div class="widget-SelfServeContent widget-instance-AMA_ManageInterests_Header">
        <div class="self-serve"><style>
    h4 {
    font-size: 20px !important;
    }
</style>
<h4>Select Your Interests</h4>
<p>Customize your JAMA Network experience by selecting one or more topics from the list below.</p></div> 
    </div>

</div><div class="manage-interests--categories">
    <ul class="category-list">
            <li><span class="category-list-item " data-categoryid="5489">Acid Base, Electrolytes, Fluids</span></li>
            <li><span class="category-list-item " data-categoryid="44018">Allergy</span></li>
            <li><span class="category-list-item " data-categoryid="5504">Allergy and Clinical Immunology</span></li>
            <li><span class="category-list-item " data-categoryid="5510">Anesthesiology</span></li>
            <li><span class="category-list-item " data-categoryid="42143">Anticoagulation</span></li>
            <li><span class="category-list-item " data-categoryid="44015">Art of the JAMA Network</span></li>
            <li><span class="category-list-item " data-categoryid="42099">Bleeding and Transfusion</span></li>
            <li><span class="category-list-item " data-categoryid="5548">Cardiology</span></li>
            <li><span class="category-list-item " data-categoryid="44036">Caring for the Critically Ill Patient</span></li>
            <li><span class="category-list-item " data-categoryid="6255">Challenges in Clinical Electrocardiography</span></li>
            <li><span class="category-list-item " data-categoryid="44038">Clinical Challenge</span></li>
            <li><span class="category-list-item " data-categoryid="5589">Clinical Decision Support</span></li>
            <li><span class="category-list-item " data-categoryid="44039">Clinical Implications of Basic Neuroscience</span></li>
            <li><span class="category-list-item " data-categoryid="5614">Clinical Pharmacy and Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5575">Complementary and Alternative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44040">Consensus Statements</span></li>
            <li><span class="category-list-item " data-categoryid="5584">Critical Care Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44019">Dental Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5598">Dermatology</span></li>
            <li><span class="category-list-item " data-categoryid="44011">Diabetes and Endocrinology</span></li>
            <li><span class="category-list-item " data-categoryid="42054">Drug Development</span></li>
            <li><span class="category-list-item " data-categoryid="5620">Electronic Health Records</span></li>
            <li><span class="category-list-item " data-categoryid="5621">Emergency Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5819">End of Life</span></li>
            <li><span class="category-list-item " data-categoryid="42107">Environmental Health</span></li>
            <li><span class="category-list-item " data-categoryid="42108">Ethics</span></li>
            <li><span class="category-list-item " data-categoryid="5644">Facial Plastic Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="45314">Foodborne Illness</span></li>
            <li><span class="category-list-item " data-categoryid="44012">Gastroenterology and Hepatology</span></li>
            <li><span class="category-list-item " data-categoryid="5664">Genetics and Genomics</span></li>
            <li><span class="category-list-item " data-categoryid="44041">Genomics and Precision Health</span></li>
            <li><span class="category-list-item " data-categoryid="5668">Geriatrics</span></li>
            <li><span class="category-list-item " data-categoryid="5670">Global Health</span></li>
            <li><span class="category-list-item " data-categoryid="44042">Guide to Statistics and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5672">Guidelines</span></li>
            <li><span class="category-list-item " data-categoryid="5674">Hair Disorders</span></li>
            <li><span class="category-list-item " data-categoryid="42113">Health Care Delivery Models</span></li>
            <li><span class="category-list-item " data-categoryid="42114">Health Care Economics, Insurance, Payment</span></li>
            <li><span class="category-list-item " data-categoryid="42115">Health Care Policy</span></li>
            <li><span class="category-list-item " data-categoryid="42116">Health Care Quality</span></li>
            <li><span class="category-list-item " data-categoryid="5680">Health Care Reform</span></li>
            <li><span class="category-list-item " data-categoryid="5830">Health Care Safety</span></li>
            <li><span class="category-list-item " data-categoryid="5682">Health Care Workforce</span></li>
            <li><span class="category-list-item " data-categoryid="5679">Health Disparities</span></li>
            <li><span class="category-list-item " data-categoryid="44024">Health Informatics</span></li>
            <li><span class="category-list-item " data-categoryid="44020">Health Policy</span></li>
            <li><span class="category-list-item " data-categoryid="5688">Hematology</span></li>
            <li><span class="category-list-item " data-categoryid="5692">History of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5514">Humanities</span></li>
            <li><span class="category-list-item " data-categoryid="5697">Hypertension</span></li>
            <li><span class="category-list-item " data-categoryid="44043">Images in Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="44021">Imaging</span></li>
            <li><span class="category-list-item " data-categoryid="44022">Immunology</span></li>
            <li><span class="category-list-item " data-categoryid="5702">Infectious Diseases</span></li>
            <li><span class="category-list-item " data-categoryid="44044">Innovations in Health Care Delivery</span></li>
            <li><span class="category-list-item " data-categoryid="44070">JAMA Infographic</span></li>
            <li><span class="category-list-item " data-categoryid="5716">Law and Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45308">Leading Change</span></li>
            <li><span class="category-list-item " data-categoryid="44045">Less is More</span></li>
            <li><span class="category-list-item " data-categoryid="5720">Lifestyle Behaviors</span></li>
            <li><span class="category-list-item " data-categoryid="45311">Medical Coding</span></li>
            <li><span class="category-list-item " data-categoryid="5738">Medical Devices and Equipment</span></li>
            <li><span class="category-list-item " data-categoryid="44023">Medical Education</span></li>
            <li><span class="category-list-item " data-categoryid="5739">Medical Education and Training</span></li>
            <li><span class="category-list-item " data-categoryid="5713">Medical Journals and Publishing</span></li>
            <li><span class="category-list-item " data-categoryid="5746">Melanoma</span></li>
            <li><span class="category-list-item " data-categoryid="44025">Mobile Health and Telemedicine</span></li>
            <li><span class="category-list-item " data-categoryid="5766">Narrative Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5769">Nephrology</span></li>
            <li><span class="category-list-item " data-categoryid="5777">Neurology</span></li>
            <li><span class="category-list-item " data-categoryid="44052">Neuroscience and Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="44053">Notable Notes</span></li>
            <li><span class="category-list-item " data-categoryid="5787">Nursing</span></li>
            <li><span class="category-list-item " data-categoryid="5788">Nutrition</span></li>
            <li><span class="category-list-item " data-categoryid="44027">Nutrition, Obesity, Exercise</span></li>
            <li><span class="category-list-item " data-categoryid="5791">Obesity</span></li>
            <li><span class="category-list-item " data-categoryid="44013">Obstetrics and Gynecology</span></li>
            <li><span class="category-list-item " data-categoryid="5796">Occupational Health</span></li>
            <li><span class="category-list-item " data-categoryid="5801">Oncology</span></li>
            <li><span class="category-list-item " data-categoryid="44054">Ophthalmic Images</span></li>
            <li><span class="category-list-item " data-categoryid="5804">Ophthalmology</span></li>
            <li><span class="category-list-item " data-categoryid="5808">Orthopedics</span></li>
            <li><span class="category-list-item " data-categoryid="5811">Otolaryngology</span></li>
            <li><span class="category-list-item " data-categoryid="44028">Pain Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44029">Pathology and Laboratory Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="45306">Patient Care</span></li>
            <li><span class="category-list-item " data-categoryid="6258">Patient Information</span></li>
            <li><span class="category-list-item " data-categoryid="5843">Pediatrics</span></li>
            <li><span class="category-list-item " data-categoryid="44060">Performance Improvement</span></li>
            <li><span class="category-list-item " data-categoryid="45315">Performance Measures</span></li>
            <li><span class="category-list-item " data-categoryid="42050">Perioperative Care and Consultation</span></li>
            <li><span class="category-list-item " data-categoryid="42125">Pharmacoeconomics</span></li>
            <li><span class="category-list-item " data-categoryid="42126">Pharmacoepidemiology</span></li>
            <li><span class="category-list-item " data-categoryid="5851">Pharmacogenetics</span></li>
            <li><span class="category-list-item " data-categoryid="44030">Pharmacy and Clinical Pharmacology</span></li>
            <li><span class="category-list-item " data-categoryid="5856">Physical Medicine and Rehabilitation</span></li>
            <li><span class="category-list-item " data-categoryid="42059">Physical Therapy</span></li>
            <li><span class="category-list-item " data-categoryid="45313">Physician Leadership</span></li>
            <li><span class="category-list-item " data-categoryid="44061">Poetry</span></li>
            <li><span class="category-list-item " data-categoryid="45316">Population Health</span></li>
            <li><span class="category-list-item " data-categoryid="45309">Professional Well-being</span></li>
            <li><span class="category-list-item " data-categoryid="44064">Professionalism</span></li>
            <li><span class="category-list-item " data-categoryid="5871">Psychiatry</span></li>
            <li><span class="category-list-item " data-categoryid="42128">Public Health</span></li>
            <li><span class="category-list-item " data-categoryid="5877">Pulmonary Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="42129">Radiology</span></li>
            <li><span class="category-list-item " data-categoryid="42058">Regulatory Agencies</span></li>
            <li><span class="category-list-item " data-categoryid="5916">Research, Methods, Statistics</span></li>
            <li><span class="category-list-item " data-categoryid="42142">Resuscitation</span></li>
            <li><span class="category-list-item " data-categoryid="5896">Rheumatology</span></li>
            <li><span class="category-list-item " data-categoryid="38802">Scientific Discovery and the Future of Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5833">Shared Decision Making and Communication</span></li>
            <li><span class="category-list-item " data-categoryid="5912">Sleep Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="5915">Sports Medicine</span></li>
            <li><span class="category-list-item " data-categoryid="44032">Statistics and Research Methods</span></li>
            <li><span class="category-list-item " data-categoryid="5533">Stem Cell Transplantation</span></li>
            <li><span class="category-list-item " data-categoryid="5921">Substance Use and Addiction</span></li>
            <li><span class="category-list-item " data-categoryid="5923">Surgery</span></li>
            <li><span class="category-list-item " data-categoryid="44065">Surgical Innovation</span></li>
            <li><span class="category-list-item " data-categoryid="44066">Surgical Pearls</span></li>
            <li><span class="category-list-item " data-categoryid="44067">Teachable Moment</span></li>
            <li><span class="category-list-item " data-categoryid="45310">Technology and Finance</span></li>
            <li><span class="category-list-item " data-categoryid="6257">The Rational Clinical Examination</span></li>
            <li><span class="category-list-item " data-categoryid="5936">Tobacco and e-Cigarettes</span></li>
            <li><span class="category-list-item " data-categoryid="5938">Toxicology</span></li>
            <li><span class="category-list-item " data-categoryid="42136">Trauma and Injury</span></li>
            <li><span class="category-list-item " data-categoryid="5942">Treatment Adherence</span></li>
            <li><span class="category-list-item " data-categoryid="44068">United States Preventive Services Task Force</span></li>
            <li><span class="category-list-item " data-categoryid="5947">Urology</span></li>
            <li><span class="category-list-item " data-categoryid="44069">Users' Guide to the Medical Literature</span></li>
            <li><span class="category-list-item " data-categoryid="5950">Vaccination</span></li>
            <li><span class="category-list-item " data-categoryid="5955">Venous Thromboembolism</span></li>
            <li><span class="category-list-item " data-categoryid="45312">Veterans Health</span></li>
            <li><span class="category-list-item " data-categoryid="5957">Violence</span></li>
            <li><span class="category-list-item " data-categoryid="42139">Women's Health</span></li>
            <li><span class="category-list-item " data-categoryid="45307">Workflow and Process</span></li>
            <li><span class="category-list-item " data-categoryid="42140">Wound Care, Infection, Healing</span></li>
    </ul>
</div>

    
<div class="manage-interests--save-preferences">
    <div class="save-preferences-btn thm-bg ">
        <span class="save-preferences-btn-text fw-b">Save Preferences</span>
    </div>
</div>
<div class="manage-interests--privacy-terms"> <a class="manage-interests--privacy-terms-color" href="https://jamanetwork.com/pages/privacy-policy">Privacy Policy</a> | <a class="manage-interests--privacy-terms-color" href="https://jamanetwork.com/pages/terms-of-use">Terms of Use</a></div>

    
    <a class="close-reveal-modal icon-close"></a>
</div> 
    </div>

        </div>

</div>



<div id="comments-tab" class="resource-tab comments-tab" style="display: none!important">



</div> 
</div>
</div>

<div id="content-panel" class="content-panel">
    <a id="top"></a>

    <div id="full-text-tab" class="resource-tab full-text-tab">
    <div class="widget-ArticleLinks widget-instance-AMA_ErrataArticleLinks_FullText">
         
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_ArticleLinks_ToErrata_FullText">
        
 
    </div>
    <div class="widget-ArticleNavLinks widget-instance-AMA_ArticleNavLinks">
                <a class="toc-link btn" href="https://jamanetwork.com/journals/jama/issue/281/3">This Issue</a>
 
    </div>



            <div class="article-metrics-wrapper" id="divArticleLevelMetrics">
    <div class="widget-ArticleLevelMetrics widget-instance-AMA_ArticleMetrics">
        

    <div class="artmet-condensed-wrap clearfix">
        <div class="artmet-condensed-stats clearfix">
                            <div class="artmet-item artmet-citations">
                        <a class="artmet-citations-link" href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=WOS:000078052800028&amp;DestLinkType=CitingArticles&amp;DestApp=ALL_WOS&amp;UsrCustomerID=61f30d8ae69c46f86624c5f98a3bc13a" target="_blank">
                            <span class="artmet-text">Citations</span>
                            <span class="artmet-number">580</span>
                        </a>
                </div>
                                </div>

        <div class="artmet-modal-trigger-wrap">
            <a class="artmet-modal-trigger" data-article-id="188381"><i class="icon-metrics"></i><span>View Metrics</span></a>
        </div>
    </div>

 
    </div>

            </div>
                    <ul class="toolbar">
                        <li class="toolbar-pdf-wrap toolbar-tool-wrap">
            <a id="pdf-link" class="toolbar-tool toolbar-pdf al-link pdfaccess" data-article-id="188381" data-article-url="/journals/jama/articlepdf/188381/joc80835.pdf" data-ajax-url="/Content/CheckPdfAccess"><span class="toolbar-pdf-text"><span class="toolbar-link-text-extra">Download </span><span class="toolbar-link-text">PDF</span></span>
            </a>

                        </li>
                        <li class="toolbar-share-wrap toolbar-tool-wrap">
                            <div class="toolbar-tool">
                                <a class="addthis_button_twitter is-b toolbar-twitter toolbar-share at300b" rel="nofollow" data-utm-source="twitter" title="Twitter" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text">Twitter</span></a>
                                <a class="addthis_button_facebook is-b toolbar-facebook toolbar-share at300b" rel="nofollow" data-utm-source="facebook" title="Facebook" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text">Facebook</span></a>
                                <a class="toolbar-share-more-link is-a" rel="nofollow">More</a>
                                <div class="toolbar-share-more">
                                    <a class="addthis_button_email is-b toolbar-email toolbar-share at300b" rel="nofollow" target="_blank" title="Email" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text">Email</span></a>
                                    <a class="addthis_button_linkedin is-b toolbar-linkedin toolbar-share at300b" rel="nofollow" data-utm-source="linkedin" target="_blank" title="LinkedIn" href="https://jamanetwork.com/journals/jama/article-abstract/188381#"><span class="share-text">LinkedIn</span></a>
                                </div>
                            </div>
                        </li>

                        <li class="toolbar-citation-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxGetCitation widget-instance-AMA_Get_Citation">
        <a class="toolbar-tool toolbar-citation is-b" rel="nofollow" data-reveal-id="get-citation" data-reveal=""><span class="toolbar-link-text">Cite</span> <span class="toolbar-link-text-extra">This</span></a>

<div id="get-citation" class="reveal-modal get-citation" data-reveal="">
    <h3 class="get-citation-title">Citation</h3>
    <p class="get-citation-citation">Davidson MH, Hauptman J, DiGirolamo M, et al. Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>A Randomized Controlled Trial</span>. <em>JAMA.</em> 1999;281(3):235–242. doi:10.1001/jama.281.3.235</p>
    <h4 class="get-citation-download-heading">Download citation file:</h4>
    <div class="get-citation-types">
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=0">Ris (Zotero)</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=1">EndNote</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=2">BibTex</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=3">Medlars</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=0">ProCite</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=3">RefWorks</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=0">Reference Manager</a>
        <a class="get-citation-format" rel="nofollow" href="https://jamanetwork.com/Citation/Download?resourceId=188381&amp;resourceType=3&amp;citationFormat=0">Mendeley</a>
    </div>

    <p class="get-citation-copyright">© 2019 </p>
    <a class="close-reveal-modal icon-close" rel="nofollow"></a>
</div> 
    </div>

                        </li>
            <li class="toolbar-permissions-wrap toolbar-tool-wrap">
    <div class="widget-ToolboxPermissions widget-instance-">
            <a href="http://s100.copyright.com/AppDispatchServlet?publisherName=AMA&amp;publication=0098-7484&amp;title=Weight+Control+and+Risk+Factor+Reduction+in+Obese+Subjects+Treated+for+2+Years+With+Orlistat%26lt%3bspan+class%3d%26quot%3bsubtitle%26quot%3b%26gt%3b%26lt%3bspan+class%3d%26quot%3bcolon-for-citation-subtitle%26quot%3b%26gt%3b%3a+%26lt%3b%2fspan%26gt%3bA+Randomized+Controlled+Trial%26lt%3b%2fspan%26gt%3b&amp;publicationDate=1999-01-20&amp;volumeNum=281&amp;issueNum=3&amp;author=Davidson%2c+Michael+H.%3b+Hauptman%2c+Jonathan&amp;startPage=235&amp;endPage=242&amp;contentId=10.1001%2fjama.281.3.235&amp;oa=&amp;orderBeanReset=True" rel="nofollow" id="PermissionsLink" class="toolbar-tool toolbar-permissions is-b" target="_blank"><span class="toolbar-link-text">Permissions</span></a>
 
    </div>

            </li>
                    </ul>

    <div class="widget-ArticleTopInfo widget-instance-AMA_ArticleTop_Info_Widget">
        

    <div class="meta-access-type free-access is-b"></div>


            <span class="hide tagmanagervalue" data-attribute="articleId" data-value="188381" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="arrArticleAuthor" data-value="Michael%20H.%20Davidson%2C%20MD,Jonathan%20Hauptman%2C%20MD,Mario%20DiGirolamo%2C%20MD,John%20P.%20Foreyt%2C%20PhD,Charles%20H.%20Halsted%2C%20MD,David%20Heber%2C%20MD,Douglas%20C.%20Heimburger%2C%20MD,Charles%20P.%20Lucas%2C%20MD,David%20C.%20Robbins%2C%20MD,Jain%20Chung%2C%20PhD,Steven%20B.%20Heymsfield%2C%20MD" data-type="array"></span>
            <span class="hide tagmanagervalue" data-attribute="articleDOI" data-value="10.1001/jama.281.3.235" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articleTitle" data-value="Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat&lt;span class=&quot;subtitle&quot;&gt;&lt;span class=&quot;colon-for-citation-subtitle&quot;&gt;: &lt;/span&gt;A Randomized Controlled Trial&lt;/span&gt;" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articleType" data-value="Original Contribution" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="issueVolume" data-value="281" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="issueNo" data-value="3" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="publishDate" data-value="January%2020%2C%201999" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="journalClub" data-value="No" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articleStatus" data-value="Free" data-type="string"></span>
            <span class="hide tagmanagervalue" data-attribute="articlePubState" data-value="Final" data-type="string"></span>


        <div class="meta-article-type-wrap">
            <div class="meta-article-type thm-col">Original Contribution </div>
        </div>
        <div class="meta-date">January 20, 1999</div>
        <div class="meta-article-title-wrap">
            
            <h1 class="meta-article-title ">Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat<span class="subtitle"><span class="colon-for-citation-subtitle">: </span>A Randomized Controlled Trial</span></h1>

            
        </div>
            <div class="meta-authors">
                <span class="meta-authors--limited"><span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Michael+H.+Davidson&amp;q=Michael+H.+Davidson" target="_blank">Michael H. Davidson, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Jonathan+Hauptman&amp;q=Jonathan+Hauptman" target="_blank">Jonathan Hauptman, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Mario+DiGirolamo&amp;q=Mario+DiGirolamo" target="_blank">Mario DiGirolamo, MD<sup></sup></a></span>; <a class="meta-authors--etal td-u">et al</a></span>
                <span class="meta-authors--remaining"><span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=John+P.+Foreyt&amp;q=John+P.+Foreyt" target="_blank">John P. Foreyt, PhD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Charles+H.+Halsted&amp;q=Charles+H.+Halsted" target="_blank">Charles H. Halsted, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=David+Heber&amp;q=David+Heber" target="_blank">David Heber, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Douglas+C.+Heimburger&amp;q=Douglas+C.+Heimburger" target="_blank">Douglas C. Heimburger, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Charles+P.+Lucas&amp;q=Charles+P.+Lucas" target="_blank">Charles P. Lucas, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=David+C.+Robbins&amp;q=David+C.+Robbins" target="_blank">David C. Robbins, MD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Jain+Chung&amp;q=Jain+Chung" target="_blank">Jain Chung, PhD<sup></sup></a></span>; <span class="wi-fullname brand-fg"><a href="https://jamanetwork.com/searchresults?author=Steven+B.+Heymsfield&amp;q=Steven+B.+Heymsfield" target="_blank">Steven B. Heymsfield, MD<sup></sup></a></span></span>
            </div>
        <div class="meta-citation-wrap">
            <span class="meta-citation-journal-name">JAMA. </span><span class="meta-citation"> 1999;281(3):235-242. doi:10.1001/jama.281.3.235</span>
        </div>

 
    </div>
    <div class="widget-EditorsChoice widget-instance-AMA_EditorsChoice_Links">
         
    </div>
    <div class="widget-LinkedContentToolbar widget-instance-AMA_LinkedContentToolbar">
        
<div class="linked-content-toolbar">
    
    <div class="linked-content-controls">
        <a class="linked-content-trigger td-n tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#graphical-abstract-tab" style="display: none!important">
            <i class="icon-visual-abstract"><span class="sr-t">visual abstract icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5 visuallyhidden">Visual <div>Abstract</div></div>
        </a>
        <a class="linked-content-trigger td-n tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#editorial-comment-tab" style="display: none!important">
            <i class="icon-document"><span class="sr-t">editorial comment icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5 visuallyhidden">Editorial <div>Comment</div></div>
        </a>
        <a class="linked-content-trigger td-n tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#related-articles-tab" style="display: none!important">
            <i class="icon-related"><span class="sr-t">related articles icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5 visuallyhidden">Related <div>Articles</div></div>
        </a>
        <a class="linked-content-trigger td-n tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#author-interviews-tab" style="display: none!important">
            <i class="icon-author_interview"><span class="sr-t">author interview icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5 visuallyhidden">Interviews</div>
        </a>
        <a class="linked-content-trigger td-n tab-no-content" href="https://jamanetwork.com/journals/jama/article-abstract/188381#more-multimedia-tab" style="display: none!important">
            <i class="icon-multimedia"><span class="sr-t">multimedia icon</span></i>
            <div class="trigger-text d-ib va-m ta-l fw-5 visuallyhidden">Multimedia</div>
        </a>
    </div>

    
    <div class="linked-content-tabs">
        <div id="graphical-abstract-tab" class="linked-content-tab graphical-abstract-tab" style="display: none!important">
    <div class="widget-SectionDisplay widget-instance-AMA_GraphicalAbstract_Tab">
        
 
    </div>

        </div>

        
        <div id="editorial-comment-tab" class="linked-content-tab editorial-comment-tab" style="display: none!important">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_EditorialComments">
        
 
    </div>

        </div>

        
        <div id="related-articles-tab" class="linked-content-tab related-article-tab" style="display: none!important">
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedArticle">
        
 
    </div>
    <div class="widget-ArticleLinks widget-instance-AMA_LinkedContentToolbar_RelatedEditorsChoices">
        
 
    </div>

        </div>

        
        <div id="author-interviews-tab" class="linked-content-tab linked-author-interviews-tab" style="display: none!important">

        </div>

        
        <div id="more-multimedia-tab" class="linked-content-tab more-multimedia-tab" style="display: none!important">

        </div>
    </div>
</div> 
    </div>
    <div class="widget-ArticleFulltext widget-instance-AMA_Article_FullText_Widget">
        <div class="article-full-text" data-userhasaccess="True">
    


            <a class="article-section-id-anchor" id="24723301"></a>
                        <div class="h3 cb section-type-abstract decorated-hed ">

                            <div class="heading-text thm-col">
                                Abstract
                            </div>
                        </div>
<p><strong>Context</strong>&nbsp;Orlistat, a gastrointestinal lipase
inhibitor that reduces dietary fat absorption by approximately 30%,
may promote weight loss and reduce cardiovascular risk factors.</p><p><strong>Objective</strong>&nbsp;To test the hypothesis that orlistat combined with
dietary intervention is more effective than placebo plus diet for
weight loss and maintenance over 2 years.</p><p><strong>Design</strong>&nbsp;Randomized, double-blind, placebo-controlled study
conducted from October 1992 to October 1995.</p><p><strong>Setting and Participants</strong>&nbsp;Obese adults (body mass index
[weight in kilograms divided by the square of height in meters],
30-43 kg/m<sup>2</sup>) evaluated at 18 US research centers.</p><p><strong>Intervention</strong>&nbsp;Subjects received placebo plus a controlled-energy
diet during a 4-week lead-in. On study day 1, the diet was continued
and subjects were randomized to receive placebo 3 times a day or
orlistat, 120 mg 3 times a day, for 52 weeks. After 52 weeks, subjects
began a weight-maintenance diet, and the placebo group
(n=133) continued to receive placebo and
orlistat-treated subjects were rerandomized to receive placebo 3 times
a day (n=138), orlistat, 60 mg (n=152)
or 120 mg (n=153) 3 times a day, for an additional 52
weeks.</p><p><strong>Main Outcome Measures</strong>&nbsp;Body weight change and changes in blood
pressure and serum lipid, glucose, and insulin levels.</p><p><strong>Results</strong>&nbsp;A total of 1187 subjects entered the protocol, and 892
were randomly assigned on day 1 to double-blind treatment. For
intent-to-treat analysis, 223 placebo-treated subjects and 657
orlistat-treated subjects were evaluated. During the first year
orlistat-treated subjects lost more weight (mean±SEM,
8.76±0.37 kg) than placebo-treated subjects
(5.81±0.67 kg) (<em>P</em>&lt;.001). Subjects treated
with orlistat, 120 mg 3 times a day, during year 1 and year 2 regained
less weight during year 2 (3.2±0.45 kg; 35.2% regain)
than those who received orlistat, 60 mg (4.26±0.57 kg;
51.3% regain), or placebo (5.63±0.42 kg; 63.4%
regain) in year 2 (<em>P</em>&lt;.001). Treatment with orlistat, 120 mg
3 times a day, was associated with improvements in fasting low-density
lipoprotein cholesterol and insulin levels.</p><p><strong>Conclusions</strong>&nbsp;Two-year treatment with orlistat plus diet
significantly promotes weight loss, lessens weight regain, and improves
some obesity-related disease risk factors.</p>            <div class="movable-ad-target bta"><div class="movable-ad bta">
            <div id="ad-dual-box-mobile" class="ad-dual-box-mobile lazy-ad advertisement ad-text tablet-down" data-slot="8">
            <script>
          googletag.cmd.push(function() {
              if (!App.suppressAds && (App.isAbstract || ((App.isSplitScreen || App.isMag) && !App.hasAccess))) {
                  App.Ads.Mappings.dualMobile = googletag.sizeMapping()
                      .addSize([1023, 600], [0, 0])
                      .addSize([0, 600], [[300, 250], [300, 600]])
                      .addSize([0, 0], [300, 250])
                      .build();
                  App.Ads.slots[8] = googletag.defineSlot(App.Ads.adPath + '/textbreak', [300, 250], 'ad-dual-box-mobile')
                      .setTargeting('pos', ['bta'])
                      .defineSizeMapping(App.Ads.Mappings.dualMobile)
                      .addService(googletag.pubads());

                  googletag.display('ad-dual-box-mobile');
              }
              else {
                  $(".ad-dual-box-mobile").removeClass("ad-text");
              }
          });
            </script>
        </div>


                    </div> </div>
            <a class="article-section-id-anchor" id="24723302"></a>
<p class="para">Obesity,
which affects an increasing number of Americans,<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-1" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">1</a></sup> poses a
therapeutic challenge to the clinician. Conventional nonpharmacological
interventions based on diet and exercise have limited long-term success
in producing sustained weight loss.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup> Obesity induces
multiple metabolic abnormalities that contribute to the pathogenesis of
diabetes mellitus and cardiovascular disease<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-4" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">4</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-5" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">5</a></sup> and is
associated with increased morbidity and mortality risk.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-6" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">6</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-7" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">7</a></sup>
A need therefore exists for new and effective therapeutic tools.</p>            <a class="article-section-id-anchor" id="24723303"></a>
<p class="para">A potentially promising approach is induction of negative
energy balance and weight loss by drug-mediated inhibition of nutrient
absorption. Orlistat (Xenical, Hoffman La Roche Inc, Nutley, NJ), a
minimally absorbable (&lt;1%) agent that inhibits activity of
pancreatic and gastric lipases, blocks gastrointestinal uptake of
approximately 30% of ingested fat.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-8" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">8</a></sup> Assuming incomplete
energy compensation, the treated subject consuming an average American
diet should gradually lose weight and maintain weight loss. The primary
aim of this investigation was to test this hypothesis in a large-scale,
2-year, randomized, double-blind, placebo-controlled
study.</p>            <a class="article-section-id-anchor" id="24723304"></a>
<p class="para">While weight loss is an important end point in obesity treatment, the
primary concern in medical management of obesity is morbidity and
mortality risk reduction by improving underlying cardiovascular and
metabolic risk factors: high blood pressure, atherogenic dyslipidemia,
and insulin resistance. A widely held view, which has not been
subjected to rigorous critical evaluation in large-scale prospective
studies, is that modest (approximately 5%-10%) intentional weight
loss is associated with significant improvements in obesity-related
cardiovascular and metabolic abnormalities.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-9" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">9</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-10" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">10</a></sup> A secondary
aim of this study was to examine the effectiveness of 2-year orlistat
administration in improving blood pressure, lipid, and carbohydrate
metabolism abnormalities, which often occur in obesity.</p>            <a class="article-section-id-anchor" id="24723305"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col">
                                Methods
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723306"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Subjects
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723307"></a>
<p class="para">Subjects were recruited, evaluated, and monitored at 18 clinical
research centers in the United States. Entry criteria included age
older than 18 years, body mass index (weight in kilograms divided by
the square of height in meters) of 30 to 43 kg/m<sup>2</sup>, adequate
contraception in women of childbearing potential, and absence of weight
loss (&gt;4 kg) in the previous 3 months. Subjects were excluded if they
frequently changed smoking habits or had stopped smoking within the
past 6 months, had a history or presence of substance abuse, excessive
intake of alcohol, significant cardiac, renal, hepatic,
gastrointestinal (GI), psychiatric, or endocrine disorders,
drug-treated type 2 diabetes mellitus, or the concomitant use of
medications that alter appetite or lipid levels.</p>            <a class="article-section-id-anchor" id="24723308"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Study Design
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723309"></a>
<p class="para">The hypothesis that orlistat is an effective antiobesity
agent for weight management was evaluated in a 2-year, double-blind,
randomized, placebo-controlled study. Subjects began a
controlled-energy diet that provided 30% of energy intake as fat
during a 4-week, single-blind, placebo lead-in period. Energy
intake was prescribed for each subject on the basis of
estimated daily maintenance energy requirement
(1.3 × calculated basal metabolic rate) minus 2100
to 3360 kJ/d. All vitamin and mineral preparations were discontinued 8
weeks prior to beginning the study.</p>            <a class="article-section-id-anchor" id="24723310"></a>
<p class="para">Weight change during the 4-week lead-in period was used as a
measure of weight loss potential and subjects were stratified
accordingly at randomization to ensure an even distribution between
treatment groups of individuals who lost less than 2 kg or 2 kg or more
during the run-in period. After the 4-week placebo lead-in, subjects
who had a treatment compliance of 75% or more, assessed by counting
placebo capsules taken during lead-in, were randomized for the 2 full
years of study on day 1 to receive placebo (25% of subjects) or
orlistat 120 mg capsules (75% of subjects) for 52 weeks. The study
drug was administered with the subjects' 3 main meals and the
controlled-energy diet was continued.</p>            <a class="article-section-id-anchor" id="24723311"></a>
<p class="para">Medication compliance was assessed by counting the number
of pills returned at the time of specified clinic visits. Subjects were
considered noncompliant if cumulative capsule consumption was less
than 70%. Orlistat-treated subjects who completed 1 year of treatment
with a compliance of more than 70% moved to the next phase of their
initial randomization to 1 of 3 groups: placebo, orlistat 120 mg, or
orlistat 60 mg, for an additional 52 weeks. Subjects randomized to
placebo in the first year who had 70% or higher compliance remained
taking placebo for another 52 weeks. Subjects began a
weight-maintenance diet during year 2, which was designed to help
prevent or diminish weight regain rather than to produce further weight
loss. If a subject was still losing weight during the last 3 months of
year 1, an increased energy intake of 840 to 1260 kJ/d was prescribed.
For all other subjects, no change in diet was made.</p>            <a class="article-section-id-anchor" id="24723312"></a>
<p class="para">Dietitians at each site periodically provided instruction
on dietary intake recording procedures as part of a behavior
modification program and then later used the subject's food diaries
for counseling. During year 1, there were 4 behavior modification
sessions on weight-loss strategies followed during year 2 by 4 seminars
on weight-maintenance strategies. Individuals were encouraged to
increase their physical activity by walking briskly for 20 to 30
minutes 3 to 5 times per week. The recommended changes in physical
activity throughout the study were not assessed.</p>            <a class="article-section-id-anchor" id="24723313"></a>
<p class="para">Each subject provided written informed consent before entry into the
trial. The study protocol was reviewed and approved by the
institutional review boards of each investigation site.</p>            <a class="article-section-id-anchor" id="24723314"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Assessments
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723315"></a>
<p class="para">The initial screening visit included a medical history taking, physical
examination, body weight evaluation, electrocardiogram, and clinical
chemistry, thyroid function, hematology, and urinalysis laboratory
tests. Blood and urine samples were analyzed at a central laboratory.</p>            <a class="article-section-id-anchor" id="24723316"></a>
<p class="para">Fasting serum lipid levels were evaluated according to standard
procedures with low-density lipoprotein cholesterol (LDL-C) measured
directly by ultracentrifugation. Abnormal serum lipid levels were
considered LDL-C higher than 3.36 mmol/L (129.9 mg/dL), untreated;
high-density lipoprotein cholesterol lower than 0.9 mmol/L (34.8
mg/dL); and triglycerides higher than 2.54 mmol/L (98.2 mg/dL),
untreated.</p>            <a class="article-section-id-anchor" id="24723317"></a>
<p class="para">Fasting serum glucose and insulin levels were measured, and a 3-hour
glucose tolerance test (75 g oral glucose load) was performed at the
time of randomization and at the end of years 1 and 2 of double-blind
treatment. Impaired glucose tolerance and diabetes mellitus were
defined according to the National Diabetes Data Group
criteria.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-11" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">11</a></sup> Fasting serum insulin levels higher than 90
pmol/L were considered abnormal.</p>            <a class="article-section-id-anchor" id="24723318"></a>
<p class="para">Body weight, the primary efficacy measure, was evaluated
every 2 weeks until week 16, every 4 weeks until the end of year 1,
then every 8 weeks thereafter. The last body weight measurement was
recorded at week 104. Standing waist circumference, a measure of
adipose tissue distribution and cardiovascular disease
risk,<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-6" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">6</a></sup> was determined with a Gulick anthropometric
spring-loaded tape measure (Model 5829, Bell Medical Services, Neptune,
NJ) and blood pressure was recorded at every visit using a mercury
sphygmomanometer. Fat-soluble vitamins A (retinol), D
(25-hydroxyvitamin D), and E (alpha tocopherol), prothrombin time (as
a marker for vitamin K), and beta carotene were
monitored regularly. If serum vitamin values decreased to below the
reference range on 2 consecutive visits, during year 1 only, subjects
received a once-daily multivitamin preparation (Centrum) that contained
all fat-soluble vitamins. Subjects were instructed to take vitamin
supplements at least 2 hours before or after the evening medication
dose.</p>            <a class="article-section-id-anchor" id="24723319"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Statistical Analysis
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723320"></a>
<p class="para">An analysis of the intent-to-treat population was applied to the data
from subjects who received at least 1 dose of orlistat or placebo
during double-blind treatment and who had at least 1 body weight
measurement before and after randomization. The intent-to-treat
population thus includes all randomized medication-treated subjects who
had at least 1 follow-up body weight measurement. As recommended in the
CONSORT guidelines,<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-12" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">12</a></sup> the last value carried-forward
technique was used for years 1 and 2 analyses. The last value
carried-forward analysis method uses all follow-up data, including that
obtained from subjects who withdrew prematurely, with the last recorded
data point used in statistical analysis. All reported data are the
actual observed values rather than derived data from carrying forward
the last recorded values.</p>            <a class="article-section-id-anchor" id="24723321"></a>
<p class="para">The hypothesis that the mean change in body weight from
randomization after 1 year of double-blind treatment is the same for
the placebo group and orlistat 120 mg group was tested using analysis
of variance or covariance models.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-13" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">13</a></sup> These models were also
used to test the hypothesis that the expected weight change in subjects
receiving orlistat 120 mg in year 1 is the same in year 2, when these
subjects were treated with either placebo, orlistat 60 mg, or orlistat
120 mg. The 95% confidence interval of the placebo-adjusted effect of
orlistat treatment based on the least squares mean was determined. An
analysis of covariance model was used to evaluate changes in risk
factor measures from the start of treatment, using baseline values as
covariates. Data are presented as mean±SEM.
Categorical analyses of the frequency distributions of weight loss were
performed with the use of the χ<sup>2</sup> statistic. For all
statistical analyses, <em>P</em>&lt;.05 was considered statistically
significant.</p>            <a class="article-section-id-anchor" id="24723322"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col">
                                Results
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723323"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Participation
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723324"></a>
<p class="para">A total of 1187 subjects were enrolled into the study, of
whom 892 completed the 4-week placebo lead-in and were randomized to
double-blind treatment with placebo (n=224) or orlistat
120 mg (n=668). The intent-to-treat population,
presented in the figures and tables, includes the 223 subjects in the
placebo group and 657 subjects in the orlistat 120 mg group. One
subject in the placebo group and 11 in the orlistat group were
withdrawn without at least 1 follow-up measurement. Thus, the
intent-to-treat population of 880, which is presented below, is 12
subjects smaller than the randomized population of 892.</p>            <a class="article-section-id-anchor" id="24723325"></a>
<p class="para">The study design and disposition of the subjects over 2 years
are shown in <a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure 1</a>. The characteristics of the study population at randomization were similar
in the 2 treatment groups (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#JOC80835T1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table 1</a>). Oral glucose tolerance was abnormal (impaired or diabetic) in
approximately 11% of subjects.</p>            <a class="article-section-id-anchor" id="24723328"></a>
<p class="para">A total of 591 subjects completed the first year: 133
(59%) placebo-treated subjects and 458 (69%) orlistat-treated
subjects (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure 1</a>). Fifteen subjects who completed treatment with
orlistat 120 mg did not enter the second year. Of the remaining
orlistat subjects, 138 received placebo, 152 received orlistat 60 mg,
and 153 received orlistat 120 mg in the second year. The numbers of
subjects who completed the second year are also shown in 
<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f1" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure 1</a> along
with those who withdrew because of adverse events. A total of 403
subjects (43%) completed 2 full years of treatment with a total study
2-year completion rate of 45% (403/892) for all study participants.
The completion rate was not significantly different among treatment
groups. The main reasons for withdrawal  (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#JOC80835T2" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table 2</a>) were not different between treatment
groups.</p>            <a class="article-section-id-anchor" id="24723330"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Weight Loss
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723331"></a>
<p class="para">During the 4-week placebo lead-in, subjects in both treatment arms lost
approximately 2.3 kg or 2.3% of initial body weight. Following
randomization on study day 1, both treatment groups continued to lose
weight, but the orlistat 120 mg group achieved a more rapid and
significantly greater weight loss compared with the placebo group (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f2" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure 2</a>). At the end of the first
year of lost 8.76±0.37 kg compared with treatment, the
orlistat 120 mg subjects 5.81±0.67 kg in the placebo
group (least squares mean difference, <em>P</em>&lt;.001). Identical
results were obtained when the statistical analyses were applied to the
data expressed in absolute form or as a percent change from initial
values. When expressed as a percentage, the groups lost
8.8%±0.4% vs 5.8%±0.7%,
respectively (<em>P</em>&lt;.001). In addition, 65.7% of
orlistat-treated subjects lost more than 5% of their initial body
weight compared with 43.6% of placebo-treated subjects
(<em>P</em>&lt;.01) at the end of the first year; and 38.9% in the
orlistat group lost more than 10% of initial weight compared with only
24.8% in the placebo group (<em>P</em>=.004).</p>            <a class="article-section-id-anchor" id="24723333"></a>
<p class="para">Of the subjects treated with orlistat 120 mg during the first year,
those who also received 120 mg during year 2 regained significantly
less of their first-year weight loss (3.2±0.45 kg;
35.2% regain) than those who received orlistat 60 mg
(4.26±0.57 kg; 51.3% regain) or placebo
(5.63±0.42 kg; 63.4% regain) during the second year
(<em>P</em>&lt;.001). Treatment with orlistat 120 mg for 2 years
produced a 7.6%±0.9% weight loss from initial body
weight. In contrast, subjects who received placebo for the full 2
years, or who had switched from orlistat 120 mg to placebo in year 2,
lost 4.5%±0.9% and 4.2%±0.8% of
initial body weight, respectively. Moreover, 34.1% of subjects who
completed 2 full years of orlistat 120 mg treatment maintained a weight
loss of more than 10% of initial body weight compared with only 17.5%
of subjects who received placebo for 2 years
(<em>P</em>=.02).</p>            <a class="article-section-id-anchor" id="24723334"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Obesity-Related Risk Factors
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723335"></a>
<p class="para"><strong>Blood Pressure and Waist Circumference.</strong> There was a small, though significantly greater, lowering of systolic
blood pressure between randomization and week 52 of treatment in the
orlistat 120 mg group vs placebo (119.4±0.5 to
118.6±0.6 mm Hg vs 118.6±0.9 to
119.6±1.3 mm Hg; <em>P</em>=.002).
Diastolic blood pressure also decreased more in the
orlistat 120 mg group compared with placebo (76.9±0.4
to 75.9±0.4 mm Hg vs 76.1±0.6 to
77.4±0.9 mm Hg; <em>P</em>=.009). In
addition, after 2 years of treatment, the decrease in mean waist
circumference was significantly greater in the orlistat-treated group
compared with the placebo group ( −4.52±0.8 cm
vs−2.38±1.0 cm; <em>P</em>&lt;.05).</p>            <a class="article-section-id-anchor" id="24723336"></a>
<p class="para"><strong>Lipid Profile.</strong> The mean serum lipid levels are shown in 
<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#JOC80835T3" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table 3</a>. The initial reduction in serum lipid
levels during the placebo lead-in period was similar in the 2 groups,
approximately an 8% decrease in total cholesterol and LDL-C levels.
After randomization, during year 1 total cholesterol levels continued
to decline in the orlistat-treated subjects (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f3" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure
3</a>) but started to increase immediately in
the placebo group even though the subjects were still losing weight.
Although total cholesterol levels increased from randomization to the
end of year 2, this increase was significantly smaller in the subjects
who received orlistat 120 mg for 2 years, than in those who received
placebo for 2 years (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#JOC80835T3" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table 3</a>; 
<em>P</em>&lt;.001). The LDL-C levels also
declined further after randomization over year 1 in the orlistat group (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f3" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure 3</a>) but increased in the placebo group. Similarly, after 2 years
of treatment with orlistat 120 mg, LDL-C values were reduced
significantly below initial values compared with placebo
(<em>P</em>&lt;.001). The greater improvements in total and LDL-C were
independent of the greater weight loss in the orlistat group, as
evidenced by a significant treatment effect in the analysis of
covariance using body weight loss as the covariate. The magnitude of
the treatment effect over 2 years was roughly 0.28 mmol/L (11 mg/dL)
and 0.22 mmol/L (8 mg/dL) for total cholesterol and LDL-C,
respectively.</p>            <a class="article-section-id-anchor" id="24723339"></a>
<p class="para"><strong>Glucose and Insulin.</strong> The group that received orlistat 120 mg for 2 years had less of an
increase in fasting serum glucose levels from study day 1
(0.06±0.03 mmol/L [1.1 ± 0.54 mg/dL]) than those
who received placebo for 2 years (0.26±0.04 mmol/L
[4.68 ± 0.72 mg/dL];<em>P</em>=.001) (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#JOC80835T4" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Table
4</a>). Fasting serum insulin levels decreased
significantly over 2 years in the orlistat 120 mg group but remained
unchanged in the placebo group (84.02±3.46 to
66.52±3.92 pmol/L vs 86.37±4.71 to
86.32±6.89 pmol/L, respectively;
<em>P</em>=.04).</p>            <a class="article-section-id-anchor" id="24723341"></a>
<p class="para"><strong>Adverse Events.</strong> The overall incidence of adverse events was similar in placebo and
orlistat groups. However, there were more adverse GI events associated
with orlistat. At least 1 GI event was experienced by 79% of subjects
in the orlistat group compared with 59% of subjects in the placebo
group. The majority of subjects treated with orlistat experienced 1 or
2 of these GI events, which typically occurred early during treatment,
were mild to moderate in intensity, and generally resolved
spontaneously. Seven types of GI events occurred with at least a 5%
incidence rate and in twice as many subjects in the orlistat group:
flatus with discharge (40.1%), oily spotting (32.7%), fecal urgency
(29.7%), fatty/oily stool (19.8%), oily evacuation (14.3%), fecal
incontinence (11.8%), and increased defecation (11.1%). Seven
subjects in the orlistat group and 2 in the placebo group withdrew
because of GI events. The adverse event rate was lower in year 2 than
in year 1 and did not differ between groups.</p>            <a class="article-section-id-anchor" id="24723342"></a>
<p class="para">Levels of fat-soluble vitamins and beta-carotene generally remained
within the reference range in all treatment groups throughout the
study. Vitamins D (<em>P</em>=.001) and E
(<em>P</em>=.003) levels decreased significantly in the
orlistat-treated group vs placebo at the end of year 1, but mean serum
levels remained within the reference range. When corrected for LDL-C,
vitamin E levels were unchanged in the orlistat-treated subjects.
Supplementation was required in 14.1% of subjects treated with
orlistat 120 mg for 2 years vs with 6.5% of placebo recipients. All
subjects receiving supplementation attained normal serum vitamin levels
by the end of the study and no subjects were withdrawn due to low
values.</p>            <a class="article-section-id-anchor" id="24723343"></a>
<p class="para">One (0.51%) of the 197 placebo-treated women and 3
(0.54%) of the 548 women treated with orlistat 120 mg were diagnosed
as having breast cancer during the 2-year period following
randomization. One of the orlistat-treated subjects had a 1-cm tumor
identified 32 days after randomization. Two subjects, 1 taking orlistat
and 1 taking placebo, had mammograms prior to starting the study that
revealed preexisting breast malignancies.</p>            <a class="article-section-id-anchor" id="24723345"></a>
                        <div class="h3 cb section-type-section  ">

                            <div class="heading-text thm-col">
                                Comment
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723346"></a>
<p class="para">This randomized, multicenter, double-blind, placebo-controlled, 2-year
study with the GI lipase inhibitor orlistat confirms the hypothesis
that partial inhibition of dietary fat absorption combined with dietary
intervention results in sustained negative energy balance and weight
loss. The study also shows that modest reductions in body weight
significantly improve obesity-related disease risk factors. This is the
largest, to date, placebo-controlled, double-blind intervention in
obese subjects designed to evaluate adjunctive pharmacotherapy for
weight loss and prevention of weight regain over a 2-year period. Our
findings support and extend the European orlistat trial reported by
Sjöström and colleagues.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-14" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">14</a></sup></p>            <a class="article-section-id-anchor" id="24723348"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Weight Loss Effects
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723350"></a>
<p class="para">Weight was lost and well maintained in the first year of the current
study while subjects were taking orlistat plus maintaining a
controlled-energy diet. In the second year, when the study design
focused on preventing weight regain rather than inducing further weight
loss, subjects treated with orlistat maintained about two thirds of
their loss while those initially taking orlistat who were switched to
placebo in year 2 regained most of the lost weight. As expected, there
was some weight gain in the orlistat-treated group in year 2 when the
diet was changed to weight maintenance energy intake. Additional
factors may also have
contributed to weight regain during year 2, including
reduced energy requirements due to metabolically active tissue
loss<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-15" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">15</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-16" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">16</a></sup> and partial compensation for inhibition of
dietary fat absorption with increased food intake. Nevertheless, the
greater sustained weight loss in the orlistat-treated subjects
contrasts to the gradual weight regain observed in subjects who
received placebo in year 2.</p>            <a class="article-section-id-anchor" id="24723352"></a>
<p class="para">The results of our orlistat study cannot easily be compared
with trials of other antiobesity agents because there are no published
reports of continuous double-blind treatment beyond 1 year with
medications such as dexfenfluramine hydrochloride, sibutramine
hydrochloride, and phentermine hydrochloride plus fenfluramine
hydrochloride.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-3" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">3</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-17" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">17</a></sup><sup>-<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-17" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">19</a></sup> The inability of intensive lifestyle
interventions alone to maintain weight loss in obese subjects is
highlighted by the recent 2-year trial of diet, exercise, and diet plus
exercise reported by Wing et al.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-20" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">20</a></sup> Despite the expertise of
these investigators, all treatment groups except the diet plus exercise
intervention relapsed to initial weight by the end of year 2. Moreover,
the diet plus exercise group maintained only a small amount of weight
loss (&lt;2.5 kg) over 2 years. The placebo groups in the present study
who also had a behavioral intervention similarly experienced weight
regain and by treatment week 104 had a total weight loss of about 4.5
kg. Thus, these placebo-treated overweight subjects failed to maintain
lost weight to the extent observed in the orlistat 120 mg group.
Pharmacologic plus dietary intervention therefore appears to
significantly improve the 2-year efficacy of weight management.</p>            <a class="article-section-id-anchor" id="24723353"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Risk Factor Reduction
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723354"></a>
<p class="para">During the 4-week placebo lead-in period, blood pressure
and serum levels of several lipids improved with diet alone. This is
consistent with the established independent impact of energy
restriction on metabolic and cardiovascular measures, even before
substantial weight loss.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-21" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">21</a></sup> After randomization, subjects
treated with orlistat maintained the improvements in serum lipid
levels. The improvements in LDL-C and total cholesterol levels were
independent of the greater weight loss achieved in the orlistat-treated
subjects, as indicated by analyses of covariance, and thus appear to
reflect a pharmacologic lipid-lowering effect of orlistat. In contrast,
total cholesterol levels in the placebo group increased progressively
from randomization to treatment week 32 despite continued weight loss (<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#joc80835f3" class="figure-link section-jump-link" data-tab-toggle=".tab-nav-figure-table">Figure 3</a>). Lipase inhibition by orlistat prevents the absorption of
approximately 30% of dietary fat intake<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-22" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">22</a></sup> and the
prescribed diet of roughly 30% of energy from fat would thus become,
in effect, a 20% to 24% fat diet when coupled with orlistat
treatment. A reduction in effective absorbed fat intake of this
magnitude, assuming much of it is saturated fat, could contribute to
the improved LDL-C and total cholesterol levels.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-23" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">23</a></sup></p>            <a class="article-section-id-anchor" id="24723355"></a>
<p class="para">Fasting insulin levels declined throughout year 1 in the
orlistat-treated subjects and this decrease was sustained for the full
2 years of the study. In contrast, in the placebo group, fasting
insulin levels increased progressively from about treatment week 24 in
the first year and at 52 weeks exceeded the randomization level. The
sustained lowering of insulin levels in the orlistat group appeared
related to the overall greater weight loss in these subjects rather
than an independent drug effect. The significant and sustained lowering
of insulin levels is clinically important because earlier studies link
fasting serum insulin levels with ischemic heart disease
risk,<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-24" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">24</a></sup> insulin resistance, and obesity-related
hypertension.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-25" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">25</a></sup> The sustained reduction in fasting serum
insulin levels over 2 years of treatment thus suggests that orlistat
effectively improves the constellation of metabolic risk factors, which
comprise the insulin resistance syndrome.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-26" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">26</a></sup></p>            <a class="article-section-id-anchor" id="24723356"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Adverse Effects
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723357"></a>
<p class="para">A concern with the long-term use of antiobesity
agents is the potential for serious systemic adverse effects. As
orlistat acts on GI lipases and is minimally absorbed, systemic adverse
effects are negligible. This is confirmed in the present study by the
similar systemic adverse event profiles in the placebo and orlistat
treatment groups. However, as expected based on the pharmacologic
action of orlistat, the incidence of GI effects, generally early during
treatment, was higher in the orlistat group. It is likely that the
majority of these effects occurred in subjects unable to maintain a
moderate dietary fat intake. The GI symptoms diminished over time and
study withdrawal due to adverse events was similar among all treatment
groups in year 2.</p>            <a class="article-section-id-anchor" id="24723358"></a>
<p class="para">Orlistat's mechanism of action may affect levels of fat-soluble
vitamins. Although vitamin D and E levels decreased more in the
orlistat group compared with placebo, the changes were small and all
mean vitamin and beta-carotene values stayed within reference ranges.
Subjects who required vitamin supplementation achieved normalized
values by the end of the study.</p>            <a class="article-section-id-anchor" id="24723359"></a>
<p class="para">Breast malignancies were identified in 3 women (0.54%) treated
with orlistat 120 mg and 1 woman (0.51%) treated with placebo over the
2-year study. There was strong evidence for tumor preexistence in 3 of
4 cases (2 orlistat, 1 placebo) at the time of study randomization. In
addition, animal genotoxicity and carcinogenicity studies do not
indicate any carcinogenic potential of orlistat.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">27</a></sup>
Orlistat's minimal (&lt;1%) absorption<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-28" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">28</a></sup> and lack of an
estrogen-stimulating effect in women<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-27" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">27</a></sup> support the
conclusion that no biological association exists between orlistat and
breast cancer.</p>            <a class="article-section-id-anchor" id="24723361"></a>
                        <div class="h4 cb section-type-section  ">

                            <div class="heading-text ">
                                Study Limitations
                            </div>
                        </div>
            <a class="article-section-id-anchor" id="24723363"></a>
<p class="para">A major difficulty in conducting long-term weight
management studies is the high dropout rate, especially in subjects
receiving placebo, who therefore generally experience minimal weight
loss.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-29" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">29</a></sup> The completion rate of subjects in several earlier
behavioral-pharmacologic weight loss studies over 6 months to 2 years
ranged from 30% to 63%.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-2" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">2</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-14" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">14</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-26" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">26</a></sup> The retention rates of
43% and 45% in the placebo and orlistat groups after 2 years of
treatment, respectively, in the present study are therefore in accord
with previous long-term weight loss studies.</p>            <a class="article-section-id-anchor" id="24723364"></a>
<p class="para">A second concern is potential study bias may impact either
favorably or negatively on the weight loss efficacy of orlistat.
Subjects may have dropped out of the study because of lack of treatment
efficacy in the placebo-treated group and because of GI adverse effects
in the orlistat group. Although this study was double-blind, some
subjects may have suspected
they were taking placebo or orlistat by the
presence or absence of GI adverse events specific to orlistat. This
unplanned unblinding could bias the study results. If patients in the
placebo group who experienced lesser weight loss and fewer GI symptoms
were more likely to drop out, then the comparison of subjects who
completed the study could underestimate the true benefit of orlistat by
yielding an unrepresentative cohort who were able to achieve sustained
weight loss despite inactive treatment for comparison with
orlistat-treated subjects. Another possible source of bias, operating
in the opposite direction, is that dropouts from the orlistat group may
have included noncompliant subjects who ingested large amounts of fat
and who had minimal weight loss and experienced more GI adverse
effects. Analysis of only subjects who completed 2 full years of
treatment could thus overestimate actual treatment efficacy. However,
there were no apparent systematic differences in weight loss among
subjects who experienced several, 1, or no GI adverse effects.</p>            <a class="article-section-id-anchor" id="24723365"></a>
<p class="para">Use of the data derived from the last recorded observation before
the subjects withdrew from the study attempts to compensate for the
bias inherent in using only completers' data. To evaluate the impact
of the last observation carried-forward approach on potential bias, we
compared weight loss at 12, 24, and 36 weeks of treatment in the
subjects whose weight was measured at each of these time points and who
subsequently dropped out with subjects who did not withdraw. At each
time point, the subjects who subsequently dropped out lost less weight
than those who remained in the study. Furthermore, the pattern of
differences between the placebo- and orlistat-treated cohorts was
similar in both dropouts and completers at each time point. Weight loss
was approximately 40% greater on a consistent basis in the cohorts of
dropouts and completers who received orlistat compared with placebo.
Application of the last observation carried-forward approach to the
intent-to-treat population would theoretically minimize the opposing
sources of bias by carrying forward trends in the responses of subjects
who dropped out as well as those who completed the study to the end
result.<sup><a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-29" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">29</a></sup><sup>,<a href="https://jamanetwork.com/journals/jama/article-abstract/188381#REF-JOC80835-30" class="ref-link section-jump-link" data-tab-toggle=".tab-nav-references">30</a></sup></p>            <a class="article-section-id-anchor" id="24723366"></a>
<p class="para">This study demonstrates that partial inhibition of fat absorption in
obese subjects can produce sustained weight loss. Subjects treated with
orlistat plus a mildly controlled-energy diet lost significantly more
weight than those treated with placebo plus diet even though all
subjects received a high standard of care and similar dietary
counseling. Moreover, orlistat treatment was associated with greater
improvements in fasting serum lipid and insulin levels. These
observations collectively suggest that orlistat may be a useful adjunct
to dietary intervention in producing and maintaining weight loss over 2
years.</p>            <a class="article-section-id-anchor" id="24723368"></a>
                        <div class="h3 cb section-type-references  ">

                            <div class="heading-text thm-col">
                                References
                            </div>
                        </div>
<div class="references"><div class="reference"><a class="reference-number" id="ref-joc80835-1">1.</a><div class="reference-content">Flegal&nbsp;K, Carroll&nbsp;M, Kuczmarski&nbsp;R, Johnson&nbsp;C.&nbsp;Overweight and obesity in the United States.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat
Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;22:38-47.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Overweight%20and%20obesity%20in%20the%20United%20States.&amp;author=K%20Flegal&amp;author=M%20Carroll&amp;author=R%20Kuczmarski&amp;author=C%20Johnson&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-2">2.</a><div class="reference-content">Thomas&nbsp;PR.&nbsp;<em>Weighing the Options Criteria for
Evaluating Weight-management Programs.</em>&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">Washington, DC: National
Academy Press; 1995.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-3">3.</a><div class="reference-content">National Task Force on the Prevention and
Treatment of Obesity.&nbsp;&nbsp;Long-term pharmacotherapy in the management of
obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;JAMA.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;276:1907-1915.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20pharmacotherapy%20in%20the%20management%20of%20obesity.&amp;publication_year=&amp;journal=JAMA.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-4">4.</a><div class="reference-content">Eckel&nbsp;RH.&nbsp;Obesity and heart disease.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Circulation.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;96:3248-3250.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Obesity%20and%20heart%20disease.&amp;author=RH%20Eckel&amp;publication_year=&amp;journal=Circulation.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-5">5.</a><div class="reference-content">Meigs&nbsp;J, Nathan&nbsp;D, Wilson&nbsp;P, Cupples&nbsp;L, Singer&nbsp;D.&nbsp;Metabolic risk factors worsen continuously across the spectrum of
nondiabetic glucose tolerance.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Ann Intern Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;128:524-533.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Metabolic%20risk%20factors%20worsen%20continuously%20across%20the%20spectrum%20of%20nondiabetic%20glucose%20tolerance.&amp;author=J%20Meigs&amp;author=D%20Nathan&amp;author=P%20Wilson&amp;author=L%20Cupples&amp;author=D%20Singer&amp;publication_year=&amp;journal=Ann%20Intern%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-6">6.</a><div class="reference-content">Pi-Sunyer&nbsp;FX.&nbsp;Medical hazards of obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Ann
Intern Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1993;19:655-660.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Medical%20hazards%20of%20obesity.&amp;author=FX%20Pi-Sunyer&amp;publication_year=&amp;journal=Ann%20Intern%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-7">7.</a><div class="reference-content">Bray&nbsp;GA.&nbsp;Health hazards of obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Endocrinol
Metab Clin North Am.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;25:907-919.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Health%20hazards%20of%20obesity.&amp;author=GA%20Bray&amp;publication_year=&amp;journal=Endocrinol%20Metab%20Clin%20North%20Am.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-8">8.</a><div class="reference-content">Drent&nbsp;ML, Larsson&nbsp;I, William-Olsson&nbsp;T.
    &nbsp;et al.&nbsp;&nbsp;Orlistat
(Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a
multiple dose study.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;19:221-226.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Orlistat%20(Ro%2018-0647)%2C%20a%20lipase%20inhibitor%2C%20in%20the%20treatment%20of%20human%20obesity%3A%20a%20multiple%20dose%20study.&amp;author=ML%20Drent&amp;author=I%20Larsson&amp;author=T%20William-Olsson&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-9">9.</a><div class="reference-content">Goldstein&nbsp;DJ.&nbsp;Beneficial health effects of
modest weight loss.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;16:397-415.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Beneficial%20health%20effects%20of%20modest%20weight%20loss.&amp;author=DJ%20Goldstein&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-10">10.</a><div class="reference-content">Williamson&nbsp;D.&nbsp;Intentional weight loss.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes
Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;21(suppl 1):S14-S19.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Intentional%20weight%20loss.&amp;author=D%20Williamson&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-11">11.</a><div class="reference-content">National Diabetes Data Group.&nbsp;&nbsp;Classification and
diagnosis of diabetes mellitus and other categories of glucose
intolerance.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Diabetes.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1979;28:1039-1057.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Classification%20and%20diagnosis%20of%20diabetes%20mellitus%20and%20other%20categories%20of%20glucose%20intolerance.&amp;publication_year=&amp;journal=Diabetes.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-12">12.</a><div class="reference-content">Begg&nbsp;C, Cho&nbsp;M, Eastwood&nbsp;S.
    &nbsp;et al.&nbsp;&nbsp;Improving the quality
of reporting of randomized controlled trials.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;JAMA.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;276:637-639.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Improving%20the%20quality%20of%20reporting%20of%20randomized%20controlled%20trials.&amp;author=C%20Begg&amp;author=M%20Cho&amp;author=S%20Eastwood&amp;publication_year=&amp;journal=JAMA.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-13">13.</a><div class="reference-content">Winer&nbsp;BJ.&nbsp;<em>Statistical Principles in
Experimental Design.</em>&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">2nd ed. New York, NY: McGraw-Hill Book Co;
1971.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-14">14.</a><div class="reference-content">Sjöström&nbsp;L, Rissanen&nbsp;A, Andersen&nbsp;T.
    &nbsp;et al.&nbsp;&nbsp;Randomised placebo-controlled trial of orlistat for weight loss and
prevention of weight regain in obese patients.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Lancet.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;352:167-173.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Randomised%20placebo-controlled%20trial%20of%20orlistat%20for%20weight%20loss%20and%20prevention%20of%20weight%20regain%20in%20obese%20patients.&amp;author=L%20Sj%C3%B6str%C3%B6m&amp;author=A%20Rissanen&amp;author=T%20Andersen&amp;publication_year=&amp;journal=Lancet.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-15">15.</a><div class="reference-content">Leibel&nbsp;RL, Rosenbaum&nbsp;M, Hirsch&nbsp;J.&nbsp;Changes in energy
expenditure resulting from altered body weight.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;N Engl J Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;332:621-628.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Changes%20in%20energy%20expenditure%20resulting%20from%20altered%20body%20weight.&amp;author=RL%20Leibel&amp;author=M%20Rosenbaum&amp;author=J%20Hirsch&amp;publication_year=&amp;journal=N%20Engl%20J%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-16">16.</a><div class="reference-content">Bray&nbsp;G.&nbsp;Evaluation of drugs for treating obesity.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Obes Res.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;3(suppl 4):425S-434S.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Evaluation%20of%20drugs%20for%20treating%20obesity.&amp;author=G%20Bray&amp;publication_year=&amp;journal=Obes%20Res.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-17">17.</a><div class="reference-content">Lean&nbsp;M.&nbsp;Sibutramine.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab
Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;21(suppl 1):S30-S36.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Sibutramine.&amp;author=M%20Lean&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-18">18.</a><div class="reference-content">Weintraub&nbsp;M, Sundaresan&nbsp;PR, Schuster&nbsp;B, Averbuch&nbsp;M, Stein&nbsp;EC, Byrne&nbsp;L.&nbsp;Long-term weight control study, V (weeks 190 to
210).&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Clin Pharmacol Ther.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;51:615-618.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20weight%20control%20study%2C%20V%20(weeks%20190%20to%20210).&amp;author=M%20Weintraub&amp;author=PR%20Sundaresan&amp;author=B%20Schuster&amp;author=M%20Averbuch&amp;author=EC%20Stein&amp;author=L%20Byrne&amp;publication_year=&amp;journal=Clin%20Pharmacol%20Ther.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-19">19.</a><div class="reference-content">Weintraub&nbsp;M.&nbsp;Long-term weight control
study: conclusions.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Clin Pharmacol Ther.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;51:642-646.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Long-term%20weight%20control%20study%3A%20conclusions.&amp;author=M%20Weintraub&amp;publication_year=&amp;journal=Clin%20Pharmacol%20Ther.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-20">20.</a><div class="reference-content">Wing&nbsp;R, Venditti&nbsp;E, Jakicic&nbsp;J.
    &nbsp;et al.&nbsp;&nbsp;Lifestyle
intervention in overweight individuals with a family history of
diabetes.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Diabetes Care.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1998;21:350-360.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Lifestyle%20intervention%20in%20overweight%20individuals%20with%20a%20family%20history%20of%20diabetes.&amp;author=R%20Wing&amp;author=E%20Venditti&amp;author=J%20Jakicic&amp;publication_year=&amp;journal=Diabetes%20Care.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-21">21.</a><div class="reference-content">Wing&nbsp;R, Blair&nbsp;E, Bononi&nbsp;P.
    &nbsp;et al.&nbsp;&nbsp;Caloric
restriction per se is a significant factor in improvements in glycemic
control and insulin sensitivity during weight loss in obese NIDDM
patients.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Diabetes Care.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1994;17:30-36.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Caloric%20restriction%20per%20se%20is%20a%20significant%20factor%20in%20improvements%20in%20glycemic%20control%20and%20insulin%20sensitivity%20during%20weight%20loss%20in%20obese%20NIDDM%20patients.&amp;author=R%20Wing&amp;author=E%20Blair&amp;author=P%20Bononi&amp;publication_year=&amp;journal=Diabetes%20Care.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-22">22.</a><div class="reference-content">Guerciolini&nbsp;R.&nbsp;Mode of action of orlistat.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Int J Obes Relat Metab Disord.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1997;21(suppl 3):S12-S23.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Mode%20of%20action%20of%20orlistat.&amp;author=R%20Guerciolini&amp;publication_year=&amp;journal=Int%20J%20Obes%20Relat%20Metab%20Disord.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-23">23.</a><div class="reference-content">Grundy&nbsp;S.&nbsp;Atherogenic dyslipidemia and the metabolic
syndrome.&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">In: Gotto AJ, ed. 
<em>Drugs Affecting Lipid Metabolism</em>. 
Norwell, Mass: Kluwer Academic Publishers; 1996:237-247.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-24">24.</a><div class="reference-content">Despres&nbsp;J, Lamarche&nbsp;B, Mauriege&nbsp;P.
    &nbsp;et al.&nbsp;&nbsp;Hyperinsulinemia as an independent risk factor for ischemic heart
disease.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;N Engl J Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;334:952-957.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Hyperinsulinemia%20as%20an%20independent%20risk%20factor%20for%20ischemic%20heart%20disease.&amp;author=J%20Despres&amp;author=B%20Lamarche&amp;author=P%20Mauriege&amp;publication_year=&amp;journal=N%20Engl%20J%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-25">25.</a><div class="reference-content">Landsberg&nbsp;L.&nbsp;Hyperinsulinemia.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Hypertension.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1992;(suppl)19:161-166.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Hyperinsulinemia.&amp;author=L%20Landsberg&amp;publication_year=&amp;journal=Hypertension.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-26">26.</a><div class="reference-content">Volkmar&nbsp;FR, Stunkard&nbsp;AJ, Woolston&nbsp;J, Bailey&nbsp;RA.&nbsp;High attrition rates in commercial weight reduction patterns programs.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Arch Intern Med.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1981;141:426-428.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=High%20attrition%20rates%20in%20commercial%20weight%20reduction%20patterns%20programs.&amp;author=FR%20Volkmar&amp;author=AJ%20Stunkard&amp;author=J%20Woolston&amp;author=RA%20Bailey&amp;publication_year=&amp;journal=Arch%20Intern%20Med.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-27">27.</a><div class="reference-content">Food and Drug Administration, Center for
Drug Evaluation and Research.&nbsp;&nbsp;NDA 20-766, Xenical (Orlistat).&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">Presented
at: Endocrinologic and Metabolic Drugs Advisory Committee Meeting 69;
March 1998; Gaithersburg, Md.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-28">28.</a><div class="reference-content">Zhi&nbsp;J, Melia&nbsp;AT, Eggers&nbsp;H, Joly&nbsp;R, Patel&nbsp;IH.&nbsp;Review of
limited systemic absorption of orlistat, a lipase inhibitor, in healthy
human volunteers.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;J Clin Pharmacol.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1995;35:1103-1108.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Review%20of%20limited%20systemic%20absorption%20of%20orlistat%2C%20a%20lipase%20inhibitor%2C%20in%20healthy%20human%20volunteers.&amp;author=J%20Zhi&amp;author=AT%20Melia&amp;author=H%20Eggers&amp;author=R%20Joly&amp;author=IH%20Patel&amp;publication_year=&amp;journal=J%20Clin%20Pharmacol.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-29">29.</a><div class="reference-content">Allison&nbsp;DB, Cappelleri&nbsp;JC, Carpenter&nbsp;KM.&nbsp;Design and
analysis of obesity treatment and prevention trials.&nbsp;<span class="ref-text" xmlns:helper="urn:XsltStringHelper">In: Dalton S, ed.
<em>Overweight and Weight Management</em>. Gaithersburg, Md: Aspen
Publishers Inc; 1997:557-597.</span></div></div><div class="reference"><a class="reference-number" id="ref-joc80835-30">30.</a><div class="reference-content">Little&nbsp;R, Yau&nbsp;L.&nbsp;Intent-to-treat analysis for
longitudinal studies with dropouts.&nbsp;<i xmlns:helper="urn:XsltStringHelper">&nbsp;Biometrics.</i><span class="ref-text" xmlns:helper="urn:XsltStringHelper">1996;52:1324-1333.</span><a class="google-scholar-ref-link" href="https://scholar.google.com/scholar_lookup?title=Intent-to-treat%20analysis%20for%20longitudinal%20studies%20with%20dropouts.&amp;author=R%20Little&amp;author=L%20Yau&amp;publication_year=&amp;journal=Biometrics.&amp;volume=&amp;pages=" target="_blank" xmlns:helper="urn:XsltStringHelper">Google Scholar</a></div></div></div>
    


</div> 
    </div>

                    
                </div> 

            <footer class="footer">
        
        <div id="footer-microsite" class="footer-microsite">
            <style type="text/css">
    @media (min-width: 1024px) {.split-screen .footer-microsite-contents {border-bottom:0 !important;}}
    .footer-microsite-contents {margin-bottom:1em;width:100%;}
    .footer-network-other .link-apps:before {width: 23px;}
    .footer-network-other .link-institutions-librarians:before {width: 23px;}
    .jn-ss-footer-border-top {border-top:1px solid #555;padding-top:15px;}
    .jn-ss-footer-border-bottom {border-bottom:1px solid #555;padding-bottom:10px;}
</style>
<div class="footer-heading-wrap">
<h3 id="BodyContent_Footer_h3SiteName" class="footer-heading is-b footer-microsite-heading" data-mobile-tog-target=".footer-microsite-links-wrap">JAMA</h3>
</div>
<div class="footer-microsite-links-wrap">
<div class="footer-microsite-contents  jn-ss-footer-border-bottom">
<h4 id="BodyContent_Footer_ContentHeader" class="footer-subheading">Content</h4>
<a href="https://jamanetwork.com/journals/jama">Home</a>
<a href="https://jamanetwork.com/journals/jama/newonline">New Online</a>
<a href="https://jamanetwork.com/journals/jama/currentissue">Current Issue</a>
</div>
<div class="footer-microsite-services cf">
<h4 id="BodyContent_Footer_ServiceHeader" class="footer-subheading">Journal Information</h4>
<a href="https://jamanetwork.com/journals/jama/pages/for-authors">For Authors</a>
<a href="https://jamanetwork.com/journals/jama/editors-and-publishers">Editors &amp; Publishers</a>
<a href="https://jamanetwork.com/pages/rss">RSS</a>
<a href="https://jamanetwork.com/journals/jama/pages/contact-us">Contact Us</a>
</div>
<div class="footer-network-other  jn-ss-footer-border-bottom">
<a href="https://edhub.ama-assn.org/jn-learning" class="link-network-other is-b link-learning">JN Learning</a>
<a href="https://store.jamanetwork.com/" class="link-network-other is-b link-store" target="_blank">Store</a>
<a href="https://jamanetwork.com/pages/apps" class="link-network-other is-b link-mobile" target="_blank">Apps</a>
<a href="https://careers.jamanetwork.com/" class="link-network-other is-b link-jobs" target="_blank">Jobs</a>
<a href="https://jamanetwork.com/pages/institutions-and-librarians" class="link-network-other is-b link-institutions-librarians" target="_blank">Institutions</a>
<a href="https://jamanetwork.com/pages/reprints-and-permissions" class="link-network-other is-b link-reprints-permissions">Reprints &amp; Permissions</a>
</div>
<div id="BodyContent_Footer_divSubscribe" class="footer-microsite-subscribe">
<img src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jama.jpg" class="subscribe-image" alt="Journal Cover">
<div class="subscribe-meta">
<h4 class="subscribe-heading footer-subheading">Subscribe</h4>
<a href="https://store.jamanetwork.com/productDetails.aspx?productcodeID=64" class="subscribe-submit btn">Go</a>
</div>
</div>
</div>
        </div>

        
        <div id="footer-network" class="footer-network">
            <style type="text/css">
    .footer-network-sites {width: 62.85542%;}
    .footer-network-info {width: 35.93976%}
    .jn-ss-subheading-mt {margin-top: 1.5em;}
    .jn-registered:after {content: "\00AE";font-size: 50%;vertical-align: top;}
    .jn-trademark:after {content: "\2122";font-size: 50%;vertical-align: top;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b jn-trademark" data-mobile-tog-target=".footer-network-links-wrap"><strong>JAMA</strong> Network</h3>
</div>
<div class="footer-network-links-wrap">
<div class="footer-network-sites">
<div class="internal">
<h4 id="BodyContent_Footer_JournalHeader" class="footer-subheading">Journals</h4>
<a href="https://jamanetwork.com/journals/jama">JAMA</a>
<a href="https://jamanetwork.com/journals/jamanetworkopen" target="_blank">JAMA Network Open</a>
<a href="https://jamanetwork.com/journals/jamacardiology">JAMA Cardiology</a>
<a href="https://jamanetwork.com/journals/jamadermatology">JAMA Dermatology</a>
<a href="https://jamanetwork.com/journals/jamafacialplasticsurgery">JAMA Facial Plastic Surgery</a>
<a href="https://jamanetwork.com/journals/jamainternalmedicine">JAMA Internal Medicine</a>
<a href="https://jamanetwork.com/journals/jamaneurology">JAMA Neurology</a>
<a href="https://jamanetwork.com/journals/jamaoncology">JAMA Oncology</a>
<a href="https://jamanetwork.com/journals/jamaophthalmology">JAMA Ophthalmology</a>
<a href="https://jamanetwork.com/journals/jamaotolaryngology">JAMA Otolaryngology–Head &amp; Neck Surgery</a>
<a href="https://jamanetwork.com/journals/jamapediatrics">JAMA Pediatrics</a>
<a href="https://jamanetwork.com/journals/jamapsychiatry">JAMA Psychiatry</a>
<a href="https://jamanetwork.com/journals/jamasurgery">JAMA Surgery</a>
<a href="https://jamanetwork.com/journals/archneurpsyc">Archives of Neurology &amp; Psychiatry (1919-1959)</a>
</div>
<div class="external">
<h4 class="footer-subheading">Sites</h4>
<div id="BodyContent_Footer_ssFooterSiteMenu">
<div class="selfServe">
<a target="_blank" href="http://www.amamanualofstyle.com/">AMA Manual of Style</a>
<a target="_blank" href="https://sites.jamanetwork.com/art-and-images-in-psychiatry/">Art and Images in Psychiatry</a>
<a target="_blank" href="https://sites.jamanetwork.com/breastcancerscreening/index.html">Breast Cancer Screening Guidelines</a>
<a target="_blank" href="https://sites.jamanetwork.com/colon-cancer-screening/">Colorectal Screening Guidelines</a>
<a target="_blank" href="https://sites.jamanetwork.com/declaration-of-helsinki/index.html">Declaration of Helsinki</a>
<a target="_blank" href="https://sites.jamanetwork.com/depression-screening/">Depression Screening Guidelines</a>
<a target="_blank" href="https://ebm.jamanetwork.com/index.html">Evidence-Based Medicine: An Oral History</a>
<a target="_blank" href="https://sites.jamanetwork.com/fishbein/">Fishbein Fellowship</a>
<a target="_blank" href="https://sites.jamanetwork.com/genetics/">Genomics and Precision Health</a>
<a target="_blank" href="https://sites.jamanetwork.com/health-disparities/">Health Disparities</a>
<a target="_blank" href="https://sites.jamanetwork.com/jnc8/">Hypertension Guidelines</a>
<a target="_blank" href="https://sites.jamanetwork.com/audio">JAMA Network Audio</a>
<a target="_blank" href="https://jamanetwork.com/pages/conferences">JAMA Network Conferences </a>
<a target="_blank" href="https://sites.jamanetwork.com/machine-learning">Machine Learning</a>
<a target="_blank" href="https://sites.jamanetwork.com/medmen">Med Men</a>
<a target="_blank" href="https://sites.jamanetwork.com/jama-medical-education/">Medical Education</a>
<a target="_blank" href="https://sites.jamanetwork.com/opioids/">Opioid Management Guidelines</a>
<a target="_blank" href="http://peerreviewcongress.org/index.html">Peer Review Congress</a>
<a target="_blank" href="https://sites.jamanetwork.com/research-ethics/">Research Ethics</a>
<a target="_blank" href="https://sites.jamanetwork.com/sepsis/">Sepsis and Septic Shock</a>
<a target="_blank" href="https://sites.jamanetwork.com/statins/">Statins and Dyslipidemia</a>
<a target="_blank" href="https://jamanetwork.com/pages/collections">Topics and Collections</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Featured Articles</h4>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2463262">ACS Breast Cancer Screening Guideline</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2503508">CDC Guideline for Prescribing Opioids</a>
<a href="https://jamanetwork.com/journals/jamasurgery/fullarticle/2623725">CDC Guideline for Prevention of Surgical Site Infections</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2492881">Consensus Definitions for Sepsis and Septic Shock</a>
<a href="https://jamanetwork.com/journals/jamaoncology/fullarticle/2683251">Global Burden of Cancer, 1990-2016</a>
<a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/2481809">Global Burden of Disease in Children, 1990-2013</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2596292">Global Burden of Hypertension, 1990-2015</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2698492">Global Firearm Mortality, 1990-2016</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2674671">Health Care Spending in the US and Other High-Income Countries</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2513561">Income and Life Expectancy in the US</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/1791497">JNC 8 Guideline for Management of High Blood Pressure</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2533698">President Obama on US Health Care Reform</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2529486">Screening for Colorectal Cancer</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2484345">Screening for Depression in Adults</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2680553">Screening for Prostate Cancer</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2584058">Statins for Primary Prevention of Cardiovascular Disease</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/2678018">The State of US Health, 1990-2016</a>
<a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2678113">US Burden of Cardiovascular Disease, 1990-2016</a>
<a href="https://jamanetwork.com/journals/jama/fullarticle/1760318">WMA Declaration of Helsinki, 7th Revision</a>
<h4 class="footer-subheading jn-ss-subheading-mt">Blogs</h4>
<a target="_blank" href="https://newsatjama.jama.com/">JAMA Forum</a>
<a target="_blank" href="https://blogs.jamanetwork.com/topics-in-ophthalmology/">Topics in Ophthalmology </a>
<a target="_blank" href="http://amastyleinsider.com/">AMA Style Insider</a>
</div>
</div>
</div>
</div>
<div id="footer-network-info" class="footer-network-info">
<div class="information-for-links">
<h4 id="BodyContent_Footer_InfoHeader" class="footer-subheading">Information For</h4>
<a href="https://jamanetwork.com/pages/for-authors">Authors</a>
<a href="https://jamanetwork.com/pages/institutions-and-librarians">Institutions &amp; Librarians</a>
<a href="https://jamanetwork.com/pages/advertisers">Advertisers</a>
<a href="https://jamanetwork.com/pages/subscription-agents">Subscription Agents</a>
<a href="https://careers.jamanetwork.com/" target="_blank">Employers &amp; Job Seekers</a>
<a href="https://media.jamanetwork.com/" rel="nofollow" target="_blank">Media</a>
</div>
<div class="services-links">
<h4 id="BodyContent_Footer_JAMANetworkProductsHeader" class="footer-subheading">JAMA Network Products</h4>
<a href="http://www.amamanualofstyle.com/" class="footer-service-link" target="_blank">AMA Manual of Style</a>
<a href="https://jamaevidence.mhmedical.com/" class="footer-service-link" target="_blank"><span class="jn-registered">JAMAevidence</span></a>
<a href="https://jamanetwork.com/pages/listen" class="footer-service-link" target="_blank"><span class="jn-trademark">JN Listen</span></a>
<a href="http://www.peerreviewcongress.org/" class="footer-service-link" target="_blank">Peer Review Congress</a>
</div>
<div class="learning-links">
<h4 id="BodyContent_Footer_LearningHeader" class="footer-subheading">JN Learning</h4>
<a href="https://edhub.ama-assn.org/jn-learning">CME Quizzes</a>
<a href="https://edhub.ama-assn.org/jn-learning/pages/about-cme">About CME &amp; MOC</a>
<a target="_blank" href="https://moc-reporting.jamanetwork.com/">MOC Reporting Preferences</a>
</div>
</div>
</div>
        </div>

        
        <div id="footer-resources-wrap" class="footer-resources-wrap">
            <style type="text/css">
    .footer-resources-wrap .footer-subheading {color: grey;display:block !important;font-size: 1.17647em;font-weight: 400;text-transform: uppercase;}
</style>
<div class="footer-heading-wrap">
<h3 class="footer-heading is-b footer-resources-heading" data-mobile-tog-target=".footer-resources">Help</h3>
</div>
<div class="footer-resources">
<a href="https://store.jamanetwork.com/" class="footer-service-link" target="_blank">Subscriptions &amp; Renewals</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-alerts" class="footer-service-link" rel="nofollow">Email Subscriptions</a>
<a href="https://jamanetwork.com/oauthsignin?return_url=http%3A%2F%2Fjamanetwork.com%2Fmyaccount%23my-profile" class="footer-service-link" rel="nofollow">Update Your Address</a>
<a href="https://sites.jamanetwork.com/help/" class="footer-service-link">Contact Us</a>
<a href="https://sites.jamanetwork.com/help/" class="footer-service-link">Frequently Asked Questions</a>
<h4 class="footer-subheading jn-ss-subheading-mt">JAMA Career Center</h4>
<a href="https://careers.jamanetwork.com/" class="footer-service-link" target="_blank">Physician Job Listings</a>
</div><div id="BodyContent_Footer_divSocial" class="social-links footer-social-links">
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.facebook.com/pages/JAMA-Journal-of-the-American-Medical-Association/87087958340" class="social-link is-b facebook"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://twitter.com/JAMA_current" class="social-link is-b twitter"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.linkedin.com/company/jama-network" class="social-link is-b linked-in"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.pinterest.com/thejamanetwork/" class="social-link is-b pinterest"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://www.youtube.com/user/JAMAJournalVideo" class="social-link is-b you-tube"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://jamanetwork.com/rss/site_3/67.xml" class="social-link is-b rss"></a>
<a target="_blank" rel="nofollow" data-emailid="6d35777a-fc12-4d2d-9b49-81d031835d91" href="https://jamaeditorsaudiosummary.libsyn.com/rss" class="social-link is-b podcast"></a>
</div><div id="BodyContent_Footer_divEmailUpdate" class="footer-email-updates">
                
                    <div class="widget-EmailListSignUp widget-instance-AMAv2_EmailListSignUp_Footer">
        <div class="email-signup">
    
    <div class="email-signup--text">Get the latest from JAMA</div>
    <div class="email-signup--input-wrap is-b">
        <input type="text" name="email" class="email-signup--input" placeholder="Email address" title="Email address">
    </div>
    <a rel="nofollow" class="email-signup--submit btn">Sign Up</a>
    <div class="email-signup--link"> <a class="email-signup--privacy" href="https://jamanetwork.com/pages/privacy-policy">Privacy Policy</a> | <a class="email-signup--terms" href="https://jamanetwork.com/pages/terms-of-use">Terms of Use</a></div>
    <div class="email-signup--user-message"></div>
</div> 
    </div>
</div>
        </div>

        
        <div class="footer-bar" itemscope="" itemtype="https://schema.org/Organization">
            <style type="text/css">
    .jn-bottom-bar {color: #fff; float: left;font-size: 10px;padding: 13px 20px;width: 33.33%;}
    .jn-bottom-bar p {line-height: 2;}
    @media (max-width: 900px) {.jn-bottom-bar {float: none;width: 100%;}}
    .jn-footer-copyright {font-size:12px;}
    .jn-footer-pipe {margin:0 10px;}
    .footer-bar-jn-logo img {width: 230px;}
    @media (max-width: 900px) {.footer-bar-jn-logo img {width: 200px;}}
    [data-thm=umb] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jama] .jobs-ad--text h6 {color: #d71635 !important;}
    [data-thm=jaman] .jobs-ad--text h6 {color: #ed0973 !important;}
    [data-thm=cardi] .jobs-ad--text h6 {color: #be1e32 !important;}
    [data-thm=derm] .jobs-ad--text h6 {color: #006f3b !important;}
    [data-thm=faci] .jobs-ad--text h6 {color: #ed1c24 !important;}
    [data-thm=intem] .jobs-ad--text h6 {color: #006e96 !important;}
    [data-thm=neur] .jobs-ad--text h6 {color: #981b1e !important;}
    [data-thm=oncol] .jobs-ad--text h6 {color: #3b923f !important;}
    [data-thm=ophth] .jobs-ad--text h6 {color: #66bc29 !important;}
    [data-thm=otol] .jobs-ad--text h6 {color: #34b6e4 !important;}
    [data-thm=peds] .jobs-ad--text h6 {color: #0084c0 !important;}
    [data-thm=psych] .jobs-ad--text h6 {color: #005276 !important;}
    [data-thm=surg] .jobs-ad--text h6 {color: #f47920 !important;}
</style>
<!-- This version of the code includes CSS changes to size the new logo -->
<a class="footer-bar-jn-logo d-b no-mw mb1" href="https://jamanetwork.com/" title="JAMA Network Home"><img class="mw-100" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jn-signature-reversed.svg" alt="Jama Network Logo"></a>
<div class="jn-bottom-bar">
<p>
<span class="jn-footer-copyright">© 2019 American Medical Association. All Rights Reserved.</span><br>
<a href="https://jamanetwork.com/pages/conditions-of-use" rel="nofollow" class="p0">Terms of Use</a><span class="jn-footer-pipe">|</span>
<a href="https://jamanetwork.com/pages/privacy-policy" rel="nofollow" class="p0">Privacy Policy</a><span class="jn-footer-pipe">|</span>
<a href="https://jamanetwork.com/pages/accessibility-statement" rel="nofollow" class="p0">Accessibility Statement</a>
</p>
</div>
<!--    .widget-instance-AMA_JobsAd {display:none;visibility:hidden;} -->
            <a class="footer-bar-sis no-mw relative nudge-down" href="https://www.silverchair.com/" target="_blank"><img class="footer-bar-sis-img mt05 mw-100" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/powered.png" alt="Silverchair Logo"></a>
        </div>
    </footer></div> 

<div class="hidden-jobs-ad hide">
        <div class="widget-JobsAd widget-instance-AMA_JobsAd">
            <div class="jobs-ad">

        <div class="jobs-ad--text">
            <h6 class="tt-u black">JOB LISTINGS ON JAMA CAREER CENTER®</h6>
                <div class="jobs-ad-wrapper thm-col-sec">
                    <a href="https://careers.jamanetwork.com/job/110132585/director-palliative-care/?TrackID=66" target="_blank">
                        <span class="jobs-ad-title">Director, Palliative Care</span>
                        <span class="jobs-ad-location">New York City, New York</span>
                    </a>
                </div>
                <div class="jobs-ad-wrapper thm-col-sec">
                    <a href="https://careers.jamanetwork.com/job/110129412/greater-boston-associate-medical-director-department-of-performance-excellence/?TrackID=66" target="_blank">
                        <span class="jobs-ad-title">Greater Boston – Associate Medical Director - Department of Performance Excellence</span>
                        <span class="jobs-ad-location">Boston, Massachusetts</span>
                    </a>
                </div>
                <div class="jobs-ad-wrapper thm-col-sec">
                    <a href="https://careers.jamanetwork.com/job/110120935/internists-family-practitioners-and-pediatricians/?TrackID=66" target="_blank">
                        <span class="jobs-ad-title">Internists, Family Practitioners and Pediatricians</span>
                        <span class="jobs-ad-location">New York</span>
                    </a>
                </div>
                <div class="jobs-ad-wrapper thm-col-sec">
                    <a href="https://careers.jamanetwork.com/job/110132538/staff-physician-part-time-/?TrackID=66" target="_blank">
                        <span class="jobs-ad-title">Staff Physician (Part-time)</span>
                        <span class="jobs-ad-location">Cleveland, Ohio</span>
                    </a>
                </div>
                <div class="jobs-ad-wrapper thm-col-sec">
                    <a href="https://careers.jamanetwork.com/job/110132245/division-director-neonatology/?TrackID=66" target="_blank">
                        <span class="jobs-ad-title">Division Director, Neonatology</span>
                        <span class="jobs-ad-location">Kansas City, Missouri</span>
                    </a>
                </div>
            <a href="https://careers.jamanetwork.com/" target="_blank" class="jobs-ad-see-more"> See more at JAMA Career Center </a>

        </div>

    </div>

 
    </div>


</div>

            <script>
                var App = App || {};
                App.ArticleSplitScreen = App.ArticleSplitScreen || {};
                App.ArticleSplitScreen.siteName = 'jama';
                App.ArticleSplitScreen.siteId = 3;
                App.ArticleSplitScreen.journalId = 67;
                App.ArticleSplitScreen.adDisplay = 'ArticleContentsSkyBox';
                App.ArticleSplitScreen.adSection = "scholarly";
                App.ArticleSplitScreen.adPosition = "contab";
                App.ArticleSplitScreen.controlId = "AMA_AdTag_Contents_Skybox";
                App.ArticleSplitScreen.fromGoogle = "True";
                App.ArticleSplitScreen.slotLocationOverride = "50";


            </script> 
    </div>


 
    </div>

    
    <div class="social-share hide" data-share-title="Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat"></div>

    </section>


    <section id="secFooterControl" class="master-footer">
        

        <script>
            var App = App || {};

            function scmByClass(className) {
                return document.getElementsByClassName(className);
            }

            function scmById(id) {
                return document.getElementById(id);
            }

            function scmquery(selector) {
                return document.querySelector(selector);
            }

            function queryAll(selector) {
                return document.querySelectorAll(selector);
            }

            function isTrueString(string) {
                if (typeof string === 'string') {
                    return string.toLowerCase() === 'true';
                }

                return undefined;
            }

            function updateViewportDimensions() {
                var w = window, d = document, e = d.documentElement, g = d.getElementsByTagName('body')[0], x = w.innerWidth || e.clientWidth || g.clientWidth, y = w.innerHeight || e.clientHeight || g.clientHeight;
                return { width: x, height: y };
            }

            var viewport = updateViewportDimensions();

            var debounce = function (func, wait, immediate) {
                var timeout;
                return function () {
                    var context = this, args = arguments;
                    var later = function () {
                        timeout = null;
                        if (!immediate) func.apply(context, args);
                    };
                    var callNow = immediate && !timeout;
                    clearTimeout(timeout);
                    timeout = setTimeout(later, wait);
                    if (callNow) func.apply(context, args);
                };
            };

            (function (App) {
                App.mobileUpperBreakpoint = 767;
                App.mobileAltBreakpoint = 640;
                App.tabletUpperBreakpoint = 1023;

                function setVariables() {
                    viewport = updateViewportDimensions();
                    App.isMobile = (viewport.width <= App.mobileUpperBreakpoint);
                    App.isMobileAlt = (viewport.width <= App.mobileAltBreakpoint);
                    App.isTablet = (viewport.width > App.mobileUpperBreakpoint && viewport.width <= App.tabletUpperBreakpoint);
                    App.isTabletDown = (viewport.width <= App.tabletUpperBreakpoint);
                    App.isDesktop = (viewport.width > App.tabletUpperBreakpoint);
                    App.activeViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                }

                setVariables();

                App.cachedViewport = App.isMobile ? 'small' : App.isTablet ? 'med' : 'large';
                App.isAnyArticle = !!(scmByClass('widget-ArticleFullView').length || scmByClass('pg_abstract').length || scmByClass('widget-MagazineView').length);
                App.isSplitScreen = !!scmByClass('widget-ArticleFullView').length;
                App.isAbstract = !!scmByClass('pg_abstract').length;
                App.isMag = !!scmByClass('widget-MagazineView').length;
                App.isFreeArticle = !!(scmquery('.widget-ArticleTopInfo .free-access') ||
                                        scmquery('.widget-ArticleTopInfo .open-access') ||
                                        scmquery('.widget-ArticleTopInfo .icon-free'));
                App.isTollFreeAccess = false;
                App.isIssue = !!scmByClass('pg_issue').length || !!scmByClass('pg_newonline').length || !!scmByClass('pg_currentissue').length || !!scmByClass('pg_pastissues').length;
                App.isNewOnline = !!scmByClass('pg_newonline').length;
                App.isCurrentIssue = !!scmByClass('pg_currentissue').length;
                App.isPastIssues = !!scmByClass('pg_pastissues').length;
                App.isJournal = !!scmByClass('pg_journal').length;
                App.isNetworkHome = !!scmByClass('pg_index').length;
                App.isSearch = !!scmByClass('pg_searchresults').length;
                App.isAdvancedSearch = !!scmByClass('pg_advancedsearch').length;
                App.isPlayer= !!scmByClass('pg_multimediaplayer').length;
                App.isSelfServe = !!scmByClass('pg_sspage').length;
                App.isMyAccount = !!scmByClass('pg_myaccount').length;
                App.isLearning = !!scmByClass('pg_learning').length;
                App.isLearningContent = !!scmByClass('pg_learning').length || !!scmByClass('pg_learningsearchresults').length || !!scmByClass('pg_quiz').length || !!scmByClass('pg_multimediaplayer').length || !!scmByClass('pg_journalarticlecme').length;
                App.isLearningSelfServe = window.location.pathname.indexOf("/learning/pages/") >= 0;
                App.isLearningSearchResults = !!scmByClass('pg_learningsearchresults').length;
                App.isQuiz = !!scmByClass('pg_quiz').length;
                App.supportsFlexbox = !!scmByClass('flexbox').length;
                App.isCollection = !!scmByClass('pg_collection').length;
                App.isJournalArticleCme = !!scmByClass('pg_journalarticlecme').length;
                App.isPaidUser = isTrueString(scmById('hfAppIsPaidUser').getAttribute('value'));
                App.isMember = isTrueString(scmById('hfAppIsMember').getAttribute('value'));
                App.isIndividual = isTrueString(scmById('hfAppIsIndividual').getAttribute('value'));
                App.hasAccess = isTrueString(scmById('hfAppHasAccess').getAttribute('value'));
                App.isReferredFromGoogle = isTrueString(scmById('hfAppIsReferredFromGoogle').getAttribute('value'));
                var subscribedTo = scmById('hfAppSubscribedTo').getAttribute('value');
                App.userSubscribedTo = subscribedTo ? subscribedTo.split(',') : undefined;
                App.isLucy = isTrueString(scmById('hfAppIsLucy').getAttribute('value'));
                App.currentJournalCount = 14;

                App.updateAppVariables = debounce(function () {
                    setVariables();
                }, 50, false);
            })(App);
        </script>
        

        <div id="BodyContent_Footer_divAds" class="footer-ad desktop-only">
    
        
</div>


<div class="ad-riser-wrap desktop-only">
    <div class="ad-riser--dismiss t-c">X</div>
        

</div>

<div class="footer-wrap">
    

</div>
<div class="ss-ui-only">
        <div class="widget-SelfServeContent widget-instance-AMA_SS_UI_Only">
        <div class="self-serve">.</div> 
    </div>

</div>

    </section>


        

        
        
        <div id="revealModal" class="reveal-modal" data-reveal="">
            <div id="revealContent"></div>
            <a class="close-reveal-modal icon-close"></a>
        </div>


        
        <div class="artmet-modal" id="MetricsModal">
            <div class="artmet-modal-contents">
                <a class="artmet-close-modal">×</a>
            </div>
        </div>



        
        <div id="no-access-reveal" class="no-access reveal-modal login-modal medium modal" data-reveal="">
            
            <div id="accessSignIn_SignInOptionsModal" class="modal--options">
    <h4 class="signin-hed"><span id="accessSignIn_spnSignInHeader">Sign in to access your subscriptions</span></h4>

	<div class="modal--option">
	    
	    <div id="accessSignIn_divIndSignIn" class="sign-in--personal">
		<a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="accessSignIn_oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	    </div>
	    
	    <div id="accessSignIn_divInstSignIn" class="sign-in--inst">
		Institutional sign in: <a id="accessSignIn_openAthensSignIn_lnkAuthensLogin" class="auth--athens" rel="nofollow" href="https://jamanetwork.com/PageRedirectHandler.ashx?returnurl=https://jamanetwork.com/journals/jama/fullarticle/188381&amp;redirectpage=openathens">OpenAthens</a> | <a rel="nofollow" class="sign-in--shib" href="https://jamanetwork.com/signinshibboleth">Shibboleth</a>
	    </div>
	</div>
	<div id="accessSignIn_divIndSignUp" class="modal--option">
	    <div class="sign-in--create">
		    <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="accessSignIn_oauthSignUpLink" rel="nofollow" class="sign-in--create-link">Create a free personal account</a> <span id="accessSignIn_spnDownloadMessage">to download free article PDFs,
		    sign up for alerts, and more</span>
	    </div>
    </div>

</div>

            <div class="modal--box purchase-access">
                <h4>Purchase access</h4>
                <div class="modal--option"><a id="journalLinkToSubscribe" href="https://jamanetwork.com/journals/jama/article-abstract/188381#">Subscribe</a> to the journal</div>
                <div class="modal--option"><a id="articleLinkToPurchase" href="https://jamanetwork.com/journals/jama/article-abstract/188381#" data-storeurl="https://store.jamanetwork.com">Buy</a> this article</div>
                <div id="modal_rent_this_article" class="modal--option"><a id="rentThisArticleLink" href="https://jamanetwork.com/journals/jama/article-abstract/188381#">Rent</a> this article</div>
            </div>
            <a class="close-reveal-modal icon-close"></a>
        </div>
        


        
        <div id="no-access-reveal-learning" class="no-access reveal-modal login-modal medium modal" data-reveal="">
            
            <div class="modal--options">
                <div class="modal--option modal--box">
                        <div class="widget-SelfServeContent widget-instance-Paid_Pdf_Signin_Modal_BottomLeft">
        <div class="self-serve"><link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jn-selfserve-modals.css">
<div class="modal--option">
<div class="sign-in--option">
<div class="option--personal">
Get free access to newly published articles.</div>
<div class="option--personal">
<a href="https://jamanetwork.com/oauthsignin?return_url=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Farticle-abstract%2F188381" rel="nofollow" class="js-create-link">Create a personal account</a> to register for email alerts with links to free full-text articles.
</div>
</div>
</div>
<!--<div class="jn-selfServe-modal-label">JAMA|Paid_Pdf_Signin_Modal_BottomLeft</div>--></div> 
    </div>

                </div>
            </div>
            <div class="modal--box purchase-access">
                <h4>Purchase access</h4>
                <div class="modal--option"><a id="linkSubscribeLearning" href="https://store.jamanetwork.com/productDetails.aspx?productcodeId=194" target="_blank">Subscribe</a> to JN Learning for one year</div>
                <div id="divPuchaseActivity" class="modal--option"><a id="linkPurchaseActivity" target="_blank">Buy</a> this activity</div>
            </div>
            <a class="close-reveal-modal icon-close"></a>
        </div>
        


        
        <div id="register-free-pdf-reveal" class="reveal-modal modal register-free-pdf medium" data-reveal="">
            <h4 class="modal--title">Sign in to download free article PDFs</h4>
            <div id="freePdfSignIn_SignInOptionsModal" class="modal--options">
    <h4 class="signin-hed"><span id="freePdfSignIn_spnSignInHeader">Sign in to access your subscriptions</span></h4>

	<div class="modal--option">
	    
	    <div id="freePdfSignIn_divIndSignIn" class="sign-in--personal">
		<a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381&amp;alert=article" id="freePdfSignIn_oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	    </div>
	    
	    <div id="freePdfSignIn_divInstSignIn" class="sign-in--inst">
		Institutional sign in: <a id="freePdfSignIn_openAthensSignIn_lnkAuthensLogin" class="auth--athens" rel="nofollow" href="https://jamanetwork.com/PageRedirectHandler.ashx?returnurl=https://jamanetwork.com/journals/jama/fullarticle/188381&amp;redirectpage=openathens">OpenAthens</a> | <a rel="nofollow" class="sign-in--shib" href="https://jamanetwork.com/signinshibboleth">Shibboleth</a>
	    </div>
	</div>
	<div id="freePdfSignIn_divIndSignUp" class="modal--option">
	    <div class="sign-in--create">
		    <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381&amp;alert=article" id="freePdfSignIn_oauthSignUpLink" rel="nofollow" class="sign-in--create-link">Create a free personal account</a> <span id="freePdfSignIn_spnDownloadMessage">to download free article PDFs,
		    sign up for alerts, and more</span>
	    </div>
    </div>

</div>

            <div>
                    <div class="widget-SelfServeContent widget-instance-Free_Pdf_Signin_Modal_Right">
        <div class="self-serve"><link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jn-selfserve-modals.css">
<div class="modal--box">
<h5 class="modal--subtitle">Get free access to newly published articles</h5>
<p class="modal--no-margin">Create a personal account or sign in to:</p>
<ul>
    <li>Register for email alerts with links to free full-text articles</li>
    <li>Access PDFs of free articles</li>
    <li>Manage your interests</li>
    <li>Save searches and receive search alerts</li>
</ul>
<!-- <div>Follow us on social media for full-text access through posts and tweets. </div> -->
<!--<div class="jn-selfServe-modal-label">JAMA|Free_Pdf_Signin_Modal_Right</div>-->
</div></div> 
    </div>

            </div>

            <a class="close-reveal-modal icon-close"></a>
        </div>

        
         
            <div id="login-paid-pdf-reveal" class="reveal-modal modal login-paid-pdf no-access medium" data-reveal="">
                <div class="modal--options">
                    <h4 class="signin-hed"><span id="spnSignInHeader">Sign in to access your subscriptions</span></h4>

	                <div class="modal--option">
	                    
                        <div id="divIndSignIn" class="sign-in--personal">
		                        <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	                        </div>
                        <div id="divInstSignIn" class="sign-in--inst">
		                        Institutional sign in: <a id="openAthensSignIn_lnkAuthensLogin" class="auth--athens" rel="nofollow" href="https://jamanetwork.com/PageRedirectHandler.ashx?returnurl=https://jamanetwork.com/journals/jama/fullarticle/188381&amp;redirectpage=openathens">OpenAthens</a> | <a rel="nofollow" class="sign-in--shib" href="https://jamanetwork.com/signinshibboleth">Shibboleth</a>
	                        </div>
                        
	                </div>
                    <div>
                            <div class="widget-SelfServeContent widget-instance-Paid_Pdf_Signin_Modal_BottomLeft">
        <div class="self-serve"><link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jn-selfserve-modals.css">
<div class="modal--option">
<div class="sign-in--option">
<div class="option--personal">
Get free access to newly published articles.</div>
<div class="option--personal">
<a href="https://jamanetwork.com/oauthsignin?return_url=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Farticle-abstract%2F188381" rel="nofollow" class="js-create-link">Create a personal account</a> to register for email alerts with links to free full-text articles.
</div>
</div>
</div>
<!--<div class="jn-selfServe-modal-label">JAMA|Paid_Pdf_Signin_Modal_BottomLeft</div>--></div> 
    </div>


                    </div>
                </div>

                <div class="modal--box purchase-access">
                    <h4>Purchase access</h4>
                    <div class="modal--option"><a id="journalLinkToSubscribe" href="https://jamanetwork.com/journals/jama/article-abstract/188381#">Subscribe</a> to the journal</div>
                    <div class="modal--option"><a id="articleLinkToPurchase" href="https://jamanetwork.com/journals/jama/article-abstract/188381#" data-storeurl="https://store.jamanetwork.com">Buy</a> this article</div>
                    <div id="modal_rent_this_article_purchase_access" class="modal--option"><a id="rentThisArticleLink" href="https://jamanetwork.com/journals/jama/article-abstract/188381#">Rent</a> this article</div>
                </div>

                <a class="close-reveal-modal icon-close"></a>
            </div>
        
    

        
        
        
        <div id="no-access-reveal-saved-searches" class="no-access reveal-modal login-modal medium modal" data-reveal="">
            <div id="SignInOptions_SavedSearches_SignInOptionsModal" class="modal--options">
    <h4 class="signin-hed"><span id="SignInOptions_SavedSearches_spnSignInHeader">Sign in to save your search</span></h4>

	<div class="modal--option">
	    
	    <div id="SignInOptions_SavedSearches_divIndSignIn" class="sign-in--personal">
		<a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="SignInOptions_SavedSearches_oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	    </div>
	    
	    
	</div>
	<div id="SignInOptions_SavedSearches_divIndSignUp" class="modal--option">
	    <div class="sign-in--create">
		    <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="SignInOptions_SavedSearches_oauthSignUpLink" rel="nofollow" class="sign-in--create-link">Create a free personal account</a> <span id="SignInOptions_SavedSearches_spnDownloadMessage">to access your subscriptions, sign up for alerts, and more</span>
	    </div>
    </div>

</div>
            
            <div class="modal--box purchase-access">
                <h4>Purchase access</h4>
                <div class="modal--option"><a id="linkToStore" href="https://store.jamanetwork.com/">Subscribe</a> now</div>
            </div>
            <a class="close-reveal-modal icon-close"></a>
        </div>
        <div id="no-access-reveal-saved-searches-learning" class="no-access reveal-modal login-modal medium modal" data-reveal="">
            <div id="SignInOptions_LearningSavedSearches_SignInOptionsModal" class="modal--options">
    <h4 class="signin-hed"><span id="SignInOptions_LearningSavedSearches_spnSignInHeader">Sign in to save your search</span></h4>

	<div class="modal--option">
	    
	    <div id="SignInOptions_LearningSavedSearches_divIndSignIn" class="sign-in--personal">
		<a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="SignInOptions_LearningSavedSearches_oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	    </div>
	    
	    
	</div>
	<div id="SignInOptions_LearningSavedSearches_divIndSignUp" class="modal--option">
	    <div class="sign-in--create">
		    <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="SignInOptions_LearningSavedSearches_oauthSignUpLink" rel="nofollow" class="sign-in--create-link">Create a free personal account</a> <span id="SignInOptions_LearningSavedSearches_spnDownloadMessage">to access your subscriptions, sign up for alerts, and more</span>
	    </div>
    </div>

</div>
            
            <div class="modal--box purchase-access">
                <h4>Purchase access</h4>
                <div class="modal--option"><a id="linkToStore" href="https://store.jamanetwork.com/productDetails.aspx?productcodeId=194">Subscribe</a> to JN Learning for one year</div>
            </div>
            <a class="close-reveal-modal icon-close"></a>
        </div>
        <div id="no-access-follow-collection" class="no-access reveal-modal login-modal medium modal" data-reveal="">
            <div id="FollowCollectionSignIn_SignInOptionsModal" class="modal--options">
    <h4 class="signin-hed"><span id="FollowCollectionSignIn_spnSignInHeader">Sign in to customize your interests</span></h4>

	<div class="modal--option">
	    
	    <div id="FollowCollectionSignIn_divIndSignIn" class="sign-in--personal">
		<a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="FollowCollectionSignIn_oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	    </div>
	    
	    
	</div>
	<div id="FollowCollectionSignIn_divIndSignUp" class="modal--option">
	    <div class="sign-in--create">
		    <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="FollowCollectionSignIn_oauthSignUpLink" rel="nofollow" class="sign-in--create-link">Create a free personal account</a> <span id="FollowCollectionSignIn_spnDownloadMessage">to download free article PDFs, sign up for alerts, customize your interests, and more</span>
	    </div>
    </div>

</div>
            <div class="modal--box purchase access">
                    <div class="widget-SelfServeContent widget-instance-AMAv2_PurchaseOptions">
        <div class="self-serve"><link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jn-selfserve-modals.css">
<h5 class="modal--subtitle">Get free access to newly published articles</h5>
<p class="modal--no-margin">Create a personal account or sign in to:</p>
<ul>
    <li>Register for email alerts with links to free full-text articles</li>
    <li>Access PDFs of free articles</li>
    <li>Manage your interests</li>
    <li>Save searches and receive search alerts</li>
</ul>
<!-- <div>Follow us on social media for full-text access through posts and tweets. </div> -->
<!--
<div class="jn-selfServe-modal-label">JAMA|ModalPurchaseOptionsvV2</div>
--></div> 
    </div>

                <div class="no-access-follow-collection--alerts">
                    <div class="no-access-follow-collection--alerts-content">
                        <div class="privacy-policy"><a href="https://jamanetwork.com/pages/privacy-policy" rel="nofollow">Privacy Policy</a></div>
                    </div>
                </div>
            </div>
            <a class="close-reveal-modal icon-close"></a>
        </div>
        <div id="no-access-user-comments" class="no-access reveal-modal login-modal medium modal" data-reveal="">
            
            <div id="UserCommentsSignIn_SignInOptionsModal" class="modal--options">
    <h4 class="signin-hed"><span id="UserCommentsSignIn_spnSignInHeader">Sign in to make a comment</span></h4>

	<div class="modal--option">
	    
	    <div id="UserCommentsSignIn_divIndSignIn" class="sign-in--personal">
		<a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="UserCommentsSignIn_oauthSignInLink" rel="nofollow" class="sign-in--personal-link">Sign in</a> to your personal account    
	    </div>
	    
	    
	</div>
	<div id="UserCommentsSignIn_divIndSignUp" class="modal--option">
	    <div class="sign-in--create">
		    <a href="https://jamanetwork.com/oauthsignin?return_url=https%3a%2f%2fjamanetwork.com%2fjournals%2fjama%2ffullarticle%2f188381" id="UserCommentsSignIn_oauthSignUpLink" rel="nofollow" class="sign-in--create-link">Create a free personal account</a> <span id="UserCommentsSignIn_spnDownloadMessage">to make a comment, download free article PDFs, sign up for alerts and more</span>
	    </div>
    </div>

</div>

            <div class="modal--box purchase-access">
                    <div class="widget-SelfServeContent widget-instance-AMAv2_PurchaseOptions">
        <div class="self-serve"><link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jn-selfserve-modals.css">
<h5 class="modal--subtitle">Get free access to newly published articles</h5>
<p class="modal--no-margin">Create a personal account or sign in to:</p>
<ul>
    <li>Register for email alerts with links to free full-text articles</li>
    <li>Access PDFs of free articles</li>
    <li>Manage your interests</li>
    <li>Save searches and receive search alerts</li>
</ul>
<!-- <div>Follow us on social media for full-text access through posts and tweets. </div> -->
<!--
<div class="jn-selfServe-modal-label">JAMA|ModalPurchaseOptionsvV2</div>
--></div> 
    </div>

                <div class="no-access--alerts">
                    <div class="no-access-user-comments--alerts-content">
                        <div class="privacy-policy"><a href="https://jamanetwork.com/pages/privacy-policy" rel="nofollow">Privacy Policy</a></div>
                    </div>
                </div>
            </div>
            <a class="close-reveal-modal icon-close"></a>
        </div>
        



        
        <script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/jquery-2.2.4.min.js.download"></script>
        <script>window.jQuery || document.write('<script src="/UI/app/vendor/jquery-2.2.4.min.js">\x3C/script>')</script>

        <script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/app.min.js.download"></script>
        
    
    
    <script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/chartist.min.js.download" type="text/javascript"></script>

    
    <script src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/embed.js.download" type="text/javascript"></script>

    
    <script type="text/javascript" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/addthis_widget.js.download"></script>

    
    <script defer="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/trendmd.min.js.download" data-trendmdconfig="{&quot;element&quot;:&quot;#trendmd-suggestions&quot;}"></script>

    <script>
        var App = App || {};
        App.showCmePromo = false;
    </script>


    </form><iframe src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/a591102174.html" hidden="" aria-hidden="true" tabindex="-1" height="0" width="0" style="display: none;"></iframe><script type="text/javascript" id="">"undefined"===typeof window.oldonscroll&&(window._gaScrollMilestones={"25%":!1,"50%":!1,"75%":!1,"90%":!1},window._gaResetScrollMilestones=function(){for(var b in window._gaScrollMilestones)window._gaScrollMilestones[b]=!1},window.oldonscroll=window.onscroll||function(){},window.onscroll=function(b){try{var c=Math.max(document.body.scrollHeight,document.body.offsetHeight,document.documentElement.clientHeight,document.documentElement.scrollHeight,document.documentElement.offsetHeight),d=window.scrollY||
window.pageYOffset||document.documentElement.scrollTop,e=window.innerHeight||-1,f=Math.round(d/(c-e)*100),a;for(a in window._gaScrollMilestones)if(!window._gaScrollMilestones[a]){var g=parseInt(a);f>=g&&(window._gaScrollMilestones[a]=!0,"undefined"!==typeof window.dataLayer&&window.dataLayer.push({event:"scroll milestone",scrollMilestone:a}))}}catch(h){}return window.oldonscroll(b)});</script><script type="text/javascript" id="">var DATALAYER_OBJECT_NAME="dataLayer",referrerOverride=function(d){var c=window[DATALAYER_OBJECT_NAME]||[];c.push({event:"optimizely-referrer-override","optimizely-referrer":d})},sendCampaignData=function(d,c,h,g,f,k,b,a,e){if(g=optimizely.get("data")&&optimizely.get("data").campaigns[c]&&optimizely.get("data").campaigns[c].integrationSettings&&optimizely.get("data").campaigns[c].integrationSettings.google_universal_analytics&&optimizely.get("data").campaigns[c].integrationSettings.google_universal_analytics.universal_analytics_slot)d=
d?d+"("+c+")":c,h=h.join(","),f=f?f+"("+k+")":h+"("+k+")",b=b?b+"("+a+")":a,e=e?"holdback":"treatment",e=[d,f,b,e].join(":"),b=window[DATALAYER_OBJECT_NAME]||[],b.push({event:"campaign-decided","optimizely-dimension-value":e,"optimizely-dimension-number":g})},initNewOptimizelyIntegration=function(d,c){var h=!1,g=function(b){var a=window.optimizely.get&&window.optimizely.get("state"),e=a.getRedirectInfo()&&a.getRedirectInfo().referrer;!h&&e&&(d(e),h=!0);a=a.getCampaignStates({isActive:!0});a=a[b];
e=a.campaignName;if(0<a.audiences.length){var f=a.audiences.map(function(a){return a.name});var g=a.audiences.map(function(a){return a.id})}else f=["everyone_else"],g=[0];var k=a.experiment.name,l=a.experiment.id,m=a.variation.name,n=a.variation.id;c(e,b,f,g,k,l,m,n,a.isInCampaignHoldback)},f=function(){window.optimizely=window.optimizely||[];window.optimizely.push({type:"addListener",filter:{type:"lifecycle",name:"campaignDecided"},handler:function(b){b=b.data.campaign.id;g(b)}})},k=function(){var b=
window.optimizely.get&&window.optimizely.get("state");if(b){b=b.getCampaignStates({isActive:!0});for(var a in b)g(a)}};k();f()},initOptimizelyIntegration=function(d,c){initNewOptimizelyIntegration(d,c)};initOptimizelyIntegration(referrerOverride,sendCampaignData);</script><script type="text/javascript" id="" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/init-3133s13tyvo448eled2.js.download"></script><div id="_atssh" style="visibility: hidden; height: 1px; width: 1px; position: absolute; top: -9999px; z-index: 100000;"><iframe id="_atssh865" title="AddThis utility frame" style="height: 1px; width: 1px; position: absolute; top: 0px; z-index: 100000; border: 0px; left: 0px;" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/sh.e4e8af4de595fdb10ec1459d.html"></iframe></div><style id="service-icons-0"></style>
    
        <div class="widget-GdprCookieBanner widget-instance-GdprCookieBanner">
        <div class="gdpr-cookie-wrapper">
	<div class="gdpr-cookie-body">
        Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our <a href="https://jamanetwork.com/pages/privacy-policy#cookies">cookie policy</a>&nbsp;<span class="pipe">|</span>&nbsp;<a href="javascript:;" class="js-gdpr-cookie-acceptLink">Continue</a>
	</div>
            <input id="hdnDomain" type="hidden" value=".jamanetwork.com">

    <input id="hdnDomainGdpr" type="hidden" value=".jamanetwork.com">
    <input id="hdnClientIdGdpr" type="hidden" value="3">

</div> 
    </div>

     
    <link rel="stylesheet" href="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/_trendMD.css">



<div style="position: absolute; margin: 0px; padding: 0px; border: 0px; height: 0px; width: 0px; overflow: hidden;"><a aria-hidden="true"></a><button aria-hidden="true"></button><input aria-hidden="true"></div><script type="text/javascript" id="">var xdClientId=google_tag_manager["GTM-WNKSNP"].macro(62)("_xdClientId");
window._xdCookieCheck=setInterval(function(d){return function(){if("function"===typeof window.ga.getAll){a:{var b=window.ga.getAll()||[];for(var a=0,c=b.length;a<c;a++){var e=b[a];if("_ga"===e.get("cookieName")){b=e.get("clientId");break a}}b=""}a=google_tag_manager["GTM-WNKSNP"].macro(63)("gaTAMId");c=google_tag_manager["GTM-WNKSNP"].macro(64)("gaPrevTAMId");c=""!==a&&"Unknown"!==a&&a!==c;""===d||d!==b||c?window.dataLayer.push({event:"create cross domain frame",jamaClientId:b,jamaTAMId:c?a:""}):window.dataLayer.push({event:"clientIdSet"});
google_tag_manager["GTM-WNKSNP"].macro(66)("_xdClientId",b);google_tag_manager["GTM-WNKSNP"].macro(68)("gaPrevTAMId",a);clearInterval(window._xdCookieCheck)}}}(xdClientId),100);</script><script type="text/javascript" id="">window.receiveMessage=function(b){try{if("https://newsletter.ama-assn.org"===b.origin){var a=b.data;if("object"===typeof a&&null!==a){var f=a.state||"",d=a.clientId||"",e=a.userId||"";"ready"===f&&(""!==e&&google_tag_manager["GTM-WNKSNP"].macro(79)("_gaCorpUserId",e,730),""!==d&&(window.ga("create","UA-XXXXX-Y",{cookieDomain:"jamanetwork.com",cookieName:"_gaCorp",clientId:d,name:"setCorpClientId"}),window.dataLayer.push({event:"clientIdSet",clientId:d}),window.jamaSetClientIdInterval=setInterval(function(a){return function(){if("function"===
typeof window.ga.getAll){a:{var c=window.ga.getAll()||[];for(var b=0,d=c.length;b<d;b++){var e=c[b];if("_ga"===e.get("cookieName")){c=e.get("clientId");break a}}c=""}""!==c&&(a.source.postMessage({command:"setAMAClientId",clientId:c,cookieName:"_gaJama"},a.origin),clearInterval(window.jamaSetClientIdInterval))}}}(b),1E3)),a=google_tag_manager["GTM-WNKSNP"].macro(80),"string"===typeof a&&""!==a&&"Unknown"!==a&&b.source.postMessage({command:"setAMACookie",cookieName:"gaJAMATAMID",cookieValue:a,daysToExpire:3650},b.origin))}}}catch(g){}};
window.addEventListener("message",window.receiveMessage,!1);var protocol=window.location.protocol,domain=document.domain,origin=encodeURIComponent(protocol+"//"+domain);window.xDomainIframe=document.createElement("iframe");xDomainIframe.height=xDomainIframe.width=0;xDomainIframe.style.display="none";xDomainIframe.src="https://newsletter.ama-assn.org/docs/crossdomain.html?origin\x3d"+origin;document.body.appendChild(xDomainIframe);</script><iframe width="0" height="0" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/crossdomain.html" style="display: none;"></iframe><iframe style="display:none!important" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/portal-lite.html"></iframe><script type="text/javascript" id="">for(var audios=document.getElementsByTagName("AUDIO"),i=0,numAudios=audios.length;i<numAudios;i++){var currentAudio=audios[i],src=currentAudio.src,srcParts=(src||"").match(/.*\/([^\/]*\/[^\?]*)($|\?.*)/),fileName=null!==srcParts?srcParts[1]:"";currentAudio._gaFileName=fileName;currentAudio._gaMilestones={25:!1,50:!1,75:!1,95:!1};currentAudio.addEventListener("play",function(){this._gaTrackedPlay||(dataLayer.push({event:"audio interaction",audioTitle:this._gaFileName,audioProgress:"Play",nonInteractive:!1}),
this._gaTrackedPlay=!0)});currentAudio.addEventListener("ended",function(){this._gaTrackedPlay&&(dataLayer.push({event:"audio interaction",audioTitle:this._gaFileName,audioProgress:"Complete",nonInteractive:!1}),this._gaTrackedPlay=!1,this._gaMilestones={25:!1,50:!1,75:!1,95:!1})});currentAudio.addEventListener("timeupdate",function(){for(var a in this._gaMilestones)!this._gaMilestones[a]&&this.currentTime/this.duration*100>parseInt(a)&&(dataLayer.push({event:"audio interaction",audioTitle:this._gaFileName,
audioProgress:a+"%",nonInteractive:!1}),this._gaMilestones[a]=!0)});-1<(google_tag_manager["GTM-WNKSNP"].macro(108)||"").toLowerCase().indexOf("/audio-player/")&&(dataLayer.push({event:"audio interaction",audioTitle:fileName,audioProgress:"Play",nonInteractive:!0}),currentAudio._gaTrackedPlay=!0)};</script><script type="text/javascript" id="">for(var videos=document.getElementsByTagName("VIDEO"),i=0,numVideos=videos.length;i<numVideos;i++){var currentVideo=videos[i];currentVideo._gaVideoName=function(a){return"function"===typeof jQuery&&(a=$($(a).closest("div.multimedia-item")).find("div.multimedia-title").text())?a:"n/a"}(currentVideo);currentVideo.addEventListener("play",function(){this._gaPlayed||(this._gaPlayed=!0,dataLayer.push({event:"video play",videoName:this._gaVideoName}))})};</script><script type="text/javascript" id="">window.isElementInViewport=function(a){"function"===typeof jQuery&&a instanceof jQuery&&(a=a[0]);a=null!==a?a.getBoundingClientRect():{top:-1};return 0<=a.top&&0<=a.left&&a.bottom<=(window.innerHeight||document.documentElement.clientHeight)&&a.right<=(window.innerWidth||document.documentElement.clientWidth)};
window.testVisibility=function(a){var b=!1;return function(){try{!b&&window.isElementInViewport(a)&&(b=!0,dataLayer.push({event:"ad impression",pageSection:a.attr("id"),adId:a.find("iframe[id^\x3d'google_ads_iframe']").attr("id")||"no id found"}))}catch(c){}}};if("function"===typeof jQuery)for(var ads=jQuery(".advertisement"),handlers=[],i=0,numAds=ads.length;i<numAds;i++){var handler=window.testVisibility(jQuery(ads[i]));handlers.push(handler);jQuery(window).on("resize scroll",handler)}i=0;
for(var numHandlers=handlers.length;i<numHandlers;i++)handlers[i]();</script><div id="fb-root" class=" fb_reset"><div style="position: absolute; top: -10000px; width: 0px; height: 0px;"><div></div><div><iframe name="fb_xdm_frame_https" frameborder="0" allowtransparency="true" allowfullscreen="true" scrolling="no" allow="encrypted-media" id="fb_xdm_frame_https" aria-hidden="true" title="Facebook Cross Domain Communication Frame" tabindex="-1" src="./Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat_ A Randomized Controlled Trial. _ Cardiology _ JAMA _ JAMA Network_files/d_vbiawPdxB.html" style="border: none;"></iframe></div></div></div></body><span class="gr__tooltip"><span class="gr__tooltip-content"></span><i class="gr__tooltip-logo"></i><span class="gr__triangle"></span></span></html>